What Schools Are Affiliated With Eugene Braunwald

Eugene Braunwald is affiliated with the following schools: Georgetown University, University of Adelaide, University of Oulu, University of Texas Southwestern Medical Center, University of Cambridge, University of Pennsylvania, Harvard University, University of Vermont, George Washington University, Uppsala University, McMaster University, Icahn School of Medicine at Mount Sinai, University of California, San Diego, University of California, Davis, United States Military Academy, University of Toronto, Columbia University, Massachusetts General Hospital, Duke University, New York University, Brown University, National University of Ireland, Washington University in St. Louis, University of Minnesota

Eugene Braunwald | Academic Influence

Eugene Braunwald's AcademicInfluence.com Rankings

Eugene Braunwald

Philosophy

#378

World Rank

#814

Historical Rank

#174

USA Rank

Logic

#25

World Rank

#88

Historical Rank

#11

USA Rank

philosophy Degrees

Download Badge

Philosophy

Eugene Braunwald's Degrees

Doctorate Medicine New York University

Why Is Eugene Braunwald Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eugene Braunwald is an Austrian-born American cardiologist. Early life Braunwald was born to Jewish parents Wilhelm Braunwald and Clara Wallach in Vienna. He obtained his A.B. and M.D. at New York University, then completed his residency in internal medicine at Johns Hopkins School of Medicine.

(See a Problem?)

Eugene Braunwald's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. (1996) (6618)
Bariatric surgery: a systematic review and meta-analysis. (2004) (6370)
Prasugrel versus clopidogrel in patients with acute coronary syndromes. (2007) (6103)
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. (1992) (5870)
Edoxaban versus warfarin in patients with atrial fibrillation. (2013) (3988)
Heart Disease: A Textbook of Cardiovascular Medicine (1979) (3831)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients (2002) (3666)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials (2014) (3577)
The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. (2000) (3159)
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. (2013) (3012)
The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction (1982) (2928)
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. (1990) (2868)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. (2004) (2522)
Cytochrome p-450 polymorphisms and response to clopidogrel. (2009) (2405)
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. (1998) (2280)
ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients (2002) (2245)
C-reactive protein levels and outcomes after statin therapy. (2005) (2243)
TIMI frame count: a quantitative method of assessing coronary artery flow. (1996) (1801)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. (2015) (1787)
Rivaroxaban in patients with a recent acute coronary syndrome. (2012) (1745)
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. (2014) (1564)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. (2005) (1559)
Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions (1971) (1553)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients (2000) (1551)
Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. (2001) (1502)
Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. (1997) (1481)
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. (1998) (1476)
TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy (2000) (1462)
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein (1999) (1460)
Unstable Angina A Classification (1989) (1401)
Long-term use of ticagrelor in patients with prior myocardial infarction. (2015) (1399)
Myocardial Infarct Size and Ventricular Function in Rats (1979) (1380)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. (2004) (1346)
Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. (1957) (1334)
Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. (1996) (1288)
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. (2001) (1140)
Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. (1988) (1113)
Myocardial reperfusion: a double-edged sword? (1985) (1107)
Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. (1999) (1106)
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. (2004) (1095)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial (2009) (1082)
Diuretic strategies in patients with acute decompensated heart failure. (2011) (1069)
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. (2011) (1065)
ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). (2000) (1029)
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. (1998) (1015)
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. (2013) (1013)
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials (2015) (999)
Defective cardiac parasympathetic control in patients with heart disease. (1971) (987)
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. (2000) (958)
Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications (1990) (940)
Prasugrel Compared With High Loading– and Maintenance–Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation–Thrombolysis in Myocardial Infarction 44 Trial (2007) (905)
Influence of Chronic Captopril Therapy on the Infarcted Left Ventricle of the Rat (1985) (896)
ACC/AHA 2002 guideline update for the management of patients with unstable angina and non–ST-segment elevation myocardial infarction—summary article (2002) (893)
A tale of coronary artery disease and myocardial infarction. (2012) (874)
Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. (2000) (868)
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. (2016) (854)
Control of Heart Rate by the Autonomic Nervous System: Studies in Man on the Interrelation Between Baroreceptor Mechanisms and Exercise (1966) (840)
Vorapaxar in the secondary prevention of atherothrombotic events. (2012) (839)
A sensitive cardiac troponin T assay in stable coronary artery disease. (2009) (827)
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2005) (827)
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion (1993) (800)
Control of myocardial oxygen consumption: physiologic and clinical considerations. (1971) (799)
State of the art: Using natriuretic peptide levels in clinical practice (2008) (780)
C-Reactive Protein Is a Potent Predictor of Mortality Independently of and in Combination With Troponin T in Acute Coronary Syndromes: A TIMI 11A Substudy (1998) (762)
Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 Patients (1964) (757)
Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide (2002) (756)
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. (2012) (752)
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38 (2008) (744)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials (2009) (741)
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. (2006) (739)
Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* (1987) (739)
Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". (1986) (737)
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study. (2005) (735)
Biomarkers in heart failure. (2008) (716)
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. (1999) (709)
Mechanism of action of calcium-channel-blocking agents. (1982) (703)
Idiopathic Hypertrophic Subaortic Stenosis: Clinical Analysis of 126 Patients with Emphasis on the Natural History (1968) (696)
Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. (2001) (688)
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. (1997) (668)
Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure (2019) (657)
Contractile State of the Left Ventricle in Man as Evaluated from End‐systolic Pressure‐Volume Relations (1977) (649)
Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial (2009) (640)
Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. (1998) (632)
The war against heart failure: the Lancet lecture (2015) (624)
ACC/AHA guidelines for the management of patients with unstable angina and non‐ST segment elevation myocardial infarction: Executive summary and recommendations (2000) (606)
Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded? (1989) (602)
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis (2010) (601)
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. (1999) (593)
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. (2017) (590)
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. (1980) (583)
CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE. (1965) (581)
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial (2014) (564)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. (2008) (562)
Progressive ventricular remodeling in rat with myocardial infarction. (1991) (559)
Contractile State of Cardiac Muscle Obtained from Cats with Experimentally Produced Ventricular Hypertrophy and Heart Failure (1967) (535)
Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function. SAVE investigators. Survival and Ventricular Enlargement. (1997) (533)
Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary Syndromes (2005) (530)
The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: Contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis☆ (1989) (527)
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel: Relationship to Pharmacokinetic, Pharmacodynamic, and Clinical Outcomes (2009) (521)
Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials (2015) (515)
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. (2007) (507)
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. (1997) (501)
Reflex increase in coronary vascular resistance in patients with ischemic heart disease. (1976) (500)
Ultrastructural Evidence of Microvascular Damage and Myocardial Cell Injury After Coronary Artery Occlusion: Which Comes First? (1980) (499)
Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man. (1965) (495)
Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis. (1999) (494)
Congestive Heart Failure: Fifty Years of Progress (2000) (481)
Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. (1998) (480)
VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial (2000) (478)
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). (2010) (477)
The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human Forearm (1965) (467)
Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial (2008) (467)
Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. (2008) (465)
Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial Infarction: A TIMI 14 Substudy (2001) (465)
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes (2003) (460)
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. (2003) (454)
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. (2006) (452)
Effect of Pravastatin on Cardiovascular Events in Older Patients with Myocardial Infarction and Cholesterol Levels in the Average Range: Results of the Cholesterol and Recurrent Events (CARE) Trial (1998) (448)
Nifedipine therapy for coronary-artery spasm. Experience in 127 patients. (1980) (437)
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. (1999) (432)
Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. (1999) (424)
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. (2002) (424)
Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage. (1983) (422)
Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors: The Prospective Pravastatin Pooling Project (2000) (422)
Studies on the first derivative of the ventricular pressure pulse in man. (1962) (422)
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. (1987) (422)
Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2016) (420)
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. (2013) (417)
Coronary-artery spasm. (1978) (414)
Soluble CD40L: Risk Prediction After Acute Coronary Syndromes (2003) (409)
Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure. (1962) (407)
Early versus delayed, provisional eptifibatide in acute coronary syndromes. (2009) (406)
Cardiovascular control mechanisms in the conscious state. (1975) (406)
A classification of unstable angina revisited. (2000) (405)
Oxygen consumption of the heart. Newer concepts of its multifactoral determination. (1968) (402)
Hemodynamic assessment of amrinone. A new inotropic agent. (1978) (398)
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention: Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)–TIMI 26 Trial (2005) (398)
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. (1994) (396)
Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects. (1980) (394)
Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy (2000) (393)
Influence of the thyroid state on the intrinsic contractile properties and energy stores of the myocardium. (1967) (392)
A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failure. (1968) (390)
Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction (2002) (389)
Parasympathetic control of the heart. (1973) (387)
Left Ventricular Diastolic Pressure‐Volume Relations in Rats with Healed Myocardial Infarction: Effects on Systolic Function (1981) (384)
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. (1998) (381)
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials (2019) (377)
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. (1972) (377)
Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. (1996) (369)
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. (1986) (368)
The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. (1997) (365)
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. (2004) (353)
Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease (2007) (347)
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. (1995) (346)
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial (2015) (345)
Pressure-flow relationships and vascular impedance in man. (1970) (342)
Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials. (2015) (342)
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. (2005) (341)
Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure. (1983) (340)
Time course of functional and biochemical recovery of myocardium salvaged by reperfusion. (1983) (338)
Velocity of contraction as a determinant of myocardial oxygen consumption. (1965) (336)
Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. (1981) (336)
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. (1998) (335)
Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. (2004) (333)
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38). (2006) (332)
Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. (2008) (327)
Modification of myocardial infarction size after coronary occlusion. (1973) (326)
Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition (2004) (326)
STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE. (1964) (325)
Unstable angina : diagnosis and management (1994) (323)
Limitation of Experimental Infarct Size by an Angiotensin‐converting Enzyme Inhibitor (1982) (322)
Effect of Glucose‐Insulin‐Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion (1972) (320)
RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISM (1988) (318)
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. (2005) (317)
Studies on Starling9s Law of the Heart (1961) (317)
Individual risk assessment for intracranial haemorrhage during thrombolytic therapy (1993) (307)
Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial. (1986) (306)
Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. (1991) (304)
ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. (2001) (303)
Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial (2006) (302)
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. (1998) (301)
Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. (2005) (300)
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. (2003) (300)
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. (2008) (300)
End-systolic volume as a predictor of postoperative left ventricular performance in volume overload from valvular regurgitation. (1980) (298)
Oral glycoprotein IIb/IIIa inhibition with orbofiban in patients with unstable coronary syndromes (OPUS-TIMI 16) trial. (2000) (298)
Reduction of experimental myocardial infarct size by corticosteroid administration. (1973) (298)
Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. (2003) (297)
Control of myocardial oxygen consumption: relative influence of contractile state and tension development. (1968) (296)
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1. (1986) (294)
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease. (2016) (294)
The Study of Left Ventricular Function in Man by Increasing Resistance to Ventricular Ejection with Angiotensin (1964) (294)
Studies on Cardiac Dimensions in Intact, Unanesthetized Man (1963) (293)
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial (2017) (293)
Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. (2013) (293)
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudy (2001) (291)
Benefit of an early invasive management strategy in women with acute coronary syndromes. (2002) (291)
Contractile State of the Heart Characterized by Force‐Velocity Relations in Variably Afterloaded and Isovolumic Beats (1966) (290)
Heart failure. (2013) (289)
Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. (2000) (289)
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. (2014) (288)
Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. (1993) (288)
Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. (2008) (287)
A trial of two strategies to modify the test-ordering behavior of medical residents. (1980) (287)
Contractile State of the Left Ventricle in Man: Instantaneous Tension‐Velocity‐Length Relations in Patients With And Without Disease of the Left Ventricular Myocardium (1968) (285)
Myocardial salvage after intracoronary thrombolysis with streptokinase in acute myocardial infarction. (1981) (282)
Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. (1982) (282)
MYOCARDIAL NOREPINEPHRINE CONCENTRATION IN MAN. EFFECTS OF RESERPINE AND OF CONGESTIVE HEART FAILURE. (1963) (272)
Loop Diuretics in Acute Decompensated Heart Failure: Necessary? Evil? A Necessary Evil? (2009) (269)
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. (2015) (268)
Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis. (1980) (268)
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes (2002) (268)
Unstable angina: an etiologic approach to management. (1998) (268)
Effects of Changing Heart Rate in Man by Electrical Stimulation of the Right Atrium: Studies at Rest, during Exercise, and with Isoproterenol (1965) (267)
Future of Biomarkers in Acute Coronary Syndromes Moving Toward a Multimarker Strategy (2003) (266)
Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial (2002) (265)
STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE. (1961) (264)
Relative Roles of the Sympathetic and Parasympathetic Nervous Systems in the Reflex Control of Heart Rate (1965) (262)
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. (1999) (260)
Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction. (1997) (258)
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. (2005) (256)
Lipoprotein-Associated Phospholipase A2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial (2006) (256)
Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT (2015) (253)
Transseptal Left Heart Catheterization: A Review of 450 Studies and Description of an Improved Technic (1962) (252)
Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. (2009) (252)
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. (2000) (250)
Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. (2001) (250)
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. (1997) (249)
Left Ventricular Remodeling and Ventricular Arrhythmias After Myocardial Infarction (2003) (249)
Predictors of Early Morbidity and Mortality After Thrombolytic Therapy of Acute Myocardial Infarction: Analyses of Patient Subgroups in the Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase II (1992) (247)
Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside. (1985) (247)
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data (2002) (246)
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials: Prospective Pravastatin Pooling (PPP) Project (2002) (244)
Effects of exercise on myocardial force-velocity relations in intact unanesthetized man: relative roles of changes in heart rate, sympathetic activity, and ventricular dimensions. (1965) (241)
A Hemodynamic Technic for the Detection of Hypertrophic Subaortic Stenosis (1961) (240)
Hemodynamic determinants of coronary flow: effect of changes in aortic pressure and cardiac output on the relationship between myocardial oxygen consumption and coronary flow. (1957) (238)
Alterations in the baroreceptor reflex in conscious dogs with heart failure. (1972) (237)
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. (1992) (235)
Assessment of Cardiac Contractility: The Relation Between the Rate of Pressure Rise and Ventricular Pressure During Isovolumic Systole (1971) (234)
Hemodynamics at rest and during exercise in normal pregnancy as studies by cardiac catheterization. (1955) (232)
The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. (2009) (232)
Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic Stenosis (1964) (232)
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. (1998) (232)
Congestive heart failure following chronic tachycardia. (1971) (231)
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. (2005) (229)
Transseptal left atrial puncture; new technique for the measurement of left atrial pressure in man. (1959) (229)
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. (2011) (226)
An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. (2002) (226)
ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators. (2000) (225)
Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial (2015) (225)
Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure. (1963) (224)
HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 13TH EDITION: (2004) (223)
B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. (2004) (222)
The Effect of Routine, Early Invasive Management on Outcome for Elderly Patients with NonST-Segment Elevation Acute Coronary Syndromes (2004) (222)
Tissue plasminogen activator. (1988) (222)
A new technic for left ventricular angiocardiography and transseptal left heart catheterization (1960) (221)
Time Relationship of Dynamic Events in the Cardiac Chambers, Pulmonary Artery and Aorta in Man (1956) (220)
Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. (2001) (220)
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. (2007) (220)
Response of reperfusion-salvaged, stunned myocardium to inotropic stimulation. (1984) (219)
Determinants of Duration and Mean Rate of Ventricular Ejection (1958) (219)
Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. (1998) (219)
Vorapaxar in Patients With Peripheral Artery Disease: Results From TRA2°P-TIMI 50 (2013) (219)
Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. (1989) (216)
Left ventricular end-systolic stress-shortening and stress-length relations in human. Normal values and sensitivity to inotropic state. (1982) (216)
Evaluation of Precordial Electrocardiographic Mapping as a Means of Assessing Changes in Myocardial Ischemic Injury (1975) (215)
The ventricular end-diastolic pressure. Appraisal of its value in the recognition of ventricular failure in man. (1963) (212)
Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial (2016) (212)
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. (2020) (211)
Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. (1988) (211)
Sympathetic Innervation of the Developing Rabbit Heart: Biochemical and Histochemical Comparisons of Fetal, Neonatal, and Adult Myocardium (1968) (210)
Left Ventricular Performance Following Correction of Free Aortic Regurgitation (1970) (210)
Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. (1974) (210)
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial. (2004) (208)
Effects of Amrinone on Myocardial Energy Metabolism and Hemodynamics in Patients with Severe Congestive Heart Failure Due to Coronary Artery Disease (1980) (208)
The Reduction of Infarct Size — An Idea Whose Time (For Testing) Has Come (1974) (205)
Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial (2012) (204)
Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). (1994) (203)
Comparison of Clinical Outcomes for Women and Men after Acute Myocardial Infarction (1994) (202)
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial (2016) (202)
Hemogynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs. (1962) (201)
Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy (2004) (200)
Survival of patients with severe congestive heart failure treated with oral milrinone. (1986) (200)
Myocardial mechanics in aortic and mitral valvular regurgitation: the concept of instantaneous impedance as a determinant of the performance of the intact heart. (1968) (198)
EFFECTS OF MITRAL-VALVE REPLACEMENT ON THE PULMONARY VASCULAR DYNAMICS OF PATIENTS WITH PULMONARY HYPERTENSION. (1965) (198)
Reduction of Infarct Size by Oxygen Inhalation Following Acute Coronary Occlusion (1975) (196)
CARDIAC NOREPHINEPHRINE STORES IN EXPERIMENTAL HEART FAILURE IN THE DOG. (1964) (196)
Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. (1992) (195)
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes Vytorin Efficacy International Trial) (2018) (194)
Studies on Starling's Law of the Heart: IX. The Effects of Impeding Venous Return on Performance of the Normal and Failing Human Left Ventricle (1964) (193)
Studies on Starling's Law of the Heart: IV. Observations on the Hemodynamic Functions of the Left Atrium in Man (1961) (193)
Coronary Heart Disease in Patients With Low LDL-Cholesterol: Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors (2002) (193)
Chronic Kidney Disease, Cardiovascular Risk, and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction: The Survival And Ventricular Enlargement (SAVE) Study (2004) (193)
Unstable Angina: Is It Time for a Requiem? (2013) (192)
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (2009) (190)
Braunwald's heart disease (2015) (190)
Impaired Rate of Left Ventricular Filling in Idiopathic Hypertrophic Subaortic Stenosis and Valvular Aortic Stenosis (1968) (187)
The Mechanism of the Intraventricular Pressure Gradient in Idiopathic Hypertrophic Subaortic Stenosis (1966) (186)
Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: analysis of a previously conducted randomised trial (2006) (185)
ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATOR (1986) (185)
Effects of Intraaortic Balloon Counterpulsation on the Severity of Myocardial Ischemic Injury following Acute Coronary Occlusion: Counterpulsation and Myocardial Injury (1972) (185)
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. (2009) (184)
Cytochrome P 450 Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic , Pharmacodynamic , and Clinical Outcomes (2009) (183)
Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta‐Adrenergic Blockade (1967) (182)
Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS-TIMI 54. (2016) (181)
Left Ventricular Performance During Muscular Exercise in Patients with and without Cardiac Dysfunction (1966) (180)
Long-term therapy of heart failure with prazosin: a randomized double blind trial. (1980) (179)
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes. (2002) (179)
Cardiac and Renal Effects of Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetes: JACC State-of-the-Art Review. (2018) (179)
Congenital Aortic Stenosis: I. Clinical and Hemodynamic Findings in 100 Patients; II. Surgical Treatment and the Results of Operation (1963) (179)
The Syndrome of Severe Mitral Regurgitation with Normal Left Atrial Pressure (1963) (179)
The in-hospital development of cardiogenic shock after myocardial infarction: incidence, predictors of occurrence, outcome and prognostic factors. The MILIS Study Group. (1989) (179)
Effects of decreased aortic compliance on performance of the left ventricle. (1968) (177)
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. (2003) (176)
Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials. (2008) (176)
Comparison of intensive and moderate lipid lowering with statins after acute coronary symptoms (2004) (174)
Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. (2009) (174)
Long-term preservation of ischemic myocardium after experimental coronary artery occlusion. (1978) (173)
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial. (2016) (173)
Left Atrial and Left Ventricular Pressures in Subjects without Cardiovascular Disease: Observations in Eighteen Patients Studied by Transseptal Left Heart Catheterization (1961) (173)
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. (2006) (173)
Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel—Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38) (2011) (172)
Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (1). (1984) (172)
Measurement of Instantaneous Blood Flow Velocity and Pressure in Conscious Man with a Catheter‐Tip Velocity Probe (1969) (171)
U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. (2005) (171)
Reduction by Hyaluronidase of Myocardial Necrosis following Coronary Artery Occlusion (1972) (170)
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. (2007) (170)
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. (1986) (170)
Narratives of human evolution (1992) (169)
Functional Aortic Stenosis: A Malformation Characterized by Resistance to Left Ventricular Outflow without Anatomic Obstruction (1959) (168)
Characterization of the Circulatory Response to Maximal Upright Exercise in Normal Subjects and Patients with Heart Disease (1967) (168)
Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial (2006) (168)
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. (2014) (167)
The open-artery theory is alive and well--again. (1993) (167)
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial (2018) (167)
Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial. (2007) (166)
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. (2008) (166)
Time to Add a Fifth Pillar to Bedside Physical Examination: Inspection, Palpation, Percussion, Auscultation, and Insonation (2018) (166)
Studies on digitalis. XVI. Effects on myocardial oxygen consumption. (1966) (165)
Mechanism of Norepinephrine Depletion in Experimental Heart Failure Produced by Aortic Constriction in the Guinea Pig (1965) (165)
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction. (1998) (164)
Partition of Blood Flow to the Cutaneous and Muscular Beds of the Forearm at Rest and during Leg Exercise in Normal Subjects and in Patients with Heart Failure (1969) (162)
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab (2000) (161)
Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. (1991) (161)
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial (2017) (161)
Acute Severe Mitral Regurgitation Secondary to Ruptured Chordae Tendineae: Clinical, Hemodynamic, and Pathologic Considerations (1966) (161)
Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. (1977) (160)
Thirteenth Bowditch lecture. The determinants of myocardial oxygen consumption. (1969) (160)
Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. (2008) (160)
Studies on Cardiac Dimensions in Intact, Unanesthetized Man: IV. Effects of Isoproterenol and Methoxamine (1964) (159)
Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes: Results From PROVE IT–TIMI 22 (2009) (159)
Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. (2004) (158)
Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. (2002) (157)
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. (1966) (157)
Comparison of enzymatic and anatomic estimates of myocardial infarct size in man. (1984) (156)
ACE inhibitors--a cornerstone of the treatment of heart failure. (1991) (155)
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial (2015) (154)
Studies on Starling's Law of the Heart: Determinants of the Relationship Between Left Ventricular End‐Diastolic Pressure and Circumference (1960) (154)
Use of Changes in the Epicardial QRS Complex to Assess Interventions which Modify the Extent of Myocardial Necrosis following Coronary Artery Occlusion (1976) (154)
Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators. (1999) (153)
Mummification of the Infarcted Myocardium by High Dose Corticosteroids (1978) (152)
Instantaneous measurement of left and right ventricular stroke volume and pressure-volume relationships with an impedance catheter. (1984) (152)
Reduction of the Cardiac Response to Postganglionic Sympathetic Nerve Stimulation in Experimental Heart Failure (1966) (152)
Effects of Norepinephrine on Coronary Circulation and Left Ventricular Dynamics in the Conscious Dog (1974) (152)
Impaired coronary blood flow in nonculprit arteries in the setting of acute myocardial infarction. The TIMI Study Group. Thrombolysis in myocardial infarction. (1999) (151)
Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention. (2017) (151)
Reduction of Cardiac Tyrosine Hydroxylase Activity in Experimental Congestive Heart Failure: Its Role In The Depletion Of Cardiac Norepinephrine Stores (1967) (150)
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes ☆: A TACTICS-TIMI 18 substudy (2003) (148)
Relief of Angina Pectoris by Electrical Stimulation of the Carotid-Sinus Nerves (1967) (148)
Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled Trial (2009) (148)
Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart Failure (2013) (147)
The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. (2006) (146)
Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome (2007) (146)
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial (2008) (146)
Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial (2014) (146)
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 stu (2003) (146)
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial (2009) (145)
Efforts to limit the size of myocardial infarcts. (1981) (145)
Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndromes and Planned Percutaneous Coronary Intervention: Results From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction TRI (2010) (145)
Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. (2004) (145)
Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial. (2015) (145)
Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. (2016) (145)
Review: Observations on experimental myocardial ischaemia (1980) (144)
Factors leading to shorter survival after acute myocardial infarction in patients ages 65 to 75 years compared with younger patients. (1988) (143)
Mechanisms of Contraction of the Normal and Failing Heart (1969) (143)
Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. (1990) (142)
Studies on digitalis. I. Direct effects on peripheral vascular resistance. (1960) (141)
The contractile state as the major determinant in the evolution of left ventricular dysfunction in the spontaneously hypertensive rat. (1983) (140)
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. (2000) (140)
Implications for acute intervention related to time of hospital arrival in acute myocardial infarction. (1986) (139)
Operative Treatment in Idiopathic Hypertrophic Subaortic Stenosis: Techniques, and the Results of Preoperative and Postoperative Clinical and Hemodynamic Assessments (1968) (139)
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy. (2005) (139)
Human Evolution as Narrative (1984) (139)
Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. (1987) (138)
Assessment of Cardiac Function (1969) (138)
Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion. (1980) (138)
Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial. (2012) (137)
Extent of regulation of the heart's contractile state in the conscious dog by alteration in the frequency of contraction. (1973) (137)
STUDIES ON DIGITALIS. IX. EFFECTS OF OUABAIN ON THE NONFAILING HUMAN HEART (1963) (137)
One‐Year Results of the Thrombolysis in Myocardial Infarction Investigation (TIMI) Phase II Trial (1992) (136)
Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. (2010) (136)
Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). (2002) (136)
Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function. (1983) (135)
Electroaugmentation of Ventricular Performance and Oxygen Consumption by Repetitive Application of Paired Electrical Stimuli (1965) (135)
Postischemic myocardial "stunning": a clinically relevant phenomenon. (1988) (135)
Marcus cardiac imaging : a companion to Braunwald's Heart disease (1991) (134)
Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size. (1978) (134)
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. (1995) (134)
Idiopathic Hypertrophic Subaortic Stenosis: II. Operative Treatment and the Results of Pre‐ and Postoperative Hemodynamic Evaluations (1964) (133)
Mechanisms of contraction of the normal and failing heart. (1967) (133)
Selection Bias in the Use of Thrombolytic Therapy in Acute Myocardial Infarction (1991) (133)
The Circulatory Response of Patients with Idiopathic Hypertrophic Subaortic Stenosis to Nitroglycerin and to the Valsalva Maneuver (1964) (132)
Effects of hyperlipoproteinemias and their treatment on the peripheral circulation. (1970) (132)
Update from the Thrombolysis in Myocardial Infarction Trial. (1987) (131)
Mechanisms of contraction of the normal and failing heart. (1967) (131)
The Direct Effects of Norepinephrine, Epinephrine, and Methoxamine on Myocardial Contractile Force in Man (1960) (130)
Diseases of the Spinal Cord (1933) (130)
Aortic stenosis. (1968) (130)
Harrisons principles of internal medicine - 15th edition (2001) (130)
Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine. (1967) (130)
Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: the Cholesterol and Recurrent Events trial (CARE) (1991) (129)
Prosthetic Replacement of the Mitral Valve: Preoperative and Postoperative Clinical and Hemodynamic Assessments in 100 Patients (1967) (129)
Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. (2004) (129)
Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling: ENGAGE AF-TIMI 48 Analysis. (2016) (128)
Effects of increasing frequency of contraction on the force velocity relation of left ventricle. (1967) (128)
Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. (2005) (127)
Evaluation of Multiple Biomarkers of Cardiovascular Stress for Risk Prediction and Guiding Medical Therapy in Patients With Stable Coronary Disease (2012) (127)
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. (2005) (127)
Atrial Failure as a Clinical Entity: JACC Review Topic of the Week. (2020) (127)
Impact of Atrial Fibrillation on Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study (2014) (127)
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction (2016) (126)
The pressor effect of the antidiuretic principle of the posterior pituitary in orthostatic hypotension. (1956) (126)
The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure. (2015) (126)
Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique. (1986) (126)
Mitral regurgitation: physiologic, clinical and surgical considerations. (1969) (126)
The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease. (1966) (125)
Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. (2012) (125)
Left Heart Catheterization by the Transseptal Route: A Description of the Technic and Its Applications (1960) (124)
Chronic coronary artery disease (2001) (124)
Effects of Carotid Sinus Nerve Stimulation on Blood‐Flow Distribution in Conscious Dogs at Rest and during Exercise (1970) (124)
Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol: A Prespecified Analysis of the IMPROVE-IT Trial (2017) (124)
Comparison of the Force‐Velocity Relation and the Ventricular Function Curve as Measures of the Contractile State of the Intact Heart (1966) (124)
Acute coronary syndrome without ST elevation: implementation of new guidelines (2001) (124)
Studies on Starling's law of the heart. I. The circulatory response to acute hypervolemia and its modification by ganglionic blockade. (1960) (123)
Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes (2004) (123)
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. (2006) (123)
Scar thinning due to ibuprofen administration after experimental myocardial infarction. (1983) (123)
Updates on Acute Coronary Syndrome: A Review. (2016) (122)
Growth Differentiation Factor-15 and Risk of Recurrent Events in Patients Stabilized After Acute Coronary Syndrome: Observations From PROVE IT-TIMI 22 (2011) (122)
Initial Myocardial Adjustments to Brief Periods of Ischemia and Reperfusion in the Conscious Dog (1978) (122)
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). (1997) (121)
Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy (2002) (121)
Studies on Digitalis: XV. Effects of Cardiac Glycosides on Myocardial Force‐Velocity Relations in the Nonfailing Human Heart (1966) (121)
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. (2002) (121)
Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial function. (1985) (121)
Left ventricular response to severe exertion in untethered dogs. (1972) (120)
Myocardial ischemia (first of three parts). (1977) (120)
Norepinephrine Stores and Contractile Force of Papillary Muscle from the Failing Human Heart (1966) (119)
Myocardial High Energy Phosphate Stores in Cardiac Hypertrophy and Heart Failure (1967) (119)
MYOCARDIAL FORCE-VELOCITY RELATIONS STUDIED IN INTACT UNANESTHETIZED MAN. (1965) (118)
Diabetes, heart failure, and renal dysfunction: The vicious circles. (2019) (118)
Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial. (2008) (118)
Cardiovascular Reflexes Stimulated by Reperfusion of Ischemic Myocardium in Acute Myocardial Infarction (1983) (117)
Effects of a Digitalis Glycoside on Coronary and Systemic Dynamics in Conscious Dogs (1971) (117)
Alterations in Regional Pulmonary Blood Flow in Mitral Valve Disease Studied by Radioisotope Scanning: A Simple Nontraumatic Technique for Estimation of Left Atrial Pressure (1966) (116)
SYMPOSIUM ON CARDIAC ARRHYTHMIAS. INTRODUCTION WITH COMMENTS ON THE HEMODYNAMIC SIGNIFICANCE OF ATRIAL SYSTOLE. (1964) (116)
Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48) (2017) (116)
Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. (1987) (116)
Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. (2007) (115)
PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design. (2012) (115)
Coronary-artery surgery at the crossroads. (1977) (115)
Cardiac Norepinephrine Stores and the Contractile State of Heart Muscle (1966) (115)
Hemodynamic Effects of Quantitatively Varied Experimental Aortic Regurgitation (1957) (115)
Determination of Fraction of Left Ventricular Volume Ejected per Beat and of Ventricular End‐Diastolic and Residual Volumes: Experimental and Clinical Observations with a Precordial Dilution Technic (1962) (114)
The role of skin and muscle resistance vessels in reflexes mediated by the baroreceptor system. (1970) (113)
Economic Impact of Angina After an Acute Coronary Syndrome: Insights From the MERLIN-TIMI 36 Trial (2009) (112)
Early angiography in patients with chronic kidney disease: a collaborative systematic review. (2009) (112)
Effects of anesthesia and sleep on circulatory response to carotid sinus nerve stimulation. (1971) (112)
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. (1976) (111)
ACC/AHA/ESC/WHF Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations from the TRITON-TIMI 38 Trial (2011) (110)
A Tale of Two Trials: A Comparison of the Post–Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT–TIMI 22 (2006) (110)
Hyaluronidase-induced reductions in myocardial infarct size. (1976) (110)
Studies on Digitalis: V. Comparison of the Effects of Ouabain on Left Ventricular Dynamics in Valvular Aortic Stenosis and Hypertrophic Subaortic Stenosis (1962) (109)
The Hemodynamics of the Left Side of the Heart as Studied by Simultaneous Left Atrial, Left Ventricular, and Aortic Pressures; Particular Reference to Mitral Stenosis (1955) (109)
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. (2003) (109)
Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. (2009) (109)
Unstable angina and non-ST elevation myocardial infarction. (2012) (108)
Relationship Between Nonsustained Ventricular Tachycardia After Non–ST-Elevation Acute Coronary Syndrome and Sudden Cardiac Death: Observations From the Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 36 (MERLIN (2010) (108)
Effects of Carotid Sinus Nerve Stimulation on the Coronary Circulation of the Conscious Dog (1970) (108)
Determinants of atrial contractile force in the intact heart. (1965) (108)
Supravalvular Aortic Stenosis: Clinical, Hemodynamic and Pathologic Observations (1959) (108)
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25. (2007) (107)
Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. (2012) (107)
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial. (2006) (106)
Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction. (2004) (106)
ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN THE CIRCULATORY RESPONSE TO ACUTELY INDUCED ANEMIA IN UNANESTHETIZED DOGS. (1964) (106)
Effects of catecholamines, exercise, and nitroglycerin on the normal and ischemic myocardium in conscious dogs. (1974) (106)
Alterations in Central Blood Volume and Cardiac Output Induced by Positive Pressure Breathing and Counteracted by Metaraminol (Aramine) (1957) (106)
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. (2012) (106)
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis (2009) (105)
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. (2015) (105)
Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE. (2002) (105)
Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. (2016) (104)
Design and rationale for the Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54 (PEGASUS-TIMI 54) trial. (2014) (104)
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51. (2013) (104)
Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. (1981) (103)
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial. (2017) (103)
Invasive versus conservative strategies in unstable angina and non\NQ-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 trial ☆ (1998) (103)
Effects of calcium antagonists on infarcting myocardium. (1987) (103)
Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14. The Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. (2000) (103)
Effects of a reduction in environmental temperature on the circulatory response to exercise in man. Implications concerning angina pectoris. (1969) (102)
The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study. (2011) (102)
Augmented Sympathetic Neurotransmitter Activity in the Peripheral Vascular Bed of Patients with Congestive Heart Failure and Cardiac Norepinephrine Depletion (1968) (102)
Preservation of high-energy phosphates by verapamil in reperfused myocardium. (1984) (101)
Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. Cholesterol and Recurrent Events CARE Investigators. (1999) (101)
Idiopathic Hypertrophic Subaortic Stenosis: III. Intraoperative Studies of the Mechanism of Obstruction and Its Hemodynamic Consequences (1964) (101)
Left ventricular end-systolic stress-shortening and stress-length relations in humans (1982) (100)
The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. (2007) (100)
Cardiac biomarkers: a contemporary status report (2006) (100)
Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. (2019) (100)
Effect of propranolol on mitochondrial morphology during acute myocardial ischemia. (1978) (100)
F. SYMPATHETIC ACTIVITY AND NEUROTRANSMITTER DEPLETION IN CONGESTIVE HEART FAILURE (1966) (100)
Indomethacin–induced Scar Thinning After Experimental Myocardial Infarction (1983) (99)
An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design. (2010) (99)
Regulation of the circulation. I. (1974) (99)
Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects of ventricular function in the normal and ischaemic heart. (1973) (99)
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN)-TIMI 34 trial. (2006) (99)
Thrombolytic therapy: a new strategy for the treatment of acute myocardial infarction (second of two parts) (1984) (98)
Hemodynamic Effects of Intravenous Sodium Nitroprusside in the Conscious Dog (1978) (98)
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (E (2005) (98)
Preoperative assessment of aortic regurgitation in patients with mitral valve disease. (1967) (98)
An Intrinsic Adrenergic Vasodilator Mechanism in the Coronary Vascular Bed of the Dog (1965) (98)
IDIOPATHIC MYOCARDIAL HYPERTROPHY WITHOUT CONGESTIVE HEART FAILURE OR OBSTRUCTION TO BLOOD FLOW. CLINICAL, HEMODYNAMIC AND ANGIOCARDIOGRAPHIC STUDIES IN FOURTEEN PATIENTS. (1963) (97)
Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events: A Secondary Analysis of the PEGASUS-TIMI 54 Trial. (2016) (96)
Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial. (1997) (96)
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population. (2014) (96)
Favorable effects of therapy on cardiac performance in spontaneously hypertensive rats. (1982) (96)
ALPHA AND BETA ADRENERGIC RECEPTOR MECHANISMS IN THE SYSTEMIC VENOUS BED. (1964) (95)
Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48 (2019) (95)
Effects of increased arterial pressure and positive inotropic agents on the severity of myocardial ischemia in the acutely depressed heart. (1972) (95)
Rivaroxaban in patients stabilized after a ST-segment elevation myocardial infarction: results from the ATLAS ACS-2-TIMI-51 trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction-51). (2013) (95)
Myocardial oxygen consumption associated with external work: the Fenn effect. (1969) (95)
Selecting the best reperfusion strategy in ST-elevation myocardial infarction: it's all a matter of time. (2003) (95)
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial (2016) (95)
Effects of guanethidine on tri-iodothyronine-induced hyperthyroidism in man. (1961) (95)
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. (2011) (94)
The aggressive treatment of acute myocardial infarction. (1985) (94)
Complete Interruption of the Aortic Arch (1962) (93)
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2012) (93)
A study of C-reactive protein in the serum of patients with congestive heart failure. (1956) (93)
CLINICAL OBSERVATIONS ON PAIRED ELECTRICAL STIMULATION OF THE HEART. EFFECTS ON VENTRICULAR PERFORMANCE AND HEART RATE. (1964) (93)
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials (2020) (92)
Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine. (1980) (92)
The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy. (2001) (92)
Studies on Cardiac Dimensions in Intact Unanesthetized Man: V. Effects of Nitroglycerin (1965) (91)
Study design and rationale for the Stabilization of pLaques usIng Darapladib-Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome. (2011) (91)
Evolution of the management of acute myocardial infarction: a 20th century saga (1998) (91)
Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients. (1975) (91)
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. (1986) (91)
Mechanisms and implications of vasodilator tolerance in the treatment of congestive heart failure. (1981) (91)
Announcement of protocol change in thrombolysis in myocardial infarction trial. (1987) (91)
On the natural history of severe aortic stenosis. (1990) (90)
Drug-induced expansion of infarct: morphologic and functional correlations. (1984) (90)
On the Difference Between the Heart's Output and Its Contractile State (1971) (90)
Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol). (1984) (89)
Prolonged abnormalities of myocardium salvaged by reperfusion. (1981) (89)
Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project. (2002) (89)
Obstruction to left ventricular outflow. Current concepts of management and operative treatment. (1968) (88)
Myocardial Perfusion Imaging with Radioactive‐Labeled Particles Injected Directly into the Coronary Circulation of Patients with Coronary Artery Disease (1971) (88)
Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). (2006) (88)
Epilogue: what do clinicians expect from imagers? (2006) (88)
Effects of Drugs and of Counterpulsation on Myocardial Oxygen Consumption: Observations on the Ischemic Heart (1969) (88)
Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). (2014) (87)
Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. (2013) (87)
Efficacy and Safety of Vorapaxar in Patients With Prior Ischemic Stroke (2013) (87)
Coronary spasm and acute myocardial infarction--new possibility for treatment and prevention. (1978) (87)
STUDIES ON STARLING'S LAW OF THE HEART. III. OBSERVATIONS IN PATIENTS WITH MITRAL STENOSIS AND ATRIAL FIBRILLATION ON THE RELATIONSHIPS BETWEEN LEFT VENTRICULAR END-DIASTOLIC SEGMENT LENGTH, FILLING PRESSURE, AND THE CHARACTERISTICS OF VENTRICULAR CONTRACTION. (1960) (87)
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial (2018) (87)
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2017) (87)
ST-segment mapping. Realistic and unrealistic expectations. (1976) (87)
The evolving epidemiology of acute coronary syndromes (2011) (87)
Studies on Starling's Law of the Heart: VI. Relationships between Left Ventricular End‐Diastolic Volume and Stroke Volume in Man with Observations on the Mechanism of Pulsus Alternans (1962) (86)
EFFECTS OF GUANETHIDINE, RESERPINE, AND METHYLDOPA ON REFLEX VENOUS AND ARTERIAL CONSTRICTION IN MAN. (1964) (86)
Hemodynamic Effects of Quantitatively Varied Experimental Mitral Regurgitation (1957) (86)
Circulatory Effects of Electrical Stimulation of the Carotid Sinus Nerves in Man (1969) (86)
Oral amrinone in refractory congestive heart failure. (1980) (86)
Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial Clinical Investigation and Reports (1998) (85)
Normal Oxidative Phosphorylation in Mitochondria from the Failing Heart (1967) (85)
Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial. (2015) (85)
Circulatory Effects of Acute Expansion of Blood Volume: Studies During Maximal Exercise and at Rest (1966) (85)
Hemodynamic Effects of Diuresis at Rest and During Intense Upright Exercise in Patients with Impaired Cardiac Function (1968) (85)
Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events. (1999) (85)
Contractile performance of the hypertrophied and chronically failing cat ventricle. (1972) (85)
The effects of acute hypoxia on the systemic venous and arterial systems and on myocardial contractile force. (1962) (85)
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. (2010) (85)
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease. (2014) (85)
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial: a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coronary syndro (2005) (84)
Effects of coronary-artery bypass grafting on survival. Implications of the randomized coronary-artery surgery study. (1983) (84)
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery disease. (1993) (84)
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. (1998) (83)
Evaluation of the Paraoxonases as Candidate Genes for Stroke: Gln192Arg Polymorphism in the Paraoxonase 1 Gene Is Associated With Increased Risk of Stroke (2005) (83)
Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial). (1996) (83)
Left Atrial Pressure Pulse in Mitral Valve Disease: A Correlation of Pressures Obtained by Transbronchial Puncture with the Valvular Lesion (1957) (82)
Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial. (2015) (82)
National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. (2010) (82)
Studies on digitalis. II. Extracardiac effects on venous return and on the capacity of the peripheral vascular bed. (1960) (82)
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). (2007) (82)
Electrocardiographic diagnosis of myocardial infarction in the presence of complete left bundle branch block. (1988) (82)
Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocardial infarction (The MILIS study) (1987) (82)
Interleukin‐6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID‐TIMI 52 (Stabilization of Plaque Using Darapladib—Thrombolysis in Myocardial Infarction 52) Trial (2017) (82)
Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Prevention of Events with Angiotensin-Converting Enzyme Inhibition. (1998) (81)
Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. (2002) (81)
2007 update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. (2008) (81)
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. (1994) (81)
Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. (2007) (80)
Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction. (1983) (80)
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. (2019) (80)
Mechanism of increase of myocardial oxygen uptake produced by catecholamines. (1965) (79)
Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration. (1995) (79)
Evaluation of the association of proximal coronary culprit artery lesion location with clinical outcomes in acute myocardial infarction. (2003) (79)
Alterations in Resting Length‐Tension Relations of Cardiac Muscle Induced by Changes In Contractile Force (1966) (79)
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia in Non-ST-elevation acute coronary syndromes (MERLIN)-TIMI 36 trial. (2006) (79)
Effect of intracoronary verapamil on infarct size in the ischemic, reperfused canine heart: critical importance of the timing of treatment. (1985) (79)
Extent of carotid sinus regulation of the myocardial contractile state in conscious dogs. (1972) (79)
Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy. (2002) (79)
Performance characteristics and oxygen debt in a nonfailing, metabolically supported, isolated heart preparation. (1957) (78)
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B. (1999) (78)
Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial (2017) (78)
Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial. (2019) (78)
Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48) (2016) (78)
Editorial: Hypertrophic Subaortic Stenosis—A Broadened Concept (1962) (78)
Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary Syndrome (2010) (77)
Rapid Sequential Visualization of the Heart and Great Vessels in Man Using the Wide‐Field Anger Scintillation Camera: Radioisotope‐Angiography Following the Injection of Technetium‐99m (1969) (77)
Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial. (1993) (77)
Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure. (1974) (77)
Vasodilator therapy--a physiologic approach to the treatment of heart failure. (1977) (77)
Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. (1999) (76)
Effects of Experimentally Produced Heart Failure on the Peripheral Vascular Response to Severe Exercise in Conscious Dogs (1972) (76)
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With vs. Without Diabetes: Results from IMPROVE-IT (2017) (76)
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14. (2000) (76)
Recombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trial. (2007) (76)
Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial. (2016) (76)
Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON‐TIMI 38 (2009) (76)
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial. (2018) (76)
The Effect of Propranolol on Microvascular Injury in Acute Myocardial Ischemia (1977) (75)
The Prognostic Implications of Acute Myocardial Infarct Scintigraphy with 99mTc‐Pyrophosphate (1978) (75)
Left Heart Catheterization by the Transbronchial Route: Technic and Applications in Physiologic and Diagnostic Investigations (1957) (75)
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF‐TIMI 48 (2014) (75)
The futility index. An approach to the cost-effective termination of randomized clinical trials. (1985) (74)
Myocardial High Energy Phosphate Stores in Acutely Induced Hypoxic Heart Failure (1966) (74)
Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome. (2014) (74)
Angiographic and Clinical Outcomes in Patients Receiving Low-Molecular-Weight Heparin Versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Treated With Fibrinolytics in the CLARITY-TIMI 28 Trial (2005) (74)
THE CONTRACTILE PROPERTIES OF HUMAN HEART MUSCLE: STUDIES ON MYOCARDIAL MECHANICS OF SURGICALLY EXCISED PAPILLARY MUSCLES. (1965) (73)
The Splitting of the Second Heart Sound in Normal Subjects and in Patients with Congenital Heart Disease (1962) (73)
Influence of Albuminuria on Cardiovascular Risk in Patients With Stable Coronary Artery Disease (2007) (73)
Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism. (2011) (72)
THE INFLUENCE OF INTRACARDIAC BARORECEPTORS ON VENOUS RETURN, SYSTEMIC VASCULAR VOLUME AND PERIPHERAL RESISTANCE. (1961) (72)
Collaborating with industry--choices for the academic medical center. (2002) (72)
Recovery from prolonged abnormalities of canine myocardium salvaged from ischemic necrosis by coronary reperfusion. (1981) (72)
Natriuretic peptides in heart failure: should therapy be guided by BNP levels? (2010) (72)
Alterations of cardiac performance in rats with established spontaneous hypertension. (1979) (72)
Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. (1993) (72)
Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial. (2005) (72)
Tricuspid regurgitation. A newly recognized cause of protein-losing enteropathy, lymphocytopenia and immunologic deficiency. (1968) (71)
Spontaneous Closure of Ventricular Septal Defect: Anatomic Proof in an Adult with Tricuspid Atresia (1963) (71)
Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside. (1971) (71)
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial. (2016) (71)
Usefulness of ST segment elevations as predictors of electrocardiographic signs of necrosis in patients with acute myocardial infarction. (1977) (71)
Effects and Mechanism of Action of Aminophylline on Cardiac Function and Regional Blood Flow Distribution in Conscious Dogs (1981) (71)
Efficacy and Safety of Vorapaxar as Approved for Clinical Use in the United States (2015) (71)
Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. (2004) (71)
Study of the Relationship Between the Neurotransmitter Store and Adrenergic Nerve Block Induced by Reserpine and Guanethidine (1963) (70)
Effects of digitalis on the normal and the failing heart. (1985) (70)
Detection of left-ventricular-wall motion disorders in coronary-artery disease by radarkymography. (1971) (70)
Pericarditis in acute myocardial infarction: characterization and clinical significance. (1989) (70)
Research Advances in Heart Failure: A Compendium (2013) (70)
Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54. (2017) (70)
Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II. (2001) (70)
Severe Mitral Regurgitation Following Acute Myocardial Infarction and Ruptured Papillary Muscle: Hemodynamic Findings and Results of Operative Treatment in Four Patients (1968) (70)
Physiologic assessment of the inotropic, vasodilator and afterload reducing effects of milrinone in subjects without cardiac disease. (1985) (69)
First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs. (1983) (69)
Influence of Carotid Baroreceptors and Vasoactive Drugs on Systemic Vascular Volume and Venous Distensibility (1961) (69)
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study. (2006) (69)
Operative treatment of atrial septal defect: clinical and haemodynamic assessments in 175 patients. (1967) (69)
Recurrent ventricular tachycardia and fibrillation treated with a combination of beta-adrenergic blockade and electrical pacing. (1967) (69)
Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies. (2011) (69)
Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial (2015) (69)
Role of the venous system in baroreceptor-mediated reflexes in man. (1968) (69)
The benefit of adding ezetimibe to statin therapy in patients with prior coronary artery bypass graft surgery and acute coronary syndrome in the IMPROVE-IT trial. (2016) (68)
Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS. (2006) (68)
Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. (1983) (68)
An Angiocardiographic Analysis of the Thickness of the Left Ventricular Wall and Cavity in Aortic Stenosis and Other Valvular Lesions: Hemodynamic‐Angiographic Correlations in Patients with Obstruction to Left Ventricular Outflow (1963) (68)
PULMONARY VASCULAR DILUTION CURVES RECORDED BY EXTERNAL DETECTION IN THE DIAGNOSIS OF LEFT-TO-RIGHT SHUNTS (1962) (68)
A Method for the Detection and Quantification of Impaired Sodium Excretion: Results of an Oral Sodium Tolerance Test in Normal Subjects and in Patients with Heart Disease (1965) (68)
Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) su (2010) (68)
Sequence of ventricular contraction in human bundle branch block; a study based on simultaneous catheterization of both ventricles. (1957) (67)
Natural history of mild congenital aortic stenosis elucidated by serial hemodynamic studies. (1972) (67)
Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. (1983) (67)
The myocardium; failure and infarction (1974) (67)
Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. (2012) (67)
Oxygen Cost of Electrical Activation of the Heart (1966) (67)
Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis. (2008) (67)
Direct comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 Registry. (2003) (67)
Studies on Starling's law of the heart. V. Left ventricular function in man. (1961) (67)
Letters to the editor Reply (1989) (67)
Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog. (1973) (66)
The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. (1975) (66)
Prognostic significance of nonfatal reinfarction during 3-year follow-up: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial. The TIMI Investigators. (1995) (66)
Reconsidering the role for digoxin in the management of acute heart failure syndromes. (2009) (66)
Reflex Control of the Systemic Venous Bed (1963) (66)
Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. (2001) (66)
Treatment of Angina Pectoris by Electrical Stimulation of the Carotid-Sinus Nerves: Results in 17 Patients with Severe Angina (1969) (66)
Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction (2015) (65)
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia. (1985) (65)
STUDIES ON DIGITALIS. VIII. EFFECT OF AUTONOMIC INNERVATION AND OF MYOCARDIAL CATECHOLAMINE STORES UPON THE CARDIAC ACTION OF OUABAIN (1963) (65)
A study of the electrocardiogram and vectorcardiogram in congenital heart disease. I. Electrocardiographic criteria for ventricular hypertrophy. (1955) (65)
Cholesterol and total mortality: need for larger trials. (1992) (65)
Two- and three-year results of the thrombolysis in myocardial infraction (TIMI) phaes II clinical trial (1993) (65)
Rationale, design and baseline characteristics of the survival and ventricular enlargement trial (1991) (65)
How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial) (1995) (65)
Ventricular septal defect and aortic regurgitation: clinical, hemodynamic and surgical considerations. (1965) (65)
Sympathetic activity and neurotransmitter depletion in congestive heart failure. (1966) (64)
Isolated congenital pulmonic valvular regurgitation. Diagnosis by cardiac catheterization and angiocardiography. (1960) (64)
Physiological Differences between the Effects of Neuronally Released and Bloodborne Norepinephrine on Beta Adrenergic Receptors in the Arterial Bed of the Dog (1967) (64)
The Smoker's Paradox: Insights from the Angiographic Substudies of the TIMI Trials (2002) (63)
Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial. (2019) (63)
Myocardial ischemia (second of three parts). (1977) (63)
A study of the electrocardiogram and vectorcardiogram in congenital heart disease. II. Vectorcardiographic criteria for ventricular hypertrophy. (1955) (63)
Application of Current Guidelines to the Management of Unstable Angina and Non-ST-Elevation Myocardial Infarction (2003) (63)
Comparison of long-term outcome after acute myocardial infarction in patients never graduated from high school with that in more educated patients. Multicenter Investigation of the Limitation of Infarct Size (MILIS). (1993) (63)
Familial congenital heart disease: Familial occurrence of atrial septal defect with A-V Conduction abnormalities; supravalvular aortic and pulmonic stenosis; and ventricular septal defect (1966) (62)
Pharmacokinetics of a Slower Clearing Tissue Plasminogen Activator Variant, TNK-tPA, in Patients with Acute Myocardial Infarction (1998) (62)
Effects of intravenous fluorocarbons during and without oxygen enhancement on acute myocardial ischemic injury assessed by measurement of intramyocardial gas tensions. (1982) (62)
Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators. (1990) (61)
An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point. (1992) (61)
Recognizing worsening chronic heart failure as an entity and an end point in clinical trials. (2014) (61)
The prostaglandins. Biochemical, physiologic and clinical considerations. (1972) (61)
Release of Norepinephrine from the Heart by Vasoactive Amines (1962) (61)
Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure. (1980) (61)
Extent of utilization of the Frank-Starling mechanism in conscious dogs. (1978) (61)
Clinical and hemodynamic observations in pure mitral insufficiency. (1958) (61)
Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes. (2012) (61)
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. (2002) (61)
SUSTAINED, PAIRED ELECTRICAL STIMULI: SLOWING OF THE VENTRICULAR RATE AND AUGMENTATION OF CONTRACTILE FORCE. (1964) (61)
A Method for the Detection and Estimation of Aortic Regurgitant Flow in Man (1958) (61)
Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). (2001) (61)
The treatment of acute myocardial infarction: the Past, the Present, and the Future (2012) (60)
The effect of glucose-insulin-potassium on cardiac ultrastructure following acute experimental coronary occlusion. (1973) (60)
Studies on digitalis. 13. A comparison of the effects of potassium on the inotropic and arrhythmia-producing actions of ouabain. (1966) (60)
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt‐pRo‐bnp in patients stabilized from an acute Heart Failure episode (PIONEER‐HF) trial (2018) (60)
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial (2016) (60)
Value of the QRS complex in assessing left ventricular ejection fraction. (1978) (60)
Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction. (1996) (60)
THE HEART AS AN ENDOCRINE ORGAN. (1964) (60)
Predictors of Heart Failure in Patients With Stable Coronary Artery Disease: A PEACE Study (2009) (60)
Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction (2017) (60)
THE CONTROL OF VENTRICULAR FUNCTION IN MAN* (1965) (59)
Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. (2010) (59)
Studies of Amiodarone During Experimental Myocardial Infarction: Beneficial Effects on Hemodynamics and Infarct Size (1982) (59)
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial (2019) (59)
Galectin-3 in heart failure with preserved ejection fraction. A RELAX trial substudy (Phosphodiesterase-5 Inhibition to Improve Clinical Status and Exercise Capacity in Diastolic Heart Failure). (2015) (59)
Mechanism of Prolongation of the R‐R Interval with Electrical Stimulation of the Carotid Sinus Nerves in Man (1972) (59)
Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II. (2000) (58)
General cardiology: abstractComparison of intensive and moderate lipid lowering with statins after acute coronary syndromes (2004) (58)
The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs. (1977) (58)
Patency of the infarct-related coronary artery and ventricular geometry. (1991) (58)
Cardiomyopathies: An Overview. (2017) (58)
Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial. (2009) (58)
Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. (2003) (57)
Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors: JACC State-of-the-Art Review. (2020) (57)
High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial. (1985) (57)
Dynamic TIMI Risk Score for STEMI (2013) (57)
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. (2021) (57)
A proposed model for initial assessment and management of acute heart failure syndromes. (2011) (57)
A cost-effectiveness model for coronary thrombolysis/reperfusion therapy. (1987) (57)
Neurotransmitter Control of Sinoatrial Pacemaker Frequency in Isolated Rat Atria and in Intact Rabbits (1970) (57)
Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. (2002) (57)
Predictors of the rise in vWF after ST elevation myocardial infarction: implications for treatment strategies and clinical outcome: An ENTIRE-TIMI 23 substudy. (2005) (56)
The Nitrous Oxide Test: An Improved Method for the Detection of Left‐to‐Right Shunts (1958) (56)
Expanding indications for beta-blockers in heart failure. (2001) (56)
Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction. (2004) (56)
Studies on the Function of the Adrenergic Nerve Endings in the Heart (1963) (56)
B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial. (2010) (56)
Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromes. (2002) (56)
Studies on Digitalis: III. The Influence of Triiodothyronine on Digitalis Requirements (1961) (55)
The effects of acutely increased systemic resistance on the left atrial pressure pulse: a method for the clinical detection of mitral insufficiency. (1958) (55)
Effect of alterations in the thyroid state on the intrinsic contractile properties of isolated rat skeletal muscle. (1970) (55)
Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction. (2006) (55)
Effects of altering ventricular rate on blood flow distribution in conscious dogs. (1971) (55)
Outcomes and Optimal Antithrombotic Therapy in Women Undergoing Fibrinolysis for ST-Elevation Myocardial Infarction (2007) (55)
Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial. (2016) (55)
Interatrial Communication and Left Atrial Hypertension: A Cause of Continuous Murmur (1963) (55)
Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. (2001) (55)
The Incidence and Management of “Medical” Complications Following Cardiac Operations (1965) (55)
The effect of mephentermine sulfate on myocardial oxygen consumption, myocardial efficiency and peripheral vascular resistance. (1958) (55)
Coronary reperfusion for the treatment of acute myocardial infarction: postischemic ventricular dysfunction. (1983) (54)
Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial (2013) (54)
Induced septal infarction: a new therapeutic strategy for hypertrophic obstructive cardiomyopathy. (1997) (54)
Effects of Ranolazine on Disease-Specific Health Status and Quality of Life Among Patients With Acute Coronary Syndromes: Results from the MERLIN-TIMI 36 Randomized Trial (2008) (54)
Demonstration of Lateral and Epicardial Border Zone Salvage by Flurbiprofen Using an In Vivo Method for Assessing Myocardium at Risk (1981) (54)
Association between blood glucose and long-term mortality in patients with acute coronary syndromes in the OPUS-TIMI 16 trial. (2006) (53)
Cell-Based Therapy in Cardiac Regeneration: An Overview (2018) (53)
The effects of exercise on central blood volume in man. (1960) (53)
Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease. (2018) (53)
Role of arterial baroreceptors in mediating cardiovascular response to exercise. (1976) (53)
Congenital Aortopulmonary Septal Defect: Clinical and Hemodynamic Findings, Surgical Technic, and Results of Operative Correction (1962) (53)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (53)
Effects of Angiotensin Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease: The Prevention of Events With Angiotensin Converting Enzyme Inhibition (PEACE) Trial: The PEACE Study Investigators (2005) (53)
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion. (2004) (53)
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. (2004) (53)
Cardiology: the past, the present, and the future (2003) (53)
Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Thrombolysis in Myocardial Infarction Investigators. (1995) (53)
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial. (2019) (53)
Direct Positive Inotropic Effect of Acetylcholine on Myocardium (1966) (53)
Congestive heart failure : current research and clinical applications (1982) (53)
THE EFFECTS OF AUTONOMIC NERVOUS SYSTEM INHIBITION ON THE CIRCULATORY RESPONSE TO MUSCULAR EXERCISE. (1962) (53)
HARMONIC ANALYSIS OF PRESSURE PULSES OBTAINED FROM THE HEART AND GREAT VESSELS OF MAN. (1965) (52)
Catheterization studies of cardiac hemodynamics in normal pregnant women with reference to left ventricular work. (1956) (52)
The platelet PlA2 and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction (2001) (52)
Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (2014) (52)
Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. (2007) (52)
CORRECTED TRANSPOSITION OF THE AORTA AND PULMONARY TRUNK: CLINICAL, HEMODYNAMIC AND PATHOLOGIC FINDINGS. (1964) (52)
Diagnostic Value of the First and Second Derivatives of the Arterial Pressure Pulse in Aortic Valve Disease and in Hypertrophic Subaortic Stenosis (1964) (51)
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. (2021) (51)
Hemodynamic‐Phonocardiographic Correlations of the Fourth Heart Sound in Aortic Stenosis (1962) (51)
Effect of Alterations of Coronary Blood Flow on the Oxygen Consumption of the Nonworking Heart (1963) (51)
Studies on digitalis. XI. Effects of digitoxin on the development of cardiac hypertrophy in the rat subjected to aortic constriction. (1965) (51)
Effects of Acute Valvular Regurgitation on the Oxygen Consumption of the Canine Heart (1968) (51)
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials. (1995) (51)
Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. (2001) (51)
Cardiac dimensions in intact unanesthetized man. VI. Effects of changes in heart rate. (1966) (51)
Vasodilator therapy of heart failure. Has the promissory note been paid? (1984) (51)
Present Status of Digitalis Treatment of Acute Myocardial Infarction (1972) (50)
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. (2008) (50)
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial. (2014) (50)
Sharing Data from Cardiovascular Clinical Trials--A Proposal. (2016) (50)
Discrete Subaortic Stenosis Complicated by Aortic Valvular Regurgitation: Clinical, Hemodynamic, and Pathologic Studies and the Results of Operative Treatment (1965) (50)
Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group. (1990) (50)
A risk score to estimate the likelihood of coronary artery bypass surgery during the index hospitalization among patients with unstable angina and non-ST-segment elevation myocardial infarction. (2004) (50)
Congenital heart block. (1956) (50)
Influence of aortic pressure-induced homeometric autoregulation on myocardial performance. (1968) (50)
Association Between Platelet Receptor Occupancy After Eptifibatide (Integrilin) Therapy and Patency, Myocardial Perfusion, and ST-Segment Resolution Among Patients With ST-Segment–Elevation Myocardial Infarction: An INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) Substudy (2004) (50)
Treatment of the patient after myocardial infarction. The last decade and the next. (1980) (49)
Myocardial ischemia (third of three parts). (1977) (49)
The Effects of Surgical Abolition of Left‐to‐Right Shunts on the Pulmonary Vascular Dynamics of Patients with Pulmonary Hypertension (1962) (49)
Factors associated with failure of medical therapy in patients with unstable angina and non-Q wave myocardial infarction. A TIMI-IIIB database study. (1999) (49)
Assessment of Left Ventricular Performance in Man: Instantaneous Tension‐Velocity‐Length Relations Obtained with the Aid of an Electromagnetic Velocity Catheter in the Ascending Aorta (1973) (49)
Right Bundle‐Branch Block. Hemodynamic, Vectorcardiographic and Electrocardiographic Observations (1956) (49)
Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†. (2015) (49)
Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study. (1992) (49)
Selection bias in the use of thrombolytic therapy in acute myocardial infarction. The SAVE Investigators. (1991) (49)
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. (1985) (49)
Applying the open artery theory: use of predictive survival markers. (1998) (49)
Redefining medical treatment in the management of unstable angina. (2011) (48)
GUSTO, TIMI and the case for rapid reperfusion. (1994) (48)
FAMILIAL PULMONARY HYPERTENSION. (1963) (48)
The Thrombolysis in Myocardial Infarction (TIMI) Trial (1994) (48)
Reduction of Myocardial-Infarct Size (1974) (48)
Special correspondence: A debate on coronary bypass. (1977) (47)
Left heart catheterization: an appraisal of techniques and their applications in cardiovascular diagnosis. (1960) (47)
Congestive heart failure: a half century perspective (2001) (47)
ESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007. (2008) (47)
Reduction of Infarct Size Following Coronary Occlusion (1974) (47)
Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q-wave myocardial infarction. Observations from the TIMI IIIB Trial. (1996) (47)
Outcomes of Women Compared With Men After Non-ST-Segment Elevation Acute Coronary Syndromes. (2019) (47)
Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In (2014) (47)
Determinants and assessment of cardiac function. (1977) (47)
Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. (2015) (47)
Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy (2008) (47)
Protection of hypoxic guinea pig hearts with glucose and insulin. (1974) (47)
Ventricular enlargement following infarction is a modifiable process. (1991) (47)
Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. (2019) (47)
Potent P2Y12 Inhibitors in Men Versus Women: A Collaborative Meta-Analysis of Randomized Trials. (2017) (47)
Evidence for a role of Langerhans cell-derived IL-16 in atopic dermatitis. (2002) (47)
A simplified plethysmographic system for the measurement of systemic arterial pressure and peripheral blood flow (1962) (46)
Clinical trials in cardiovascular disease : a companion to Braunwald's heart disease (1999) (46)
Congenital Aortic Stenosis: Clinical and Hemodynamic Findings, Surgical Technic, and Results of Operation (1958) (46)
Intrinsic platelet reactivity before P2Y12 blockade contributes to residual platelet reactivity despite high-level P2Y12 blockade by prasugrel or high-dose clopidogrel (2011) (46)
Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators. (1995) (46)
Topographic changes in the left ventricle after experimentally induced myocardial infarction in the rat. (1983) (46)
Reduction of Cardiac Stores of Norepinephrine in Experimental Heart Failure (1964) (46)
Long-Term Preservation of Ischemic Myocardium in the Dog by Hyaluronidase (1978) (46)
Effect of pharmacologic agents on the function of the ischemic heart. (1973) (46)
Studies on digitalis. XVII. Effects of ouabain on the hemodynamic response to exercise in patients with mitral stenosis in normal sinus rhythm. (1968) (46)
Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. (1991) (46)
Time as an adjunctive agent to thrombolytic therapy (2005) (46)
Alterations in Regional Pulmonary Blood Flow in Patients with Congenital Heart Disease Studied by Radioisotope Scanning (1968) (46)
Exercise in patients with heart disease. Effects of body position and type and intensity of exercise. (1969) (45)
Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. (1968) (45)
Studies on Digitalis XIV: Influence of Cardiac Norepinephrine Stores on the Response of Isolated Heart Muscle to Digitalis (1966) (45)
Significance of an Atrial Gallop Sound in Mitral Regurgitation: A Clue to the Diagnosis of Ruptured Chordae Tendineae (1967) (45)
Evolution of Hypertrophic Cardiomyopathy to a Contemporary Treatable Disease (2012) (45)
Gliflozins in the Management of Cardiovascular Disease. (2022) (45)
Studies on Starling's Law of the Heart: VIII. Mechanical Properties of Human Myocardium Studied in Vivo (1962) (44)
Prognostic significance of the Karnofsky Performance Status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance. The MILIS Study Group. (1991) (44)
Interactions between Changes in the Intensity and Duration of the Active State in the Characterization of Inotropic Stimuli on Heart Muscle (1967) (44)
Ventricular performance in rats with myocardial infarction and failure. (1984) (44)
Regional Hemodynamic Effects of a Digitalis Glycoside in the Conscious Dog with and without Experimental Heart Failure (1972) (44)
The path to myocardial salvage by thrombolytic therapy. (1987) (44)
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A. (1997) (44)
Coronary plaque erosion: recognition and management. (2013) (44)
OBSTRUCTION TO LEFT VENTRICULAR OUTFLOW. CURRENT CRITERIA FOR THE SELECTION OF PATIENTS FOR OPERATION. (1963) (44)
Upstream Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Treatment in Patients With Acute Coronary Syndrome: An Analysis From the Early Glycoprotein IIb/IIIa Inhibition in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) Trial (2011) (44)
Effects of Prior Aspirin and Anti-Ischemic Therapy on Outcome of Patients With Unstable Angina 1 (1998) (44)
Studies on Digitalis: VI. Reduction of the Oxygen Debt after Exercise with Digoxin in Cardiac Patients without Heart Failure (1963) (44)
Left Ventricular Function Following Replacement of the Aortic Valve: Hemodynamic Responses to Muscular Exercise (1966) (43)
Abciximab (ReoPro) potentiates thrombolysis in ST elevation myocardial infarction: results of TIMI 14 trials (1998) (43)
Morning resistance to thrombolytic therapy. (1995) (43)
Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices (2016) (43)
Evaluating the efficacy of new inotropic agents. (1984) (43)
Observations on experimental myocardial ischaemia. (1980) (43)
Ventricular Remodeling Does Not Accompany the Development of Heart Failure in Diabetic Patients After Myocardial Infarction (2002) (43)
STUDIES ON DIGITALIS. VII. INFLUENCE OF HYPER- AND HYPOTHYROIDISM ON THE MYOCARDIAL RESPONSE TO OUABAIN (1963) (43)
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. (2017) (43)
Causes of late mortality with dual antiplatelet therapy after coronary stents. (2015) (43)
The Effects of Hyaluronidase on Coronary Blood Flow following Coronary Artery Occlusion in the Dog (1977) (43)
Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2017) (43)
The rise of cardiovascular medicine. (2012) (43)
Effect of hyaluronidase during the early phase of acute myocardial ischemia: an ultrastructural and morphometric analysis. (1977) (42)
Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board (2007) (42)
GLP-1 Agonist Therapy for Advanced Heart Failure With Reduced Ejection Fraction: Design and Rationale for the Functional Impact of GLP-1 for Heart Failure Treatment Study (2014) (42)
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure (2016) (42)
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis (2021) (42)
Relations between bleeding and outcomes in patients with ST-elevation myocardial infarction in the ExTRACT-TIMI 25 trial. (2010) (42)
The Use of Ascorbate Dilution Curves in Cardiovascular Diagnosis: Applications of a Technic for Direct Intravascular Detection of Indicator (1961) (42)
Resting Ventricular–Vascular Function and Exercise Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study (2014) (41)
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial (2017) (41)
Detection of Pulmonic and Tricuspid Valvular Regurgitation by Means of Indicator Solutions (1959) (41)
Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty. (1995) (41)
Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial". (2015) (41)
Intramural PCO2: a reliable index of the severity of myocardial ischemic injury. (1979) (41)
Pharmacokinetics and Pharmacodynamics of Tenecteplase: Results from a Phase II Study in Patients with Acute Myocardial Infarction (2000) (41)
Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends. (2013) (41)
Left ventricular mechanics and oxygen consumption during arterial counterpulsation. (1969) (41)
Left ventriculo-right atrial communication (1960) (41)
Sounding Boards. Let's not let the genie escape from the bottle--again. (1981) (41)
A flow- and time-dependent index of ischemic injury after experimental coronary occlusion and reperfusion. (1983) (41)
Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial. (1989) (41)
On analysing scientific fraud (1987) (41)
Thrombolytic therapy for patients with myocardial infarction who are older than 75 years. Do the risks outweigh the benefits? (2000) (41)
Optimizing thrombolytic therapy of acute myocardial infarction. (1990) (41)
Abciximab and early adjunctive percutaneous coronary intervention are associated with improved ST-segment resolution after thrombolysis: Observations from the TIMI 14 Trial. (2001) (40)
Influence of Syrosingopine on the Cardiovascular Response to Acute Hypoxemia and Exercise (1961) (40)
Estimating treatment effects from observational data: dissonant and resonant notes from the SYMPHONY trials. (2002) (40)
50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout. (1999) (40)
Fatal familial cardiac arrhythmias. Histologic observations on the cardiac conduction system. (1972) (40)
A simplified method to predict occurrence of complete heart block during acute myocardial infarction (1986) (40)
Assessing the Current Role of Platelet Function Testing (2008) (40)
Coexistence and outcome of coronary artery disease in Takotsubo syndrome. (2020) (40)
The Problem of Persistent Platelet Activation in Acute Coronary Syndromes and Following Percutaneous Coronary Intervention (2008) (40)
Obesity and cardiovascular events in patients with established coronary disease. (2006) (40)
Severity of heart failure, treatments, and outcomes after fibrinolysis in patients with ST-elevation myocardial infarction. (2004) (39)
Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strate (1998) (39)
Acute myocardial infarction--the value of being prepared. (1996) (39)
International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. (1987) (39)
Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51). (2013) (39)
Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics (2021) (39)
Mechanochemistry of cardiac muscle. V. Influence of thyroid state on energy utilization. (1971) (39)
The Role of Arterial Baroreceptors in the Regulation of Arterial Pressure in Conscious Dogs (1976) (39)
DETERMINANTS OF THE DURATION OF THE REFRACTORY PERIOD OF THE ATRIOVENTRICULAR NODAL SYSTEM IN MAN. (1965) (39)
STUDIES ON THE CARDIOCIRCULATORY ACTIONS OF DIGITALIS (1965) (39)
Calcium-channel blockers: pharmacologic considerations. (1982) (39)
Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. (2009) (39)
50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout. (2000) (39)
Systemic hemodynamic effects of leukotrienes C4 and D4 in the rat. (1983) (38)
Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: Impact of age (A Meta-Analysis of a Decade of Trials) (2006) (38)
Congestive heart failure. Biochemical and physiological considerations. Combined clinical staff conference at the National Institutes of Health. (1966) (38)
Noninvasive detection of vulnerable coronary plaques: Locking the barn door before the horse is stolen. (2009) (38)
The management of heart failure: the past, the present, and the future. (2008) (38)
Heart failure: pathophysiology and treatment. (1981) (38)
Role of tachycardia in mediating the coronary hemodynamic response to severe exercise. (1972) (38)
Augmentation of Myocardial Oxygen Consumption in Hyperthyroid Cats (1970) (38)
Effects of amrinone on experimental acute myocardial ischaemic injury. (1980) (38)
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). (2008) (38)
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content. (2021) (38)
Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel. (2007) (38)
Prior aspirin use and outcomes in acute coronary syndromes. (2010) (38)
Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram. (2000) (38)
Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Overview of Randomized Clinical Trials (2011) (37)
Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure. (2012) (37)
The year in non-ST-segment elevation acute coronary syndrome. (2005) (37)
Effect of respiration on venous return and stroke volume in cardiac tamponade (1970) (37)
Pulsus Alternans in Aortic Stenosis: Hemodynamic Observations in 50 Patients Studied by Left Heart Catheterization (1958) (36)
Impact of treatment with saxagliptin on glycaemic stability and β‐cell function in the SAVOR‐TIMI 53 study (2015) (36)
Applicability of Starling's Law of the Heart to Man (1964) (36)
Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis In Myocardial Infarction) (2018) (36)
SLOWING OF HEART RATE, ELECTROAUGMENTATION OF VENTRICULAR PERFORMANCE, AND INCREASE OF MYOCARDIAL OXYGEN CONSUMPTION PRODUCED BY PAIRED ELECTRICAL STIMULATION. (1965) (36)
Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II. (2002) (36)
Assessment of the efficacy of interventions to limit ischemic injury by direct measurement of intramural carbon dioxide tension after coronary artery occlusion in the dog. (1979) (36)
Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure. (1981) (36)
Association of smoking with improved myocardial perfusion and the angiographic characterization of myocardial tissue perfusion after fibrinolytic therapy for ST-segment elevation myocardial infarction. (2005) (36)
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54) (2016) (36)
Treatment of Paroxysmal Supraventricular Tachycardia by Electrical Stimulation of the Carotid-Sinus Nerves (1969) (36)
Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry). (1997) (36)
Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16 (2008) (36)
The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial (2017) (36)
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction (2020) (35)
Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations. (2016) (35)
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. (1998) (35)
Transseptal left heart catheterization: a new diagnostic method. (1960) (35)
Coronary Angioplasty Performed Within the Thrombolysis in Myocardial Infarction II Study (1992) (35)
Relationships Between the Release and Tissue Depletion of Norepinephrine from the Heart by Guanethidine and Reserpine (1963) (35)
Comparison of the Peak Inotropic Effects of a Catecholamine and a Digitalis Glycoside in the Intact Canine Heart (1970) (35)
Effective Closure of the Mitral Valve without Atrial Systole (1966) (35)
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes (2012) (35)
Coronary stent thrombosis with vorapaxar versus placebo: results from the TRA 2° P-TIMI 50 trial. (2014) (35)
An editorial introduction to the symposium (1966) (34)
Treatment of Heart Failure With Preserved Ejection Fraction: Reflections on Its Treatment With an Aldosterone Antagonist. (2016) (34)
The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure. (2019) (34)
Association of platelet count with residual thrombus in the myocardial infarct-related coronary artery among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. (2004) (34)
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease. (2019) (34)
Effect of verapamil on infarct size in dogs subjected to coronary artery occlusion with transient reperfusion. (1986) (34)
Digitalis: new facts about an old drug. (1968) (34)
Congenital mitral regurgitation. Clinical, hemodynamic and angiocardiographic findings in nine patients. (1962) (34)
Left atrial structure and function and the risk of death or heart failure in atrial fibrillation (2019) (34)
Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator. (1990) (34)
Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfu (2006) (34)
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators. (1996) (34)
Klotho, fibroblast growth factor‐23, and the renin–angiotensin system — an analysis from the PEACE trial (2017) (34)
Peripheral Revascularization in Patients With Peripheral Artery Disease With Vorapaxar: Insights From the TRA 2°P-TIMI 50 Trial. (2016) (34)
The Adrenergic Nervous System in the Control of the Normal and Failing Heart (1965) (33)
Aortic valve replacement: an update at the turn of the millennium. (2000) (33)
Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog. (1980) (33)
Timing of electrical and mechanical events of the left side of the human heart. (1955) (33)
Hospitalizations for heart failure in the United States--a sign of hope. (2011) (33)
Paired electrical stimulation. A comparison of the effects on performance of the failing and nonfailing heart. (1966) (33)
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myo (2009) (33)
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome (2018) (33)
Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. (1994) (33)
Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50 (2015) (33)
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial). (1997) (33)
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial (2017) (33)
Thrombolytic reperfusion of acute myocardial infarction: resolved and unresolved issues. (1988) (33)
Intracardiac Injection of Radioactive Krypton: Clinical Applications of New Methods for Characterization of Circulatory Shunts (1960) (32)
Association of the timing of ST-segment resolution with TIMI myocardial perfusion grade in acute myocardial infarction. (2004) (32)
Thrombolysis in Myocardial Infarction (TIMI) Risk Index predicts long-term mortality and heart failure in patients with ST-elevation myocardial infarction in the TIMI 2 clinical trial. (2009) (32)
Analysis of the Acute Circulatory Effects of Guanethidine and Bretylium (1962) (32)
Aortic Stenosis: Then and Now. (2018) (32)
Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II). (1995) (32)
Cooperative study on cardiac catheterization. Summary. (1968) (32)
New ischemic stroke and outcomes with vorapaxar versus placebo: results from the TRA 2 °P-TIMI 50 trial. (2014) (32)
Thrombolytic therapy. A new strategy for the treatment of acute myocardial infarction (2). (1984) (32)
Aortic stenosis: physiological, pathological, and clinical concepts. Combined Clinical Staff Conference at the National Institutes of Health. (1963) (32)
THE KRYPTON85 INHALATION TEST FOR THE DETECTION OF LEFT-TO-RIGHT SHUNTS (1962) (32)
A study of the electrocardiogram and vectorcardiogram in congenital heart disease. III. Electrocardiographic and vectorcardiographic findings in various malformations. (1955) (31)
Ventriculo-atrial regurgitation following prosthetic replacement of the mitral valve. Angiocardiographic and hemodynamic findings. (1966) (31)
Managing Stable Ischemic Heart Disease. (2020) (31)
PROSTHETIC REPLACEMENT OF THE MITRAL VALVE. OPERATIVE METHODS AND THE RESULTS OF PREOPERATIVE AND POSTOPERATIVE HEMODYNAMIC ASSESSMENTS. (1964) (31)
Discharge aspirin dose and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel: an analysis from the TRITON-TIMI 38 study (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial (2014) (31)
CLINICAL APPLICATIONS OF AN IMPROVED, RAPIDLY RESPONDING FIBEROPTIC CATHETER. (1965) (31)
Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54 (2019) (31)
JACC: Cardiovascular Interventions: the end of the beginning. (2008) (31)
Inhibition of the adrenergic nervous system in the treatment of angina pectoris. (1968) (31)
Effects of Changes in Body Position on the Severity of Obstruction to Left Ventricular Outflow in Idiopathic Hypertrophic Subaortic Stenosis (1966) (31)
Treatment of Hypertension: Addressing a Global Health Problem. (2018) (31)
Heparin inhibits bovine testicular hyaluronidase activity in myocardium of dogs with coronary artery occlusion. (1984) (30)
Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c. (2016) (30)
The development of elevated pulmonary vascular resistance in man following increased pulmonary blood flow from systemic-pulmonary anastomoses (1962) (30)
A New, Noninvasive Technique for Inducing Post-extrasystolic Potentiation during Echocardiography (1977) (30)
Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat. (1983) (30)
Effects of Frequency of Contraction and lonic Environment on the Responses of Heart Muscle to Acetylcholine (1967) (30)
Use of composite endpoints in thrombolysis trials of acute myocardial infarction. (1993) (30)
Localization of left-to-right cardiac shunts by dye-dilution curves following injection into the left side of the heart and into the aorta. (1958) (30)
Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. (1997) (30)
Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction. (2020) (30)
Myocardial infarct extension: occurrence, outcome, and risk factors in the Multicenter Investigation of Limitation of Infarct Size. (1988) (30)
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia. (1998) (30)
Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. (1987) (30)
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators. (1999) (30)
Linking Endogenous Factor Xa Activity, a Biologically Relevant Pharmacodynamic Marker, to Edoxaban Plasma Concentrations and Clinical Outcomes in the ENGAGE AF-TIMI 48 Trial (2018) (30)
Metformin Use and Clinical Outcomes among Patients with Diabetes with or without Heart Failure or Kidney Dysfunction: Observations from the SAVOR-TIMI 53 Trial. (2019) (29)
Evidence-Based Coronary Care (1997) (29)
PROTEIN-LOSING ENTEROPATHY SECONDARY TO CONSTRICTIVE PERICARDITIS IN CHILDHOOD. (1964) (29)
Time to reperfusion: The critical modulator in thrombolysis and primary angioplasty (2004) (29)
Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure. (1981) (29)
Effects of Acutely Induced Ischemic Heart Failure on Myocardial High Energy Phosphate Stores (1967) (29)
Feasibility and hazards of the intracoronary injection of radioactive serum albumin macroaggregates for external myocardial perfusion imaging. (1971) (29)
Calcific Pulmonic Stenosis (1968) (29)
The Effects of Mitral Regurgitation on the Pattern of Instantaneous Aortic Blood Flow Clinical and Experimental Observations (1967) (29)
Effects of Acute Hypoxia on the Volume of Blood in the Thorax (1960) (29)
Effects of hypoxemia on the extent of myocardial necrosis after experimental coronary occlusion. (1975) (28)
Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. (2016) (28)
Effects of Aortic Regurgitation on Left Ventricular Performance: Direct Determinations of Aortic Blood Flow Before and After Valve Replacement (1965) (28)
Origin of Heart Sounds as Elucidated by Analysis of the Sequence of Cardiodynamic Events (1958) (28)
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients: Design and Rationale of the EXACT-HF Study (2013) (28)
Selective left heart angiocardiography by the transseptal route. (1962) (28)
Treatment of angina pectoris by electrical stimulation of the carotid-sinus nerves. (1970) (28)
Problems in assessment of new pharmacologic agents for the heart failure patient. (1981) (28)
Harrison's Advances in Cardiology (2002) (28)
Targeting the Kidney in Acute Heart Failure: Can Old Drugs Provide New Benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) Trial (2013) (28)
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial (2018) (28)
Unstable angina and non-ST-segment elevation myocardial infarction: part I. Initial evaluation and management, and hospital care. (2004) (28)
The Thrombolysis in Myocardial Infarction (TIMI) trials: the first decade. (1995) (28)
Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial. (1993) (28)
Association of a History of Systemic Hypertension With Mortality, Thrombotic, and Bleeding Complications Following Non‐ST‐Segment Elevation Acute Coronary Syndrome (2006) (27)
Uptake and Metabolism of Tritiated Norepinephrine in the Isolated Canine Heart (1963) (27)
Hypertrophic cardiomyopathy--continued progress. (1989) (27)
Diastolic Dysfunction in Individuals With Human Immunodeficiency Virus Infection: Literature Review, Rationale and Design of the Characterizing Heart Function on Antiretroviral Therapy (CHART) Study. (2018) (27)
Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trail (1991) (27)
Future shock in academic medicine. (1972) (27)
Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. (2011) (27)
Impact of ADCY9 Genotype on Response to Anacetrapib (2019) (27)
Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure. (1981) (27)
Coronary artery spasm as a cause of myocardial ischemia. (1981) (27)
Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials (2018) (27)
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: Observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS–TIMI 16) trial (2005) (27)
Limitation of infarct size. (1978) (27)
Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classification. (2002) (27)
Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists. (2020) (26)
Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial. (2019) (26)
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial. (2015) (26)
CIRCULATORY RESPONSE TO HYPOXIA IN UNANESTHETIZED DOGS WITH AND WITHOUT CARDIAC DENERVATION. (1964) (26)
Abnormalities in reflex control of the circulation in familial dysautonomia. Effects of changes in posture on venous and arterial constriction in normal subjects and in patients with dysautonomia. (1966) (26)
Mechanism of norepinephrine-induced stimulation of myocardial oxygen consumption. (1971) (26)
Seasonal variation of myocardial infarct size. (2001) (26)
Effects of hypertension on cardiac performance in rats with myocardial infarction. (1982) (26)
Personal reflections on efforts to reduce ischemic myocardial damage. (2002) (26)
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. (2001) (26)
Atlas of heart diseases (1995) (26)
Antecedent hypertension and the effect of captopril on the risk of adverse cardiovascular outcomes after acute myocardial infarction with left ventricular systolic dysfunction: Insights from the Survival and Ventricular Enlargement Trial. (2004) (26)
CLINICAL AND HEMODYNAMIC APPRAISAL OF BETA ADRENERGIC BLOCKING DRUGS (1967) (26)
First report of an intravenous and oral glycoprotein IIb/IIIa inhibitor (RPR 109891) in patients with recent acute coronary syndromes: results of the TIMI 15A and 15B trials. (2000) (25)
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT). (2016) (25)
Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. (2002) (25)
The Use of β-Blockers After Myocardial Infarction (1983) (25)
The Risk Score Profile: a novel approach to characterising the risk of populations enrolled in clinical studies. (2004) (25)
STUDIES ON THE MECHANISM OF ACTION OF METARAMINOL (ARAMINE). (1963) (25)
Integrity of Energy Stores in Cat Papillary Muscle (1968) (25)
Clinical importance of stunned and hibernating myocardium (2001) (25)
Dye-Dilution Curves from Left Heart and Aorta for Localization of Left-to-Right Shunts and Detection of Valvular Insufficiency (1957) (25)
The Prognostic Significance of Cardiac Structure and Function in Atrial Fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy. (2016) (25)
Effects of transient increased afterload during experimentally induced acute myocardial infarction in dogs. (1985) (25)
Symposium on Diagnostic Methods in the Study of Left‐to‐Right Shunts (1957) (24)
Abstract 16612: Efficacy and Safety of Edoxaban for the Management of Elderly Patients With Atrial Fibrillation: Engage AF-TIMI 48 (2014) (24)
Precordial Scanning: Applications in the Detection of Left‐to‐Right Circulatory Shunts (1961) (24)
Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction (2019) (24)
Determination of a weight-adjusted dose of TNK-tissue plasminogen activator. (2001) (24)
Adrenergic control of myocardial contractility in conscious hyperthyroid dogs. (1979) (24)
The year in acute coronary syndrome. (2014) (24)
Beta-adrenergic blockade : a new era in cardiovascular medicine (1978) (24)
Enhancing thrombolytic efficacy by means of "front-loaded" administration of tissue plasminogen activator. (1989) (24)
Coronary Artery Graft Disease (1994) (24)
The Thrombolysis in Myocardial Infarction (TIMI) Trial phase II: additional information and perspectives. (1990) (24)
Catheterization of the left side of the heart. A key to the solution of some perplexing problems in cardiovascular diagnosis and management. (1960) (24)
Effects of Reserpine and Guanethidine on Venous Reflexes (1962) (24)
Effects of Prostaglandin A1 on the Systemic and Coronary Circulations in the Conscious Dog (1971) (24)
Neurohormones in heart failure: predicting outcomes, optimizing care. (2004) (24)
Fundamental mechanisms in congestive heart failure. (1968) (24)
Cooperative study on cardiac catheterization. Total population studied, procedures employed, and incidence of complications. (1968) (24)
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention. (2018) (24)
Performance of the thrombolysis in myocardial infarction risk index for early acute coronary syndrome in the national registry of myocardial infarction: A simple risk index predicts mortality in both ST and non-ST elevation myocardial infarction (2003) (23)
Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration. (2002) (23)
The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial. (2001) (23)
Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation myocardial infarction. (2009) (23)
Effects of isoproterenol on contractile function of the ischemic and anoxic heart. (1974) (23)
The year in non-ST-segment elevation acute coronary syndrome. (2009) (23)
Usefulness of tirofiban among patients treated without percutaneous coronary intervention (TIMI high risk patients in PRISM-PLUS). (2004) (23)
Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies. (2006) (23)
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial. (2007) (23)
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy (2006) (23)
Intensive lipid lowering with atorvastatin in coronary disease. (2005) (23)
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry. (2002) (23)
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials (2022) (23)
Nonobstructive Hypertrophic Cardiomyopathy Out of the Shadows: Known from the Beginning but Largely Ignored … Until Now. (2017) (23)
High‐Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network (2018) (23)
Combined Prosthetic Replacement of the Mitral and Aortic Valves: Preoperative and Postoperative Hemodynamic Studies at Rest and the Left Ventricular Response to Muscular Exercise (1967) (23)
Non-Q wave and ST segment depression myocardial infarction: is there a role for thrombolytic therapy? (1996) (23)
Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available. (1983) (22)
2004 ACC/AHA guideline for the management of patients with STEMI: the implications for clinicians (2005) (22)
Intracoronary thallium-201 scintigraphy after thrombolytic therapy for acute myocardial infarction compared with 10 and 100 day intravenous thallium-201 scintigraphy. (1987) (22)
The role of propranolol's negative chronotropic effect on protection of the ischemic myocardium. (1979) (22)
Quantitative Comparison of Coronary Artery Flow and Myocardial Perfusion in Patients with Acute Myocardial Infarction in the Presence and Absence of Recent Cocaine Use (2002) (22)
Will diabetes save the platelet blockers? (2001) (22)
TIHROMBOLYSIS Thrombolysis in Myocardial Infarction ( TIMI ) Trial , Phase I : a comparison between intravenous tissue plasminogen activator and intravenous streptokinase (22)
Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world. (2012) (22)
Prevalence and Outcomes of Polyvascular (Coronary, Peripheral, or Cerebrovascular) Disease in Patients With Diabetes Mellitus (From the SAVOR-TIMI 53 Trial). (2019) (22)
Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: a TIMI 14 analysis (1999) (22)
Coronary artery patency in patients with myocardial infarction. (1990) (22)
Effects of Chronic Heart Failure on the Inotropic Response of the Right Ventricle of the Conscious Dog to a Cardiac Glycoside and to Tachycardia (1974) (22)
PERCUTANEOUS PUNCTURE OF THE LEFT VENTRICLE (1961) (22)
Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines. (2020) (22)
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial. (2017) (22)
Statin and Aspirin Therapy for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus (2012) (22)
Editorial: Paired Electrical Stimulation of the Heart A Physiologic Riddle and a Clinical Challenge (1965) (22)
Effect of hyaluronidase on mortality and morbidity in patients with early peaking of plasma creatine kinase MB and non-transmural ischaemia. Multicentre investigation for the limitation of infarct size (MILIS). (1988) (21)
Molecular Changes After Left Ventricular Assist Device Support for Heart Failure (2013) (21)
Cardiovascular science: opportunities for translating research into improved care. (2013) (21)
Myocardial Stunning and Hibernation: Mechanisms and Clinical Implication (1992) (21)
Myocardial contractility in man: The acute effects of digitalis, sympathomimetic amines, and anoxic cardiac arrest. (1960) (21)
Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction. (1997) (21)
Lower dose heparin with thrombolysis is associated with lower rates of intracranial hemorrhage: results from TIMI 10B and ASSENT I (1997) (21)
Clinical Efforts to Reduce Myocardial Infarct Size—The Next Step (2011) (21)
Saxagliptin, alogliptin, and cardiovascular outcomes. (2014) (21)
Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome (2018) (21)
The Simon Dack lecture. Cardiology: the past, the present, and the future. (2003) (21)
The effect of verapamil on myocardial ultrastructure during and following release of coronary artery occlusion. (1982) (21)
Carotid sinus nerve stimulation in the treatment of angina pectoris and supraventricular tachycardia. (1970) (21)
Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial). (2011) (21)
Diagnosing and Managing Unstable Angina, Quick Reference Guide for Clinicians (1994) (21)
The stunned myocardium: newer insights into mechanisms and clinical implications. (1990) (21)
The effect of rivaroxaban on myocardial infarction in the ATLAS ACS 2 - TIMI 51 trial (2015) (20)
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial (2021) (20)
Studies on digitalis. XII. The effects of paired electrical stimulation on digitalis-induced arrhythmias. (1966) (20)
Incidence, treatment, and outcomes of atrial fibrillation complicating non-ST-segment elevation acute coronary syndromes. (2013) (20)
The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. (2001) (20)
Effects of serotonin on the contractile state of the myocardium. (1967) (20)
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation. (2021) (20)
Sympathetic Innervation of the Developing Rabbit Heart (2005) (20)
Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction (2012) (20)
Idiopathic hypertrophic subaortic stenosis. Effects of changes in heart rate on the severity of obstruction to left ventricular outflow. (1967) (20)
A Simplified Indicator‐Dilution Technic for the Localization of Left‐to‐Right Circulatory Shunts: An Experimental and Clinical Study of Intravenous Injection with Right Heart Sampling (1959) (20)
HÆMODYNAMIC ALTERATIONS INDUCED BY ISOPRENALINE IN PATIENTS WITH OBSTRUCTION TO RIGHT VENTRICULAR OUTFLOW (1965) (20)
Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36 (2015) (20)
The use of simultaneous left heart pressure pulse measurements in evaluating the effects of mitral valve surgery. (1955) (20)
The Denolin lecture. Congestive heart failure: a half century perspective. (2001) (20)
Diastolic Dysfunction in Patients with Human Immunodeficiency Virus Receiving Antiretroviral Therapy: Results from the CHART Study. (2020) (20)
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy). (2018) (20)
Coronary Artery Graft Disease: Mechanisms and Prevention (1994) (20)
Departments, divisions and centers in the evolution of medical schools. (2006) (20)
Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. (2019) (19)
Regulation of the circulation (second of two parts). (1974) (19)
Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)‐TIMI 50 (2016) (19)
Left heart catheterization in infants and children. (1962) (19)
High-Sensitivity Troponin I in Stable Patients with Atherosclerotic Disease in the TRA 2°P - TIMI 50 Trial. (2017) (19)
Intravenous Bovine Testicular Hyaluronidase Depolymerizes Myocardial Hyaluronic Acid in Dogs with Coronary Artery Occlusion (1981) (19)
Carotid Sinus Nerve Stimulation for the Treatment of Intractable Angina Pectoris: Surgical Technic (1970) (19)
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. (2021) (19)
Effects of ventricular stimulation and potassium administration on digitalis-induced arrhythmias. (1970) (19)
Medication Discontinuation in the IMPROVE-IT Trial (2019) (19)
Recent trials of lipid lowering (2007) (19)
Simultaneous Pressure Pulses in the Human Left Atrium, Ventricle and Aorta: Preliminary Communication (1954) (19)
Comparative effects of sotalol and propranolol on myocardial contractility. (1973) (19)
Pleiotropic effect of lovastatin, with and without cholestyramine, in the post coronary artery bypass graft (Post CABG) trial. (2008) (19)
Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial (2020) (19)
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. (1998) (19)
Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial). (2018) (19)
Effects of hyaluronidase and hydrocortisone on myocardial necrosis after coronary occlusion. (1976) (19)
Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. (2020) (19)
The year in non-ST-segment elevation acute coronary syndromes. (2005) (19)
Familial occurrence of primary pulmonary hypertension. (1966) (19)
Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure. (1967) (19)
A second look at bivalirudin. (2001) (19)
Prognostic Implications of Low Level Cardiac Troponin Elevation Using High‐Sensitivity Cardiac Troponin T (2015) (19)
Reflex Control of the Systemic Venous Bed: Effects on Venous of Vasoactive Drugs, and of Baroreceptor and Chemoreceptor Stimulation (1963) (19)
The ten advances that have defined modern cardiology. (2014) (18)
Association between duration of tirofiban therapy before percutaneous intervention and tissue level perfusion (a TACTICS-TIMI 18 substudy). (2004) (18)
Subspecialists and internal medicine: a perspective. (1991) (18)
Measurement of ascending aortic flow patterns in man. (1973) (18)
Introduction: calcium channel blockers. (1980) (18)
Rivaroxaban in Patients Stabilized after a ST-Elevation Myocardial Infarction: Results from the ATLAS ACS 2-TIMI 51 Trial. (2013) (18)
Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy. (2012) (18)
Heart motion video-tracking (radarkymography) in diagnosis of congenital and acquired heart disease. (1968) (18)
Comparison of patients with <60%to≥60% diameter narrowing of the myocardial infarct-related artery after thrombolysis (1994) (18)
Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48 (2018) (18)
Drug-induced thrombocytopenia and thrombosis: Evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial (2006) (18)
TNK-tissue plasminogen activator compared with front-loaded tissue plasminogen activator in acute myocardial infarction: primary results of the TIMI 10B trial (1997) (18)
ELECTROAUGMENTATION OF HUMAN AND CAT PAPILLARY MUSCLE PRODUCED BY PAIRED ELECTRICAL STIMULATION. (1965) (18)
Prognostic utility of secretory phospholipase A(2) in patients with stable coronary artery disease. (2011) (18)
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. (2011) (18)
Congenital aortic regurgitation. Clinical and hemodynamic findings in four patients. (1961) (18)
Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial. (2020) (18)
An Important Step for Thrombocardiology. (2017) (18)
DIFFERENTIAL DIAGNOSIS OF MITRAL REGURGITATION IN CHILDHOOD: CLINICAL PATHOLOGICAL CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH (1961) (17)
Coronary artery spasm. Mechanisms and clinical relevance. (1981) (17)
Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis (2017) (17)
Hypertrophic Cardiomyopathy: The Early Years (2009) (17)
Left ventricular angiocardiography in the diagnosis of persistent atrioventricular canal and related anomalies (1959) (17)
Mechanochemistry of Cardiac Muscle: IV. Utilization of High‐Energy Phosphates in Experimental Heart Failure in Cats (1969) (17)
End-systolic pressure-volume and stress-length relations in the assessment of ventricular function in man. (1985) (17)
Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study. (1989) (17)
Applications of the catheter-tip electromagnetic velocity probe in the study of the central circulation in man. (1970) (17)
Impact of Sacubitril/Valsartan Versus Ramipril on Total Heart Failure Events in the PARADISE-MI Trial. (2021) (17)
Paired electric stimulation of the heart: physiologic observations and clinical implications. (1967) (17)
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial (2021) (17)
Silent myocardial ischemia : a critical appraisal (1990) (17)
Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial. (2018) (17)
Prognostic use of echocardiography 1 year after a myocardial infarction. (2005) (17)
Protection of the ischemic myocardium. Introductory remarks. (1976) (16)
Delay in transmission of a pressure impulse through a cardiac catheter and vinyl plastic tubing. (1956) (16)
Killing controversy (2006) (16)
Chronic beta adrenergic receptor blockade in the treatment of idiopathic hypertrophic subaortic stenosis. (1968) (16)
755-2 Current Management of ST Elevation Myocardial Infarction and Outcome of Thrombolytic Ineligible Patients: Results of the Multicenter TIMI 9 Registry (1995) (16)
Peri-operative Adverse Outcomes in Patients with Atrial Fibrillation Taking Warfarin or Edoxaban: Analysis of the ENGAGE AF-TIMI 48 Trial (2018) (16)
Treatment of Left Main Coronary Artery Disease. (2016) (16)
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial. (2016) (16)
Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications. (1966) (16)
Clot-selective coronary thrombolysis with lowdose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator☆ (1991) (16)
EFFICACY AND SAFETY OF TICAGRELOR AS LONG-TERM SECONDARY PREVENTION IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION AND PERIPHERAL ARTERY DISEASE (2016) (16)
Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction. (2006) (16)
Role of reflex sympathetic withdrawal in the hemodynamic response to an increased inotropic state in patients with severe heart failure. (1986) (16)
PROTECTION OF THE ISCHEMIC MYOCARDIUM. (1973) (16)
Cooperative study on cardiac catheterization. Deaths related to cardiac catheterization. (1968) (16)
New oral anticoagulants in patients with atrial fibrillation – Authors'reply (2014) (15)
Abstract of paper to be presented at the 27th Annual Scientific Session of the American College of Cardiology Anaheim, California, March 6 to 9, 1978Long-term preservatl on of ischemic myocardlum by ibuprofen after experimental coronary artery occlusion (1978) (15)
Comprar Harrison's Principles of Internal Medicine, Self-Assessment and Board Review | Joseph Loscalzo | 9780071496193 | Mcgraw-Hill Education (2008) (15)
Preventive Cardiology: A Companion to Braunwald's Heart Disease (2011) (15)
Biomarkers in heart failure. Preface. (2009) (15)
Reperfusion therapy for acute myocardial infarction: historical context and future promise (2002) (15)
Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial. (2013) (15)
A new treatment for hypertrophic cardiomyopathy? (1997) (15)
Pattern of differential vasoconstriction in response to acute and chronic low-output states in the conscious dog. (1974) (15)
Time course of regional function after coronary occlusions of 1- to 120-min duration. (1981) (15)
Effect of thyroid state on myocardial contractility. (1968) (15)
REVERSED DIFFERENTIAL CYANOSIS WITH EQUAL DESATURATION OF THE UPPER LIMBS. SYNDROME OF COMPLETE TRANSPOSITION OF THE GREAT VESSELS WITH COMPLETE INTERRUPTION OF THE AORTIC ARCH. (1965) (15)
Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease (2017) (15)
Comparison of Events Across Bleeding Scales in the ENGAGE AF-TIMI 48 Trial. (2019) (15)
A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38. (2008) (15)
Review: Will Warfarin Ever Be Replaced? (2010) (15)
Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial. (2020) (15)
Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (T (2010) (15)
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion. (1976) (15)
Eugene Braunwald, MD and the early years of hypertrophic cardiomyopathy: a conversation with Dr. Barry J. Maron. (2012) (15)
Starling's law of the heart. VII. Ventricular function in closed-chest unanesthetized dogs. (1963) (15)
Thrombolysis in myocardial infarction (TIMI) phase II trial. (1989) (15)
Vorapaxar in Patients With Diabetes and Prior MI: Findings from the TRA 2°P-TIMI 50 Trial (2015) (15)
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study. (2008) (15)
REDUCTION IN ISCHEMIC EVENTS WITH TICAGRELOR IN DIABETIC PATIENTS FROM THE PEGASUS-TIMI 54 TRIAL (2016) (15)
Use of radioactive krypton and cardio-green dilution curves in the detection of experimental portal-systemic venous shunts. (1960) (14)
Partial persistent atrioventricular canal simulating pure mitral regurgitation. (1962) (14)
Effect of Alterations of Coronary Blood Flow the Oxygen Consumption of the Working Heart (1963) (14)
Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54 (2015) (14)
Coronary artery bypass surgery--an assessment. (1976) (14)
Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial. (2020) (14)
A Simplified Technic for the Detection of Patent Ductus Arteriosus and of Other Left‐to‐Right Shunts Originating from the Aorta (1961) (14)
Evaluation of the efficacy of coronary bypass surgery--II. (1978) (14)
Efficacy of nifedipine therapy in patients with refractory angina pectoris: significance of the presence of coronary vasospasm. (1983) (14)
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. (2001) (14)
Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition (2013) (14)
The Thrombolysis in Myocardial Infarction (TIMI) Study Group experience. (2012) (14)
Hypertrophic cardiomyopathy--the benefits of a multidisciplinary approach. (2002) (14)
Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients. (2005) (14)
Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease. (2020) (14)
Bilateral diaphragmatic contraction synchronous with cardiac systole. (1960) (14)
The Surgical Treatment of Calcific Aortic Stenosis: Operative Methods and the Results of the Pre‐and Postoperative Hemodynamic Assessments (1963) (14)
Persistent atrioventricular dissociation with block and nodal rhythm after cardiac catheterization. (1966) (14)
RESERPINE AND NORADRENALINE STORES (1962) (14)
Patients with diabetes mellitus and atrial fibrillation treated with NOACs: Meta-analysis of 8 outcomes in 58, 634 patients across 4 randomized controlled trials. (2020) (13)
COMBINED MITRAL AND AORTIC STENOSIS (1962) (13)
Responsiveness to loop diuretics in heart failure. (2014) (13)
Causes and Risk Factors for Death in Diabetes: A Competing-Risk Analysis From the SAVOR-TIMI 53 Trial. (2021) (13)
Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy. (2012) (13)
C-reactive protein and coronary heart disease. (2004) (13)
Another step toward personalized care of patients with heart failure (2015) (13)
The localization of asynergistic areas of the left ventricular wall by radarkymography (1970) (13)
Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome. (2020) (13)
Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes (2017) (13)
Obstruction in hypertrophic cardiomyopathy: how often does it occur? Should it be treated? If so, how? (2012) (13)
Adventures in Cardiovascular Research (2009) (13)
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction (2021) (13)
Predictors of mortality, coronary angiography, and revascularization in unstable angina pectoris and acute non-ST elevation myocardial infarction (the TIMI III Registry). (2002) (13)
Intra-aortic balloon counterpulsation: an assessment. (1972) (13)
DRAINAGE PATHWAYS OF PULMONARY VEINS IN ATRIAL SEPTAL DEFECT (1960) (12)
Thrombolysis In Myocardial Infarction (TIMI) Study Group: JACC Focus Seminar 2/8. (2021) (12)
Cardiac and Inflammatory Biomarkers Are Associated with Worsening Renal Outcomes in Patients with Type 2 Diabetes Mellitus: Observations from SAVOR-TIMI 53. (2019) (12)
Chronic heart failure: a look through the rear view mirror. (2013) (12)
Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease. (2016) (12)
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome. (2018) (12)
Circulatory effects of profound hypothermia during extracorporeal circulation. (1962) (12)
The influence of cardiac output, aortic pressure and heart rate on myocardial oxygen utilization. (1957) (12)
The year in non-ST-segment elevation acute coronary syndromes. (2006) (12)
Nina Starr Braunwald: some reflections on the first woman heart surgeon. (2001) (12)
Investigating the Mechanisms of Hyporesponse to Antiplatelet Approaches (2008) (12)
Diagnosing and managing unstable angina (1994) (12)
Chapter 4: Deaths Related to Cardiac Catheterization (1968) (12)
On future directions for cardiology. The Paul D. White lecture. (1988) (12)
Association between Angiographic Complications and Clinical Outcomes among Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: An EARLY ACS Angiographic Substudy (2012) (12)
Simultaneous recording of oscillographic and radiologic events on cine film. Applications of the cinetrace during cardiac catheterization. (1965) (12)
Mortality in the TRITON trial: update from the FDA prasugrel action package. (2010) (12)
One-year outcomes after a strategy using enoxaparin vs. unfractionated heparin in patients undergoing fibrinolysis for ST-segment elevation myocardial infarction: 1-year results of the ExTRACT-TIMI 25 trial. (2010) (11)
Symposium on Beta Adrenergic Receptor Blockade (1966) (11)
The Assessment of Operative Results in Congenital Heart Disease by Intraoperative Indicator‐Dilution Curves (1966) (11)
Biosynthesis of Norepinephrine in Isolated Canine Heart (1963) (11)
Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial (2016) (11)
Abstract 3288: Association of Treatment with Non-Steroidal Anti-Inflammatory Agents (NSAIDS) on Study Entry with 30 Day Adverse Outcomes Among ST Elevation MI (STEMI) Patients Treated with a Fibrinolytic Agent. An EXTRACT-TIMI 25 Analysis (2006) (11)
Antiplatelet Strategies: Evaluating Their Current Role in the Setting of Acute Coronary Syndromes (2008) (11)
Abstract 19119: Concomitant Use of Antiplatelet Therapy with Edoxaban or Warfarin in Patients with Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial (2014) (11)
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 Trial. (2018) (11)
Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial. (2013) (11)
Effect of rescue or adjunctive percutaneous coronary intervention of the culprit artery after fibrinolytic administration on epicardial flow in nonculprit arteries. (2004) (11)
ASSOCIATION OF FIBROBLAST GROWTH FACTOR (FGF)-23 LEVELS WITH RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE (2012) (11)
Meta-analysis of individual patient data from trials of long-term ACE-inhibitor treatment after acute myocardial infarction (SAVE, AIRE, and TRACE studies) (1997) (11)
Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial (2019) (11)
The potentiation of the cardiovascular responses to sympathomimetic amines by reserpine. (1963) (11)
How to live to 100 before developing clinical coronary artery disease: a suggestion. (2021) (11)
Topics in clinical medicine. The pathogenesis and treatment of shock in myocardial infarction. (1967) (11)
The spatial vectorcardiogram in mitral valve disease. (1957) (11)
Thanks be to zebrafish. (2010) (11)
Stunning of the myocardium: An update (1991) (11)
Effects of prostaglandin A 1 on left ventricular dynamics in the conscious dog. (1972) (10)
Circulation Research: reflections on the founding editor, Carl J. Wiggers. (2003) (10)
Clinical and research training in parallel: the Internal Medicine Research Residency Track at the Brigham and Women's Hospital. (1986) (10)
Systematic Review of Bariatric Surgery—Reply (2005) (10)
The American Journal of Cardiology: Introduction (2001) (10)
Congestive heart failure: A propitious time for intensified research (1983) (10)
Antiplatelet Therapy and Platelet Function Testing (2008) (10)
Regional hemodynamic effects of prostaglandin A1 in the conscious dog (1973) (10)
Predictors of Nonuse of a High‐Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib‐Thrombolysis in Myocardial Infarction 52 (SOLID‐TIMI 52) Trial (2017) (10)
Mechanism of reduction of myocardial injury by hyaluronidase (1976) (10)
Ventriculo-right atrial communication; diagnosis by clinical, hemodynamic and angiographic methods. (1960) (10)
46. The effects of amyl nitrite and nitroglycerin on the arterial and venous beds in man (1965) (10)
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial). (2014) (10)
A method for demonstrating the efficacy of interventions designed to limit infarct size following coronary occlusion: beneficial effect of hyaluronidase. (1978) (10)
Thermal dilution curves in the study of circulatory shunts. Instrumentation and clinical applications. (1960) (10)
Combination Reperfusion Therapy with Eptifibatide and Tenecteplase for Acute Myocardial Infarction (2000) (10)
Protection of the ischemic myocardium. (1978) (10)
The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population (2017) (10)
Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction (2001) (10)
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction. (2001) (10)
Harrison's principles of internal medicine CD-ROM (2001) (10)
Heart failure with preserved ejection fraction: a stepchild no more! (2021) (10)
Investigations on protection of the ischemic myocardium. (1973) (10)
Beta-Adrenergic Receptor Blockade Propranolol and Related Drugs (1967) (10)
Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT. (2021) (10)
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial. (2019) (9)
Trials and tribulations of thrombin inhibition. (1996) (9)
The year in non-ST-segment elevation acute coronary syndrome. (2007) (9)
Transbronchial left heart catherization: a modified technique and its physiologic evaluation. (1957) (9)
Cardiac frequency: control and adjustments to alterations. (1972) (9)
Myocardial infarction in experimental hypertension in rats: mechanism of the reduction in blood pressure. (1980) (9)
Evaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trial. (2006) (9)
???The Pathogenesis of Congestive Heart Failure???: Then and Now (1991) (9)
The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes. (2008) (9)
Biosynthesis of Norepinephrine in Isolated Canine Heart (1963) (9)
Cooperative study on cardiac catheterization. Transseptal left heart catheterization. (1968) (9)
SGLT2 inhibitors: the statins of the 21st century. (2021) (9)
A functional approach to understanding the role of NCKX5 in Xenopus pigmentation (2017) (9)
Survival to adulthood in a patient with complete transposition of the great vessels: including a note on the association of endocrine tumors with heart disease. (1962) (9)
Results of the Treat Angina With Aggrastat and Determine the Cost of Therapy With an Invasive or Conservative Strategy (TACTICS-TIMI 18) Trial: A Comparison of Invasive Versus Conservative Strategy in Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction (2000) (9)
Acute Myocardial Infarction: A Status Report (1971) (9)
Can't Get No Reproduction: Leading Researchers Discuss the Problem of Irreproducible Results. (2015) (9)
Evaluation of the time saved byprehospital initiation of reteplase forST-elevation myocardial infarction (2002) (9)
Thrombolytic therapy in acute myocardial infarction. (1990) (9)
Association of Hypertrophic Obstructive Cardiomyopathy With Outcomes Following Transcatheter Aortic Valve Replacement (2020) (9)
Meeting report ESC forum on drug eluting stents, European Heart House, Nice, 27-28 September 2007. (2009) (9)
Effects of aminophylline in the conscious dog after coronary occlusion. (1981) (9)
The measurement of portal-systemic circulation time: A new method for detecting esophageal varices and determining the patency of a portacaval anastomosis. (1960) (9)
Estimation of volume of a circulatory model by the Hamilton and the Bradley methods at varying flow volume ratios. (1958) (9)
Autoradiography with 99Tc labeled albumin microspheres, a new method for delineation of ischemic tissue at risk of infarction: Demonstration of the protective effect of verapamil (1980) (9)
Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. (2005) (9)
Chapter 17: Transseptal Left Heart Catheterization (1968) (9)
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction. (2004) (9)
Paradoxical effects of isoproterenol, nitroglycerin and exercise in conscious dogs with myocardial ischemia. (1973) (9)
A strategy of using enoxaparin as adjunctive antithrombin therapy reduces death and recurrent myocardial infarction in patients who achieve early ST-segment resolution after fibrinolytic therapy: the ExTRACT-TIMI 25 ECG study. (2007) (9)
Delay in the onset of right ventricular contraction in patients with surgically induced disturbance of right ventricular conduction. (1962) (9)
Mechanisms of contraction of the normal and failing heart. (1967) (9)
Standards and Concepts in Valve Surgery (2000) (9)
Factor IX gene mutations in haemophilia B: a New Zealand population‐based study (1996) (9)
Abstract 1515: Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting. Results From the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE-IT-TIMI 22) and the Aggrastat to Zocor (A to Z) trials. (2007) (9)
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials (2021) (9)
Vorapaxar in patients with coronary artery bypass grafting: Findings from the TRA 2°P-TIMI 50 trial (2017) (8)
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes Vytorin Efficacy International Trial) (2017) (8)
Progress in the Noninvasive Detection of High-Risk Coronary Plaques. (2015) (8)
James B. Herrick Lecture. The present state and future of academic cardiology. (1982) (8)
Mortality for women after acute myocardial infarction (1989) (8)
Mechanisms of contraction of the normal and failing heart. (1967) (8)
LEFT ATRIAL, “PULMONARY CAPILLARY”, AND ŒSOPHAGEAL BALLOON PRESSURE TRACINGS IN MITRAL VALVE DISEASE (1956) (8)
Intravenous milrinone: therapeutic responses in heart failure. (1991) (8)
Chapter 3: Total Population Studied, Procedures Employed, and Incidence of Complications (1968) (8)
Adrenergic receptors: new concepts and implications for cardiovascular therapeutics. (1984) (8)
Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs (2018) (8)
On circadian variation of myocardial reperfusion injury. (2012) (8)
Thirty‐five years of progress in cardiovascular research (1984) (8)
Limitation of Infarct Size and the Open Artery Hypothesis: A Conversation With Eugene Braunwald, MD. (2016) (8)
Efficacy and Safety of Ticagrelor as Long-Term Secondary Prevention in Patients with Peripheral Artery Disease and Prior Myocardial Infarction (2016) (8)
Influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on myocardial salvage (1976) (8)
Determination of cardiac output and pressure gradients at operation; a technic for the immediate assessment of the results of operations for stenotic valvular disease. (1958) (8)
EFFECTS OF HEART FAILURE, VENTRICULAR HYPERTROPHY, AND ALTERATIONS IN THE THYROID STATE ON THE CONTRACTILITY OF ISOLATED CARDIAC MUSCLE (1969) (8)
Research on the diagnosis and treatment of myocardial infarction. (1971) (8)
Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group. (2001) (8)
Essential Atlas of Heart Diseases (1997) (8)
Direct evidence for the beneficial effect of propranolol on myocardial ischemia following coronary artery occlusion (1978) (8)
Early initiation of lipid-lowering therapy for acute coronary syndromes improves compliance with guideline recommendations: observations from the Orbofiban in Patients with Unstable Coronary Syndromes (OPUS-TIMI 16) trial. (2005) (8)
EFFICACY AND SAFETY OF EDOXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AND ACTIVE MALIGNANCY: AN ANALYSIS OF ENGAGE AF – TIMI 48 RANDOMIZED CLINICAL TRIAL (2017) (8)
Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: One-year TIMI phase II pilot results (1990) (8)
Sustained Seizure Control in a Child with Drug Resistant Epilepsy after Subacute Cortical Electrical Stimulation (SCES) (2016) (8)
Cardiology--division or department? (1993) (8)
The use of radioisotopes in clinical studies of the central circulation. (1962) (8)
The clinical features and surgical treatment of congenital aortic stenosis (1958) (8)
The first patient clinically diagnosed with hypertrophic cardiomyopathy. (2008) (8)
Structure and function of the normal myocardium1 (1971) (8)
Effect of Hypertrophy on Myocardial Distensibility (1966) (8)
Can medical schools remain the optimal site for the conduct of clinical investigation? Presidential address before the 67th annual meeting of the American Society for Clinical Investigation, Atlantic City, New Jersey, 5 May 1975. (1975) (8)
Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction. (2010) (7)
Baseline Characteristics of the VANISH Cohort. (2019) (7)
EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL (2016) (7)
Editorial: Reduction of myocardial-infarct size. (1974) (7)
Tissue plasminogen activator and acute pulmonary embolism (1988) (7)
Use of Krypton85 for the Measurement of Cardiac Output by the Single‐Injection Indicator‐Dilution Technique (1961) (7)
Abstract 17392: Gastrointestinal Bleeding With Edoxaban versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (2015) (7)
Use of calcium channel blocking agents in the management of ischaemic heart disease. (1985) (7)
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction. (2007) (7)
Mechanics and energetics of the normal and failing heart. (1971) (7)
Point-of-care echocardiography: asking the right questions. (2001) (7)
EDOXABAN VERSUS WARFARIN IN 841 PATIENTS WITH ATRIAL FIBRILLATION AND PERIPHERAL ARTERIAL DISEASE: INSIGHTS FROM THE ENGAGE AF-TIMI 48 TRIAL (2016) (7)
Transmethylamine‐N‐Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV (2021) (7)
C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). (2005) (7)
Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis (2022) (7)
The hemodynamic differentiation of obstructive from nonobstructive cardiomyopathy (1967) (7)
The Evidence Supporting Cardiovascular Guidelines: Is There Evidence of Progress in the Last Decade? (2019) (7)
Safety and Efficacy of Rivaroxaban When Added to Aspirin Monotherapy Among Stabilized Post‐Acute Coronary Syndrome Patients: A Pooled Analysis Study of ATLAS ACS‐TIMI 46 and ATLAS ACS 2‐TIMI 51 (2019) (7)
BASELINE LDL-C AND CLINICAL OUTCOMES WITH ADDITION OF EZETIMIBE TO STATIN IN 18,144 PATIENTS POST ACS (2015) (7)
Ezetimibe plus a Statin after Acute Coronary Syndromes. (2015) (7)
Biomarker of Collagen Turnover (C‐Terminal Telopeptide) and Prognosis in Patients With Non‐ST‐Elevation Acute Coronary Syndromes (2019) (7)
Investigation and management of an A. Baumannii outbreak in ICU. (2011) (7)
Unstable angina and non-ST-segment elevation myocardial infarction: part II. Coronary revascularization, hospital discharge, and post-hospital care. (2004) (7)
Association of a pulsatile blood flow pattern on coronary arteriography and short-term clinical outcomes in acute myocardial infarction. (2004) (7)
861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial (2004) (7)
A symposium: Amrinone. Introduction. (1985) (6)
Myocardial Force-Velocity Relations Studied in Intact (6)
Effects of fluorocarbons and supplemental oxygen on acute myocardial ischemia assessed by intramyocardial gas tension measurement (1981) (6)
Mechanism of action of digitalis glycosides (II). (1968) (6)
The training of manpower needed for biomedical research. (1975) (6)
Front-loaded accelerated infusions of tissue plasminogen activator: putting a better foot forward. (1992) (6)
Reduction of LDL-cholesterol: important at all ages. (2016) (6)
Abstract 3994: Pharmacodynamic Assessment of Platelet Inhibition by Prasugrel versus Clopidogrel in the TRITON-TIMI 38 Trial (2008) (6)
High Prevalence of Asymptomatic Malaria in Gold Mining Areas in Brazil (1995) (6)
Results of Open Commissurotomy in Acquired Calcific Aortic Stenosis: Clinical and Hemodynamic Studies in Patients Operated upon With General Hypothermia. (1960) (6)
TCT-78 Efficacy of Long-Term Ticagrelor in Stented Patients in PEGASUS-TIMI 54 (2015) (6)
A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes (2021) (6)
Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy. (2008) (6)
Alterations in regional hemodynamics in experimental heart failure in conscious dogs. (1972) (6)
Heart Failure: An Update (2013) (6)
Comprar Harrison's Manual of Medicine | Dennis Kasper | 9780071477437 | Mcgraw-Hill Education (2009) (6)
Cardiology: how did we get here, where are we today and where are we going? (2005) (6)
Clostridium perfringens type D epsilon toxin produces a rapid and dose-dependent cytotoxic effect on cerebral microvascular endothelial cells in vitro (2020) (6)
A randomized prospective comparison of tPA with TNK using the TIMI frame count: results of TIMI 10B (1997) (6)
Erratum: Prognostic value of cardiac troponin i measured with a highly sensitive assay in patients with stable coronary artery disease (J Am Coll Cardiol (2013) 61 (1240-1249)) (2014) (6)
Eugene Braunwald: Escaping Death and Prolonging Lives [Part 1] (2010) (6)
Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction. (2000) (6)
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial (2021) (6)
Rate of disappearance of creatine kinase-MB after acute myocardial infarction: clinical determinants of variability. (1988) (6)
Circulatory Responses to Cardioaccelerator Nerve Stimulation after Induction of Tyramine Tachyphylaxis (1963) (6)
Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial (2018) (6)
Happy birthday, GISSI! (2004) (6)
Rates of Serious Bleeding Events Requiring Transfusion in AMI Patients Treated with TNK-tPA (1999) (6)
Harrison's principles of internal medicine, eleventh edition, Companion handbook (1988) (6)
Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE Investigators. (1991) (6)
Abciximab + tPA Improves Coronary Flow in a Wide Range of Subgroups: Results from TIMI 14 (1998) (6)
Abstract 17503: Outcomes of Patients With Type 2 Diabetes and Known Congestive Heart Failure Treated With Saxagliptin: Analyses of the SAVOR-TIMI 53 Study (2013) (6)
Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST elevation myocardial infarction in the TIMI III (1990-1993) and the GUARANTEE (1995-1996) Registries. (2002) (6)
Human Origins A Century After Darwin (1982) (6)
Abstract 14508: Vorapaxar for Secondary Prevention after Myocardial Infarction According to Aspirin Dose - Insights from the TRA2{degrees}P-TIMI 50 Trial (2012) (6)
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50). (2016) (6)
Can infarct size be limited in patients with acute myocardial infarction? (1983) (6)
Abstract 1999: Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndrome Presenting with Isolated Anterior ST-Segment Depressions (2008) (6)
Alterations in the activity of the adrenergic nervous system in heart failure. (1970) (5)
The Localization of Left‐to‐Right Cardiac Shunts (1958) (5)
Changing the practice of cardiovascular medicine. (2001) (5)
Slowing of the left atrial “y descent”: Evidence of impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and aortic stenosis (1967) (5)
Congenital Heart Disease (1997) (5)
Robert Lefkowitz: godfather of G protein-coupled receptors. (2010) (5)
Cardiovascular pharmacology: a look back and a glimpse into the future. (2015) (5)
DISCHARGE ASPIRIN DOSE AND CLINICAL OUTCOMES IN PATIENTS WITH ACS: AN ANALYSIS FROM THE TRITON-TIMI 38 STUDY (2012) (5)
Hypertrophic cardiomyopathy: The first century 1869–1969 (2012) (5)
Mechanisms of contraction of the normal and failing heart. (1967) (5)
The effects of early indomethacin administration on late scar formation following myocardial infarction. (1982) (5)
Angiographic and clinical characteristics associated with the development of Q-wave and non-Q-wave myocardial infarction in the thrombolysis in myocardial infarction (TIMI) 14 trial. (2003) (5)
Inotropic effect of amrinone in severe congestive heart failure: Lack of attenuation with sequential doses (1980) (5)
The Natural History of Mild Congenital Aortic Stenosis in Patients Studied by Serial Left Heart Catheterization. (1968) (5)
The ineffectiveness of an inotropic agent, mephentermine (Wyamine), in the treatment of congestive heart failure. (1961) (5)
Abstract 18595: Efficacy of Vorapaxar is not Modified by Thienopyridine Therapy: Results from TRA 2°P-TIMI 50 Trial (2012) (5)
Coronary artery disease Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction : a collaborative meta-analysis of randomized trials (2016) (5)
The contribution of modern hemodynamic techniques to the diagnosis of acquired heart disease. (1962) (5)
Genetic Polymorphisms and the Response to Prasugrel Relationship to Pharmacokinetic , Pharmacodynamic , and Clinical Outcomes (2009) (5)
Medical Progress Biomarkers in Heart Failure (2008) (5)
Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE) acute coronary syndromes Critical Pathway Toolkit. (2003) (5)
Influence of background autonomic activity upon the response to carotid sinus nerve stimulation in man (1970) (5)
Abstract 9150: Re-Elevation of Troponin Following Percutaneous Coronary Intervention Significantly Predicts 1-Year Mortality in Patients with High-risk Non-ST-Segment Elevation Acute Coronary Syndromes (2011) (5)
Position of power (2006) (5)
ABCB1 GENETIC VARIANTS, PHARMACODYNAMIC RESPONSE, AND CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH CLOPIDOGREL AND PRASUGREL (2010) (5)
Abstract of papers to be presented at the 31st annual scientific session of the American College of Cardiology Atlanta, Georgia, April 25–29, 1982Biochemical and functional recovery of subepicardial border zone salvaged by reperfusion (1982) (5)
A polygenic risk score predicts atrial fibrillation in cardiovascular disease. (2022) (5)
The predictive value of LV systolic sphericity index, a magnification-independent assessment of LV shape (1996) (5)
Insights in cardiovacular physiology derived from muscle mechanics. (1967) (5)
EFFECT OF HEMORRHAGIC SHOCK ON RELEASE OF NOREPINEPHRINE BY TYRAMINE. (1964) (5)
Management of the residual stenosis following thrombolytic therapy of acute myocardial infarction. (1986) (5)
Leaders in Cardiovascular Medicine. Eugene Braunwald MD: an icon of the 20th century still going strong. (2015) (5)
Herabsetzung der Herzfrequenz und Verbesserung der Ventrikelleistung durch gekoppelte elektrische Stimulation beim Menschen (1965) (5)
Tolerability of Sacubitril/Valsartan in Patients With Advanced Heart Failure: Analysis of the LIFE Trial Run-In. (2022) (5)
Exercise ECG test results in the TIMI II trial (1990) (5)
Prospective pravastatin pooling project: Relative risk reduction by baseline HDL and TG concentrations (2000) (5)
Comprar Harrison Manual de Medicina Interna 18ed | Dan Longo | 9786071509505 | Mcgraw-Hill Interamericana (2013) (4)
Arthrogryposis multiplex congenita associated with congenital aortic stenosis. (1965) (4)
Outcomes of adjunctive PTCA/stenting for TIMI grade 2 flow following thrombolysis (1998) (4)
Impaired Cardiac Performance in Rats with Long-Term Spontaneous Hypertension (1981) (4)
Evidence for reflex coronary artery spasm in patients with ischemic heart disease. (1976) (4)
Efforts to Limit Myocardial Infarct Size: Historical Considerations (1985) (4)
Combination therapy with clopidogrel and proton-pump inhibitors – Authors' reply (2010) (4)
eart disease:a textbook of cardio vascular medicine (2013) (4)
THE MECHANISM OF ACTION OF CARDIAC DRUGS. (1964) (4)
TIMING AND CLINICAL SETTING OF CARDIOVASCULAR DEATH OR MYOCARDIAL INFARCTION FOLLOWING PCI FOR ACS – OBSERVATIONS FROM THE TRITON-TIMI 38 TRIAL (2012) (4)
Cardiovascular- and Bleeding-Related Hospitalization Rates With Edoxaban Versus Warfarin in Patients With Atrial Fibrillation Based on Results of the ENGAGE AF–TIMI 48 Trial (2020) (4)
Relation of White Blood Cell Count to Bleeding and Ischemic Events in Patients With Acute Coronary Syndrome (from the ATLAS ACS 2-TIMI 51 Trial). (2019) (4)
Improving antithrombotic treatment in patients after myocardial infarction (2003) (4)
Clinical and genetic aspects of cardiac myxomas (4)
Cholesterol: the race to the bottom. (2021) (4)
Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction (2001) (4)
Preventing overcorrection of hyponatraemia with desmopressin (2011) (4)
Tetralogy of Fallot with rheumatic stenosis of the aortic valve. (1960) (4)
Training the clinician investigator. (2008) (4)
Rivaroxaban and Post-Stroke Neurological Outcomes in Patients With Acute Coronary Syndrome. (2018) (4)
Tensions between academic cardiology and internal medicine. (1984) (4)
Uniquely human: The evolution of speech, thought, and selfless behavior. Philip Lieberman. Cambridge: Harvard University Press. 1991. 210 pp. ISBN 0-674-92182-8. $27.95 (cloth) (1991) (4)
Extension of myocardial necrosis into normal epicardium followng hypotension during experimental coronary occlusion. (1982) (4)
On analyzing scientific fraud. (1987) (4)
Featuring: Eugene Braunwald. (2019) (4)
Abstract 13152: A Net Clinical Outcome Analysis Comparing Fatal or Irreversible Ischemic and Bleeding Events in ATLAS ACS 2 - TIMI 51 (2012) (4)
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial (2021) (4)
Abstract 5020: Effect of Rivaroxaban on Markers of Coagulation in Patients With Acute Coronary Syndromes: An ATLAS ACS-TIMI 46 Substudy (2009) (4)
Sacubitril/valsartan versus ramipril for patients with acute myocardial infarction: win‐ratio analysis of the PARADISE‐MI trial (2022) (4)
Intensive antiplatelet therapy for reduction of ischaemic events – Authors' reply (2008) (4)
Cardiac cell therapy: a call for action. (2022) (4)
Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators. (1994) (4)
The use of beta-blockers after myocardial infarction. (1983) (4)
Dose Ranging Study of Intravenous RPR 109891 in Patients With Acute Coronary Syndromes - Results of TIMI 15A (1998) (4)
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo (2020) (4)
Another look at the age-old question: which came first, the elevated c-reactive protein or the atherothrombosis? (2005) (4)
The effect of perfluorocarbons on experimental myocardial ischemia and infarction. (1983) (4)
Mortality for women after acute myocardial infarction: MILIS Study Group. (1989) (4)
Association of culprit lesion calcium with angiographic and clinical outcomes in patients with ST-elevation myocardial infarction treated with fibrinolytic therapy. (2005) (4)
Effects of variations in arterial pO2 on the severity of myocardial ischemic injury following experimental coronary occlusion (1974) (3)
Effects of exercise performed at constant heart rate on myocardial force-velocity relations and ventricular dimensions in intact unanesthetized man (1964) (3)
Circulation Editors and Editorial Board. (2018) (3)
Treatment Strategies for Patients With Ischemic Chest Pain-Reply (1996) (3)
Abstract 17862: Benefit and Safety of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes in 4416 Women in the IMPROVE-IT Trial (2015) (3)
A new angiographic method to calculate coronary velocity & its relationship to clinical outcomes after thrombolysis (1998) (3)
Sacubitril/Valsartan Initiated in Black Patients Admitted for Acute Decompensated Heart Failure Reduced NT-proBNP, was Safe and Led to Improved Clinical Outcomes- A Secondary Analysis of the PIONEER-HF Trial (2019) (3)
PROGNOSTIC IMPLICATIONS OF SIMULTANEOUS BIOMARKER ASSESSMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL (2014) (3)
Abstract 11748: Edoxaban versus Warfarin in Patients at Increased Risk of Falling - A Subgroup Analysis of the ENGAGE AF-TIMI 48 Trial (2015) (3)
Joseph Goldstein and Michael Brown: Demoting Egos, Promoting Success (2010) (3)
Heart Failure Compendium Research Advances in Heart Failure a Compendium Circulation Research Compendium on Heart Failure: Research Advances in Heart Failure: a Compendium Epidemiology of Heart Failure Genetic Cardiomyopathies Causing Heart Failure Non-coding Rnas in Cardiac Remodeling and Heart Fai (2013) (3)
Correlation between ST resolution and angiographic findings in ST elevation myocardial infarction (2002) (3)
Cardiovascular effects of dobutamine, a cardiospecific β adrenergic stimulant, in conscious dogs (1973) (3)
Does coronary artery bypass grafting improve survival? (1982) (3)
Eugene Braunwald: Escaping Death and Prolonging Lives [Part 2] (2010) (3)
The Spectrum of Myocardial Ischemia: The Paradigm of Acute Coronary Syndromes (2002) (3)
PRIOR EXPOSURE TO A CONVENTIONAL RENIN-ANGIOTENSIN SYSTEM ANTAGONIST AND ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION IN ACUTE DECOMPENSATED HEART FAILURE: A PRESPECIFIED SUBGROUP ANALYSIS OF THE PIONEER-HF TRIAL (2019) (3)
Weapons of self-destruction (2006) (3)
Is myocardial stunning important from a clinical standpoint (1995) (3)
Thrombosis and antithrombotic therapy Ischaemic risk and efficacy of ticagrelor in relation to time from P 2 Y 12 inhibitor withdrawal in patients with prior myocardial infarction : insights from PEGASUS-TIMI 54 (2016) (3)
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54. (2022) (3)
Myeloid-Related Protein-8/14 and the Risk of Cardiovascular Death or Myocardial Infarction after an Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial (2009) (3)
Differences in an author's conflict of interest disclosures. (2012) (3)
Postprandial redistribution of regional blood flow at rest and during exercise in conscious dogs with experimental heart failure. (1974) (3)
The clinical department as a critical scientific mass: implications for instruction in the preclinical disciplines. (1970) (3)
Effects of inotropic interventions on the normal and ischemic myocardium in conscious dogs (1974) (3)
Eugene Braunwald, MD: a conversation with the editor. Interview by William Clifford Roberts. (1998) (3)
Use of precordial R wave mapping to detect changes in myocardial ischemic injury (1975) (3)
RIVAROXABAN REDUCES SPONTANEOUS AND LARGE MYOCARDIAL INFARCTIONS: FINDINGS FROM THE ATLAS ACS 2 – TIMI 51 TRIAL (2013) (3)
An Interview with Dr. Eugene Braunwald (2012) (3)
P3670Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54 (2017) (3)
Abstract 16551: Efficacy and Safety of Oral Anticoagulation in 21105 Patients With Atrial Fibrillation Stratified by Diabetic Status in the ENGAGE AF-TIMI 48 Trial (2016) (3)
External precordial scanning. Preliminary report of a simplified method for the detection of left-to-right circulatory shunts. (1960) (3)
Chapter 18: Percutaneous Left Ventricular Puncture (1968) (3)
Prasugrel STEMI subgroup analysis – Authors' reply (2009) (3)
The Management of Heart Failure (2008) (3)
Blood velocity and pressure wave-forms in the major arteries in man. (1970) (3)
Alterations in the function of the adrenergic nervous system in heart failure. (1979) (3)
Atrial amyloidosis: mechanisms and clinical manifestations (2022) (3)
Control of residual dyslipidaemic risk. (2022) (3)
Ligation of the Main Pulmonary Artery and Systemic‐Pulmonary Arterial Anastomosis: A New Palliative Operation for Complete Transposition of the Great Arteries (1966) (3)
Abstract 16764: Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus and Heart Failure or Kidney Dysfunction - Observations From the SAVOR-TIMI 53 Trial (2016) (3)
Academic-industrial collaboration in the development of the first angiotensin receptor blocker: neprilysin inhibitor in the treatment of heart failure. (2016) (3)
UPFRONT CLOPIDOGREL USE AND THE EFFICACY AND SAFETY OF EARLY EPTIFIBATIDE USE IN PATIENTS WITH ACUTE CORONARY SYNDROME: AN ANALYSIS FROM THE EARLY VERSUS DELAYED PROVISIONAL EPTIFIBATIDE IN ACUTE CORONARY SYNDROMES (EARLY ACS) TRIAL (2010) (3)
RISK STRATIFICATION FOR CARDIOVASCULAR EVENTS IN THE IMPROVE-IT TRIAL (2015) (3)
Presentation of the Kober medal of the Association of American Physicians to Kurt J. Isselbacher, M.D. (2001) (3)
Abstract 2658: Growth Differentiation Factor-15 (GDF-15) and the Risk of Recurrent Events in Patients Stabilized after Acute Coronary Syndrome: Observations from PROVE IT-TIMI 22 (2008) (3)
EFFECT OF SACUBITRIL/VALSARTAN INITIATION ON 30-DAY READMISSIONS AFTER A HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE: A SECONDARY ANALYSIS OF THE PIONEER-HF TRIAL (2019) (3)
Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial (2021) (3)
Management of unstable angina based on considerations of aetiology (1999) (3)
The use of hyaluronidase and hydrocortisone in the reduction of myocardial infarct size following coronary occlusion. Experimental and clinical observations. (2009) (3)
Intravenous Beta-Blockade for Limiting Myocardial Infarct Size: Rejuvenation of a Concept. (2016) (3)
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status. (2018) (3)
Braunwald NS: Treatment of paroxysmal supraventricular trachycardia by electrical stimulation of the carotid-sinus nerves. (1969) (3)
Selection of patients for the surgical treatment of coronary artery disease. (1988) (3)
Elevated C Reactive Protein (CRP) is associated with a higher risk of thrombotic occlusion and poorer flow following percutaneous coronary intervention in patients with acute coronary syndromes: a TACTICS TIMI 18 angiographic substudy (2002) (3)
Persistent myoglobin elevation is associated with slower flow in patent culprit arteries following successful thrombolysis (1997) (3)
Myeloid-related protein 8 / 14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy : Thrombolysis in Myocardial Infarction (2009) (3)
Clinical Considerations with the Use of Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention (2008) (3)
Spatial vectorcardiography in the diagnosis of congenital cardiac malformations. (1956) (3)
Captopril for left ventricular dysfunction after myocardial infarction reduced mortality and morbidity (1993) (3)
Antiplatelet Therapy and Platelet Function Testing (2008) (3)
The endosome effect (2006) (3)
An Interview with David Millington. (2016) (2)
EFFECT OF SACUBITRIL/VALSARTAN ON BIOMARKERS OF MYOCARDIAL STRESS IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN PIONEER-HF (2019) (2)
James Willerson: Leading the Texans' Fight Against Heart Disease (2012) (2)
Atlas of cardiovascular pathology for the clinician (2001) (2)
Advances in unstable angina: the role of low molecular weight heparins (1999) (2)
The rt-PA versus streptokinase. Controversy--II. (1992) (2)
GALECTIN-3 FOR HEART FAILURE RISK STRATIFICATION IN PATIENTS AFTER ACUTE CORONARY SYNDROMES (ACS): INSIGHTS FROM THE SOLID-TIMI 52 TRIAL (2015) (2)
Creating the right environment (2006) (2)
NIH clinical staff conference. Assessment of cardiac function. (1969) (2)
The path to universality (2021) (2)
On the frontiers of cardiology: an interview with Eugene Braunwald. Interview by Elaine Musgrave. (2010) (2)
Oliver Smithies: born inventor. (2011) (2)
Abstract 18928: Vorapaxar Reduces Coronary Stent Thrombosis: Results From the TRA2P-TIMI 50 Trial (2013) (2)
Achieving Extended Longevity and Quality of Life for Senior Patients With Hypertrophic Cardiomyopathy: What Is Possible. (2017) (2)
Clinical trials in heart disease : a companion to Braunwald's heart disease (2004) (2)
Observations on the experimental reduction of infarct size and on the delayed consequences of transient myocardial ischemia. (2009) (2)
Myocardial ischemia, infarction, and failure: an odyssey. (1994) (2)
The emerging role of low-molecular-weight heparins in cardiology practice. Introduction. (1998) (2)
Dendritic cells: One SIGN, different paths (2009) (2)
The benefit of an early invasive strategy in women versus men with non-ST-elevation acute coronary syndromes: A collaborative meta-analysis of randomized trials (2007) (2)
Safety of adjunctive glycoprotein IIb/IIIa blockade during rescue/early percutaneous coronary intervention following full-dose fibrinolytic therapy for acute myocardial infarction (2003) (2)
Ischemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full and half-dose Edoxaban vs. Warfarin: insights from ENGAGE AF-TIMI 48. (2021) (2)
Effects of aminophylline on regional blood flow distribution in conscious dogs (1979) (2)
A reliable recipe for heart cells? (2010) (2)
Cardiology in 2021. (2021) (2)
RISK STRATIFICATION WITH THE TIMI RISK SCORE FOR SECONDARY PREVENTION AMONG PATIENTS WITH DIABETES AND ELEVATED CARDIOVASCULAR RISK (2017) (2)
Coronary Stent Thrombosis With Vorapaxar Versus Placebo (2015) (2)
Abstract 17121: Reduction in Total Cardiovascular Events With Long-term Use of Ticagrelor in Patients With Prior Myocardial Infarction in the PEGASUS-TIMI 54 Trial (2015) (2)
PROGNOSTIC PERFORMANCE OF A SINGLE-MOLECULE HIGH-SENSITIVITY CARDIAC TROPONIN ASSAY AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN-TIMI 36 (2012) (2)
Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group. (1991) (2)
Effects of Aminophylline in the Conscious Dog After Coronary Occlusion (1982) (2)
Improved cardiac performance with long term reduction of blood pressure in old spontaneously hypertensive rats (1980) (2)
Abstract 12658: Humoral Activation in Decompensated Heart Failure with Preserved or Reduced Ejection Fraction (2010) (2)
731-1 Contemporary PTCA for Acute Coronary Ischemia: Results in Women Match Those of Men (1995) (2)
Increased myocardial ischemic injury during insulin induced hypoglycemia (1974) (2)
Coarctation of the Aorta: Hemodynamic, Angiographic, and Anatomic Correlations. (1968) (2)
Cardiovascular Events and Long‐Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE‐IT (2022) (2)
Cooperative study on cardiac catheterization. Introduction. (1968) (2)
Acute MI management in the 1990s. (1990) (2)
The American Society for Clinical Investigation, 1952--1975: a personal perspective. (2008) (2)
Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog. (1981) (2)
CARDIAC STRUCTURE AND FUNCTION AND CHADS2 RISK SCORE IN PATIENTS WITH ATRIAL FIBRILLATION: THE EFFECTS ANTICOAGULATION WITH FACTOR XA NEXT GENERATION IN AFTHROMBOLYSIS IN MYOCARDIAL INFARCTION 48 (ENGAGE AF -TIMI 48) ECHOCARDIOGRAPHIC STUDY (2013) (2)
The mass spectrometric measurement of intramural carbon dioxide tension to assess the efficacy of interventions to limit myocardial ischemic injury. (1978) (2)
The first 20 years of The American Journal of Cardiology. A chronicle of the golden age of cardiology. (1978) (2)
An indicator dilution method for the detection an quantification of pulmonic or tricuspid regurgitation. (1960) (2)
Adolfo J. de Bold PhD OC FRSC: a pioneer in cardiovascular medicine. (2015) (2)
923-7 Infarct Artery Patency does not Prevent LV Remodeling (1995) (2)
Problem in differential diagnosis: clinical pathological conference at the National Institutes of Health. (1960) (2)
Is pre-discharge coronary arteriography beneficial in patients with myocardial infarction treated with thrombolytic therapy? (1990) (2)
Innervation of the transplanted heart. (1969) (2)
Hypertrophic Cardiomyopathy: The Past, the Present, and the Future (2015) (2)
Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients with Cardiometabolic Disease. (2021) (2)
Abstract: 1051 ONGOING CLINICAL TRIALS OF THE STATIN/EZETIMIBE COMBINATION (2009) (2)
RELATIONSHIP BETWEEN DOSE, ANTI-FACTOR XA ACTIVITY, AND OUTCOMES IN PATIENTS RANDOMIZED TO EDOXABAN IN THE ENGAGE AF-TIMI 48 TRIAL (2014) (2)
1135Angiotensin receptor-neprilysin inhibition in patients with de novo acute decompensated heart failure: a prespecified subgroup analysis of the PIONEER-HF trial (2019) (2)
22. Clinical application of an improved, rapidly responding intravascular fiberoptic catheter (1965) (2)
Inhibitors of factor XI: game changers of anti-thrombotic therapy? (2022) (2)
HMG CoA reduction in patients with average cholesterol concentrations. (2011) (2)
Atlas of Internal Medicine (2002) (2)
Retraction of: Early recovery of regional performance in salvaged ischemic myocardium following coronary artery occlusion in the dog. (1982) (2)
Prediction of biochemical derangement in ischemic myocardium following experimental coronary artery occlusion (1980) (2)
Corporate Backing for Research? Get Over It (2010) (2)
Prognostic Performance of Multiple Biomarkers in Patients with Non-ST Elevation Acute Coronary Syndrome: Analysis from MERLIN-TIMI 36 (2014) (2)
Effect of Darapladib onMajor Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial (2014) (2)
Abstract 1710: Platelet Function in Diabetes Mellitus: Observations From the PRINCIPLE-TIMI 44 Trial (2009) (2)
Cholesterol and total mortality (1992) (2)
Digoxin therapy and mortality following confirmed or suspected myocardial infarction: Experience in the MILIS study (1986) (2)
Abstract 17950: High-Dose Edoxaban Regimen versus Warfarin in Patients With Atrial Fibrillation and Established Coronary Artery Disease: Insights From the ENGAGE AF-TIMI 48 Trial (2017) (2)
Abstract 977: Baseline Troponin Levels Predict 30 Day CV Mortality in STEMI Independent of Clinical and Electrocardiographic Factors: Analysis from CLARITY-TIMI 28 (2008) (2)
Reduction in experimental myocardial infarct size by glucose-insulin-potassium administration☆ (1972) (2)
Patients With ST-Segment Elevation Myocardial Infarction U-Shaped Relationship of Blood Glucose With Adverse Outcomes Among (2011) (2)
Efficacy And Safety Outcomes In 8040 Women Compared With 13085 Men With Atrial Fibrillation Treated With Edoxaban Vs Warfarin For An Average 2 . 8 Years (2015) (2)
Standards and concepts in valve surgery. Report of the task force: European Heart Institute (EHI) of the European Academy of Sciences and Arts and the International Society of Cardiothoracic Surgeons (ISCTS). (2000) (2)
Abstract of papers to be Presented at the 29th Annual Scientific Session of the American College of Cardiology Houston, Texas, March 9 to 13, 1980Characterization of myocardial atp degradation following coronary artery occlusion (1980) (2)
Abstract 11559: Determination of Cardiac Troponin with a Single-Molecule High-Sensitivity Assay and Outcomes in Patients with Stable Coronary Artery Disease: Analysis from PROVE IT-TIMI 22 (2012) (2)
Abstract 11382: The Efficacy and Safety of Low-Dose Rivaroxaban With or Without a Proton Pump Inhibitor: Insights From the ATLAS ACS 2-TIMI 51 Trial (2013) (2)
Targeting AID (2007) (2)
RELIABLE EVALUATION OF DYSPNEA (RED-ROSE): A PROSPECTIVE ANCILLARY STUDY FROM THE RENAL OPTIMIZATION STRATEGIES EVALUATION IN ACUTE HEART FAILURE (ROSE-AHF) TRIAL (2014) (2)
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction. (2005) (2)
Pathologic physiology of valvular regurgitation. (1965) (2)
Abstract 19221: Rates of Arterial Revascularization in Patients Treated with Vorapaxar vs. Placebo in the TRA 2{degrees}P-TIMI 50 Trial (2012) (2)
Assessment of future directions by session chairmen. (1976) (2)
Abstract 9309: Benefit of Prasugrel in ST-Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention: Insight from the TRITON-TIMI 38 Study (2011) (2)
Yuk-Ming Dennis Lo. (2012) (2)
Measurement of instantaneous blood flow velocity and intravascular pressure with a catheter incorporating an electromagnetic velocity probe. (1969) (2)
An Interview with George Church. (2020) (2)
Myocardial and vascular effects of intracoronary versus intravenous milrinone. (1985) (2)
Myocardial Infarction The Prognostic Value of Serum Myoglobin in Patients With Non – ST-Segment Elevation Acute Coronary Syndromes Results From the TIMI 11 B and TACTICS-TIMI 18 Studies (2016) (2)
The Ventricle (1985) (2)
VORAPAXAR REDUCES PERIPHERAL REVASCULARIZATION REGARDLESS OF THE NUMBER OF DISEASED TERRITORIES: INSIGHTS FROM THE TRA2P–TIMI 50 TRIAL (2013) (2)
A new endpoint to evaluate the sucess of reperfusion therapy following ST-elevation myocardial infarction (2003) (2)
TELOMERE LENGTH AND CARDIOVASCULAR OUTCOMES (2012) (2)
NATRIURETIC PEPTIDES VERSUS A CLINICAL HISTORY OF HEART FAILURE FOR RISK PREDICTION IN PATIENTS WITH DIABETES (2019) (1)
The accurate estimation of left atrial pressure without cardiac catheterization in patients with mitral valve disease (1966) (1)
Reexamination of the Thrombin Hypothesis: What We Have Learned from TIMI 9B and GUSTO IIb (2004) (1)
Abstract 9944: Temporal Relationship Between Major Hemorrhagic Events and Mortality among Patients with Recent Acute Coronary Syndrome: Insights from ATLAS ACS 2-TIMI 51 (2012) (1)
Reply: Ezetimibe, Risk Stratification, and Secondary Prevention. (2017) (1)
The Effects of Amyl Nitrite and Nitroglycerin on the Arterial and Venous Beds in Man. (1965) (1)
Trans-Septal Left Heart Catheterisation : a New Diagnostic Method : PROCEEDINGS OF THE SECOND CONGRESS OF ASIAN-PACIFIC SOCIETY OF CARDIOLOGY (1961) (1)
Abstract 979: Novel Nanoparticle Cardiac Troponin I Assay Detects Myocardial Injury in Most Patients with Unstable Angina: Observations from the PROTECT-TIMI 30 Trial (2008) (1)
INTERLEUKIN-6 AND THE RISK OF ADVERSE OUTCOMES IN PATIENTS AFTER AN ACUTE CORONARY SYNDROME: OBSERVATIONS FROM THE SOLID-TIMI 52 TRIAL (2016) (1)
Atlas of Vascular Disease (2000) (1)
Abstract 17307: Biomarkers, Cardiovascular Outcomes and Effect of Ezetimibe After Acute Coronary Syndrome in the IMPROVE-IT Trial (2017) (1)
Abstract 16123: D-Dimer Levels and Clinical Outcomes in Acute Coronary Syndrome Patients: An ATLAS ACS TIMI 46 Trial Substudy (2018) (1)
Digitalis, a consideration of its mechanism of action. (1962) (1)
Diagnosis of congenital cardiac defects with use of a fiberoptic catheter-pressure-cinetrace system. (1970) (1)
Patent Foramen Ovale — Beauty Spot or Health Threat ? (1)
VORAPAXAR AND PERIPHERAL REVASCULARIZATION: INSIGHTS FOM THE TRA2P-TIMI 50 TRIAL (2015) (1)
A conversation with Eugene Braunwald. Interview by Ushma S. Neill. (2013) (1)
Plasma Renin Activity (PRA) Predicts Diuretic Resistance in Acute Heart Failure Patients: An Ancillary Study of the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF) (2011) (1)
DEPRESSION OF CENTRAL BLOOD VOLUME AND CARDIAC OUTPUT DURING POSITIVE PRESSURE BREATHING, RE ELEVATION BY ARAMINE (1957) (1)
Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities (1)
Biomarkers in Heart Failure, An Issue of Heart Failure Clinics (2009) (1)
Gender differences in cardiac biomarkers in patients with unstable angina and non-ST elevation myocardial infarction in TACTICS-TIMI 18 (2003) (1)
Cardiac biomarkers: a contemporary status report (2006) (1)
Chronic infection , Chlamydia and coronary heart disease – the story evolves (1)
Reflections on Hypertrophic Cardiomyopathy. (2021) (1)
A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48. (2021) (1)
Circadian variation and possible triggers of acute myocardial infarction (1995) (1)
VORAPAXAR AND ACUTE LIMB ISCHEMIA: INSIGHTS FROM THE THROMBIN RECEPTOR ANTAGONIST IN SECONDARY PREVENTION OF ATHEROTHROMBOTIC ISCHEMIC EVENTS-TIMI 50 TRIAL (2015) (1)
EFFICACY AND SAFETY OF VORAPAXAR FOR SECONDARY PREVENTION IN OLDER PATIENTS: OBSERVATIONS FROM TRA 2°P-TIMI 50 (2016) (1)
Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful? (2016) (1)
Abstract 5581: Cardiovascular Outcomes of Women and Men with Acute Coronary Syndromes and Angiographically Confirmed Epicardial Coronary Artery Disease in TRITON-TIMI 38 (2008) (1)
The Birth of Cardiology: The Golden Decade. (2021) (1)
A HEARTY Welcome to JACC: Cardiovascular Imaging (2008) (1)
Abstract 13035: Impact of Ezetimibe on Hospitalization-Related Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (2015) (1)
Reducing myocardial injury by minimizing imbalance between oxygen supply and demand. (2007) (1)
Discussion—Session II (1981) (1)
OUTCOMES OF ASIAN PATIENTS WITH ATRIAL FIBRILLATION COMPARED TO NON-ASIANS IN THE ENGAGE AF-TIMI 48 TRIAL (2017) (1)
Comparing the U.S. and Canadian approaches to coronary angiography: what have we learned? (1999) (1)
5719Edoxaban versus warfarin in patients with atrial fibrillation in relation to stroke risk. A subanalysis of the ENGAGE AF-TIMI 48 study (2017) (1)
Reply: Do We Need to Define Therapeutic Ranges for Edoxaban Plasma Concentration? (2021) (1)
DIRECT DETERMINATIONS OF AORTIC REGURGITANT FLOW IN MAN. (1964) (1)
Interview with Eugene Braunwald by Ruth Williams: escaping death and prolonging lives [part 2]. (2010) (1)
Capillary Limitation of Oxygen Distribution in the Isolated Rete Mirabile of the Eel ( Anguilla anguilla ) (2005) (1)
Abstract 17338: Development of a TIMI Risk Score for Stable Ischemic Heart Disease (2015) (1)
MARKERS OF CONGESTION, SYMPTOM RELIEF AND CLINICAL OUTCOMES AMONG PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE: DATA FROM THE DIURETIC OPTIMAL STRATEGY EVALUATION IN ACUTE HEART FAILURE STUDY (2011) (1)
Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Amer. J. Cardiol. 27:416-32, 1971 (2004) (1)
Nitrates in Heart Failure with Preserved Ejection Fraction. (2016) (1)
Standards and concepts in valve surgery. A report of the task force of european heart institute (EHI) of the european academy of sciences and arts and the international society of cardiothoracic surgeons (ISCTS). (2000) (1)
Research Diagnosing and managing unstable angina. Agency for Health Care Policy and (2011) (1)
Is recurrent myocardial infarction following thrombolytic administration associated with long-term mortality? (2002) (1)
Abstract 10398: Vorapaxar in Patients With Diabetes and Prior MI: Findings From the TRA 2P - TIMI 50 Trial (2013) (1)
Preface—Adapted from the First Edition (2012) (1)
Abstract 3015: Dynamic Updating of TIMI Risk Score for STEMI: An ExTRACT-TIMI 25 Analysis (2007) (1)
What future does the pharmaceutical industry have in the cardiovascular world? (2013) (1)
Atlas of cardiovascular magnetic resonance imaging : imaging companion to Braunwald's Heart disease (2010) (1)
Effect of verapamil on cardiac ultrastructure during and following release of coronary occlusion (1982) (1)
PROGNOSTIC PERFORMANCE OF SERIAL HIGH SENSITIVITY CARDIAC TROPONIN DETERMINATION IN STABLE ISCHEMIC HEART DISEASE: ANALYSIS FROM PROVE IT-TIMI 22 (2013) (1)
The year in non-ST-segment elevation acute coronary syndrome. (2011) (1)
Abstract 16708: Increasing Age and the Benefit From Higher-intensity Lipid Lowering With Ezetimibe/Simvastatin vs. Simvastatin Alone: Results From the IMPROVE-IT Trial (2015) (1)
Myocardial Function—1972: Seventh Annual Becton M.D. Dickinson and Company Oscar Schwidetzky Memorial Lecture (1972) (1)
In Memoriam-John Ross Jr, MD: 1928-2019. (2019) (1)
Abstract 19642: Consistent Benefit of Ticagrelor Both Early and Late in Patients With Prior MI in PEGASUS-TIMI 54 (2015) (1)
Anatomic evidence for long-term reduction of infarct size by hyaluronidase (1978) (1)
Association Between Angiographic Complications During Percutaneous Coronary Intervention and Clinical Outcomes Among Patients with Acute Coronary Syndrome: An EARLY ACS Angiographic Substudy (2011) (1)
Abstract 3075: Evaluation of Monocyte Chemoattractant Protein 1 as a Prognostic Marker in the A to Z Trial (2006) (1)
Radioimmunoassay for Human Myoglobin Initial Experience in Patients with Coronary Heart Disease (1)
Vascular impedance in man. (1969) (1)
Chapter 13: Severe Hypotension (1968) (1)
IMPACT OF ATRIAL FIBRILLATION ON EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE: A RELAX TRIAL ANCILLARY STUDY (2013) (1)
Newer positive inotropic agents Concluding comments (2005) (1)
Critical pathway for acute ST segment elevation myocardial infarction: evaluation of the potential impact in the TIMI 9 registry (1998) (1)
An interview with Dr. Eugene Braunwald. Interview by Misia Landau. (2012) (1)
Detection of valvular regurgitation by a precordial dilution technique. (1961) (1)
RIVAROXABAN IN THE SETTING OF CONTINUED DUAL ANTIPLATELET THERAPY: FINDINGS FROM THE ATLAS ACS 2-TIMI 51 TRIAL (2013) (1)
Reply: Personalize and Optimize Lipid-Lowering Therapies. (2016) (1)
Biomarkers and Myocardial Ischemia Association of Elevated B-Type Natriuretic Peptide Levels With Angiographic Findings Among Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction (2004) (1)
Abstract 5765: 9p21 Genetic Variant and Benefit From Intensive Statin Therapy After an Acute Coronary Syndrome (2009) (1)
The Spectrum of Myocardial Ischemia (2003) (1)
792 Do Concurrent Gastroprotective Agents Impact Gastrointestinal Bleeding Rates in Edoxaban Users? Results From the ENGAGE-AF TIMI 48 Trial (2016) (1)
Abstract 11255: PON1 Q192R (rs662) Genetic Variant and Response to Clopidogrel and Prasugrel (2011) (1)
Symposium on beta adrenergic receptor blockade. An editorial introduction to the symposium. (1966) (1)
Aortic Stenosis and Other Valvular Lesions (2005) (1)
Elevated serum myoglobin is associated with increased long-term mortality, independent of cardiac troponin I, electrocardiographic variables, and other baseline variables: combined analyses from TIMI 11B and TACTICS/TIMI 18 (2002) (1)
Association of major bleeding with adverse clinical outcomes and length of stay: A TACTICS TIMI 18 substudy (2003) (1)
Natriuretic peptides in heart failure: should therapy be guided by BNP levels? (2010) (1)
Historical Milestones in Reperfusion Therapy for Myocardial Infarction (2008) (1)
A risk score for predicting coronary artery bypass surgery in patients with non-ST elevation acute coronary syndromes (2003) (1)
Microangiopathy, Arterial Stiffness, and Risk Stratification in Patients With Type 2 Diabetes-Reply. (2017) (1)
Fondation Leducq. (2014) (1)
[Decrease of heart rate and improvement of ventricle efficiency by paired electric stimulation in man]. (1965) (1)
Operative Treatment in Idiopathic Hypertrophic Subaortic Stenosis: Surgical Methods and the Results of Operation (2008) (1)
Chairmen’s summary (1999) (1)
Circulation: The Beat Goes On. (2016) (1)
P3526Heart Failure hospitalization and mortality in non-valvular Atrial Fibrillation: The ENGAGE-AF TIMI 48 Trial (2019) (1)
Sir James W. Black, MD, FRS: 1924–2010 (2010) (1)
Abstract 2453: Effect of Ranolazine on Hemoglobin A1c in the MERLIN-TIMI 36 Randomized Controlled Trial (2007) (1)
Diagnostic Value of the Configuration of the Transaortic Pressure Gradient for the Differentiation Between Idiopathic Hypertrophic Subaortic Stenosis and the Discrete Forms of Left Ventricular Outflow Obstruction. (1968) (1)
Myocardial Infarction Myoglobin , Creatine-Kinase-MB and Cardiac Troponin-I 60-Minute Ratios Predict Infarct-related Artery Patency After Thrombolysis for Acute Myocardial Infarction Results from the Thrombolysis in Myocardial Infarction Study ( TIMI ) 10 B (2016) (1)
Abstract 15134: Comparison of Events Across Definitions of Major Bleeding in the Engage AF-TIMI 48 Trial (2017) (1)
Coronary reperfusion stimulates cardiac reflexes. (1984) (1)
Abstract 15480: The Efficacy and Safety of More Potent Antiplatelet Therapy With Vorapaxar in Patients With Impaired Renal Function: Insights From the TRA 2P-TIMI 50 Trial (2017) (1)
Micro vascular damage and myo cardial cell injury following coronary artery occlusion which comes 1st (1979) (1)
PROGNOSTIC VALUE OF HIGH-SENSITIVITY CRP FOR CARDIOVASCULAR OUTCOMES IN TRA 2°P-TIMI 50 (2013) (1)
Flow patterns in the heart and great vessels of man. Preliminary report on the radiopaque streamer technique. (1962) (1)
The worst symptom visual analogue scale: a prospective ancillary study from the renal optimization strategies evaluation in acute heart failure (rose-AHF) trial (2014) (1)
Artery Occlusions Factors Influencing Infarct Size Following Experimental Coronary (2011) (1)
Benefit of invasive strategy for women with acute coronary syndromes: observations from the TACTICS-TIMI 18 trial (2002) (1)
Year book of cardiovascular medicine and surgery (1968) (1)
Abstract 13702: A Novel Genetic Risk Score Predicts Ischemic Stroke in Patients With Cardiometabolic Disease (2020) (1)
CARDIAC CATHETERIZATION. (1964) (1)
Eugene Braunwald Unstable Angina : An Etiologic Approach to Management (1998) (1)
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits Part 1 - Health Benefits (2006) (1)
Asymptomatic ischemia: resolved and unresolved issues. (1990) (1)
Harrison's 14 CD-ROM (2000) (1)
Subgroup analysis of the TIMI II study (1991) (1)
1000–39 Advanced Age Does not Diminish the Results of PTCA for Acute Ischemic Syndromes (1995) (1)
STATIN INTENSITY AND OUTCOME IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: INSIGHTS FROM THE TRA2P-TIMI 50 TRIAL (2015) (1)
Invasive or Conservative Strategy for Stable Coronary Disease. Reply. (2020) (1)
2864Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54 (2017) (1)
Abstract 11317: Plasma Renin Activity on Admission Predicts Diuretic Resistance and Poor Outcomes in Acute Decompensated Heart Failure: An Ancillary Study of the Diuretic Optimization Strategies Evaluation Trial (2011) (1)
Interview: C. Ronald Kahn (2011) (1)
Primate visions: Gender, race and nature in the world of modern science: By Donna Haraway (1989). New York: Routledge. 486 pp. $35.00. ISBN 0-415-90114-6 (1991) (1)
The ape that spoke: Language and the evolution of the human mind. John McCrone. New York: William Morrow. 1991. 288 pp. ISBN 0-688-10326-X. $19.95 (cloth) (1991) (1)
Movember-Owen Sharp and Paul Villanti. (2019) (1)
An Interview with Ronald DePinho (2013) (1)
A People's History of Human Biodiversity (1997) (1)
An interview with Bert Vogelstein and Kenneth Kinzler. (2015) (1)
Peter Wilding. (2012) (1)
The effects of digitalis on the hemodynamic response to intense upright exercise in patients with mitral stenosis (1967) (1)
Reply: Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups. (2018) (1)
Statin Therapy and the Risk f Hospitalization for Heart Failure After an Acute oronary Syndrome in the PROVE IT – TIMI 22 Study (2006) (1)
Abstract 17211: Edoxaban versus Warfarin in Patients With Atrial Fibrillation in the US FDA Approval Population: An Analysis From the ENGAGE AF-TIMI 48 Trial (2015) (1)
Detection of cardiac neurohormonal activation complements cardiac troponin for predicting recurrent events in UA/NSTEMI: prognostic utility of BNP in TACTICS-TIMI 18 (2002) (1)
Bone destruction by Th17 (2006) (1)
Abstract 20483: Outcomes in Stable Patients With Prior Atherothrombosis Receiving Vorapaxar Who Present With a New Acute Coronary Syndrome: Insights From the TRA2P-TIMI 50 Trial (2014) (1)
CLINICAL FACTORS ASSOCIATED WITH SUDDEN CARDIAC DEATH IN TYPE 2 DIABETES: INSIGHTS FROM THE SAVOR-TIMI 53 TRIAL (2016) (1)
The year in non-ST-segment elevation acute coronary syndrome. (2012) (1)
The Mechanism of Action of Metaraminol (Aramine). (1963) (1)
Chapter 257. Tumours of the large and small intestine (1994) (1)
Measurement of force-velocity-length relationships in man using an electromagnetic flowmeter catheter. (1974) (1)
Cholesterol Lowering in Older Patients (1999) (1)
TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction Results of the TIMI 10B Trial Clinical Investigation and Reports (1998) (1)
Cardiac xenotransplantation: a new path for the treatment of advanced heart failure? (2022) (1)
Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes. (2023) (1)
Edoxaban vs. Warfarin in High-risk Patients with Atrial Fibrillation: A Comprehensive Analysis of High-Risk Subgroups. (2022) (1)
Glucose-Insulin-Potassium Therapy for Acute Myocardial Infarction: 50 Years On and Time for a Relook. (2022) (1)
Advancing the knowledge base on the efficacy-safety ratio with drug-eluting stents contributions from the European Society of Cardiology Congress, Vienna, Austria, September 1-5, 2007. (2007) (1)
Sixty-Year Evolution of Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy with Insights From the Historic NIH Surgical Experience to Present. (2022) (1)
Heart Disease: Review and Assessment : A Question and Answer Book With Explanations and References (1989) (1)
Changing the Trajectory of Heart Failure and Kidney Disease. (2022) (1)
Atrial Failure as a Clinical Entity (2020) (1)
Coronary NET Burden and DNase Activity in STE-ACS (2015) (1)
Circulation Research “In This Issue” Anthology (2018) (1)
Eric Olson Fulfilling a Dream of Freedom (2010) (1)
Brian Kobilka: Chipping Away at the β2-Adrenergic Receptor (2013) (1)
Katey Rayner: Always Asking Questions. (2016) (1)
Louis Ignarro: NO Stupid Questions (2010) (1)
John Ross: epitome of a medical triple-threat. (2012) (1)
The year's successes in failure: Circulation Research takes a look at the key research developments of 2009 that are providing hope in the field of heart failure. (2010) (1)
Garrett Gross: Probing the Processes of Protection (2011) (1)
Circulation Research "In This Issue" Anthology. (2015) (1)
Amplification of a 29.7 kb Region of the Factor VIII Gene Using the Expand™ PCR System (1996) (1)
Jeffery Molkentin: Delves Into Cell Death (2014) (1)
Robert Jennings: A Labor of Love in the Laboratory (2011) (1)
Blue skies for the best people. (2014) (1)
Profiles in Cardiovascular Science: Shinya Yamanaka - Purveyor of Pluripotency (2013) (1)
Stefanie Dimmeler: Passionate, Persistent, and Highly Productive (2013) (1)
Abstract 5336: Presence of Ischemia and Non-Sustained Ventricular Tachycardia is Strongly Associated With the Risk of Cardiovascular Outcomes: Observations From the MERLIN-TIMI 36 Trial (2009) (0)
Editorial Board (2011) (0)
André Cournand, Bellevue's Cardiopulmonary Laboratory, and Research on Heart Failure. (2018) (0)
Systematic review of bariatric surgery. Authors' replay (2005) (0)
Abstract 3996: Intrinsic Platelet Variability in Response to ADP Before Exposure to Thienopyridines Contributes to the Variability in Residual Platelet Reactivity to ADP After Treatment with Clopidogrel or Prasugrel: Results from PRINCIPLE-TIMI 44 (2008) (0)
THE RT-PA VERSUS STREPTOKINASE CONTROVERSY-II. REPLIES (1992) (0)
Rationale of the EXACT-HF Study Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients : Design and (2013) (0)
Abstract 3297: The Impact of Renal Dysfunction on Bleeding and Outcome in ST-Elevation MI: Results of the ExTRACT-TIMI25 Study (2006) (0)
Response to Letter Regarding Article, "Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT". (2016) (0)
Trial Levels : Subgroup Analyses in the Cholesterol And Recurrent Events ( CARE ) Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and (1998) (0)
Expert Answers to Three Key Questions (2008) (0)
Venter's build-a-bug workshop. (2010) (0)
Effects of alterations in heart rate on aortic regurgitant flow in man. (1965) (0)
Expert Answers to Three Key Questions (2008) (0)
Highlights From the Circulation Family of Journals (2017) (0)
The Year in NonST-Segment Elevation Acute Coronary Syndrome (2011) (0)
Hypertrophic Cardiomyopathy: The Past, the Present, and the Future (2018) (0)
High-Dose Statins in Acute Coronary Syndromes—Reply (2005) (0)
410Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus (2019) (0)
The Accurate Estimation of Left Atrial Pressure Without Cardiac Catheterization in Patients with Mitral Valve Disease. (1966) (0)
Diminished arterial dilator capacity: A characteristic defect of peripheral blood flow in human congestive heart failure (1967) (0)
Abstract 3108: Single Molecule Troponin Detection to Assess for Transient Myocardial Ischemia (2007) (0)
Abstract 5338: Universal Definition of Myocardial Infarction Classification and the Risk of Cardiovascular Death: Observations From the TRITON-TIMI 38 Trial (2009) (0)
Symposium on myocardial metabolism. Foreword. (1974) (0)
QUETIAPINE INDUCED MYOCLONUS (2008) (0)
Abstract 10454: Inhibition of Renin-Angiotensin System (RAS) Reduces the Rise in Plasma Aldosterone Levels After Acute Coronary Syndromes in Patients with Preserved Left Ventricular Function: Insight From AVANT GARDE-TIMI 43 Trial (2011) (0)
Increased platelet receptor occupancy following eptifibatide therapy is associated with improved patency, tissue level perfusion, and ST-segment resolution in ST-segment elevation myocardial infarction: An INTEGRITI substudy (2003) (0)
Foreword to the First Edition (2010) (0)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. (2015) (0)
Baseline troponin in acute coronary syndromes managed invasively. (2004) (0)
Impact of the Prediabetic State for the Treatment of Cardiovascular Disease in Prediabetic Patients (0)
Thrombolytic therapy in patients with acute myocardial infarction Summary and comments (2005) (0)
Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial (2014) (0)
Abstract 17270: Outcomes of Patients With Type 2 Diabetes at High Risk of Cardiovascular Events Treated With Saxagliptin: Outcomes by Baseline HgbA1c (2013) (0)
Abstract 13389: High-Sensitivity Cardiac Troponin at Any Detectable Concentration Identifies Higher Risk of Major Cardiovascular Events in Patients With Stable Ischemic Heart Disease (2018) (0)
Kathy Griendling: A Modest Molecular Biologist (2011) (0)
Intensive Lipid-Lowering Therapy with Simvastatin/Ezetimibe Combination Does Not Affect the Progression of Aortic Valve Stenosis: Results from the SEAS Study (2008) (0)
Abstract 3006: The Association of Culprit and Non-Culprit Myocardial Perfusion with Clinical Events Following an ST-Elevation MI (STEMI): An Analysis from the CLARITY-TIMI 28 Study (2007) (0)
Glyceryl trinitrate for acute stroke: Main results from the Efficacy of Nitric Oxide in Stroke (ENOS) trial (2014) (0)
The association between LDL-C and outcome: The pravastatin pooling project (2000) (0)
Thrombolytic therapy after GUSTO: medical roundtable. Discussion (1994) (0)
Letter from Eugene Braunwald. (2002) (0)
Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents : Primary Endpoint Results from the Dual Antiplatelet Therapy Study (2014) (0)
On future directions for cardiology The Lecture* (2005) (0)
Abstract 16818: Circulating Cardiac Troponin I as Detected By a High-Sensitivity Assay among Patients Hospitalized with Acute Decompensated Heart Failure (2011) (0)
[Editorial: Factors affecting the magnitude of myocardial damage following acute coronary occlusion]. (1973) (0)
PROGNOSTIC UTILITY OF FIBROBLAST GROWTH FACTOR-23 AFTER AN ACUTE CORONARY SYNDROME (2015) (0)
Adjuvant Therapy for Coronary Reperfusion in Evolving Acute Myocardial Infarction (1989) (0)
Comprar Atlas of Cardiovascular Pathology for the Clinician | McManus, Bruce M. | 9781573402798 | Springer (2008) (0)
Retraction: border zone salvage by flurbiprofen. (1982) (0)
Reproducibility of centralized laboratory interpretations of measures of myocardial infarct size, ventricular function, and ventricular electrical instability scintigraphy (1991) (0)
LUNG SCANNING APPLICATION IN CARDIOLOGY. (1969) (0)
Diagnostic Value of the First Derivative of the Arterial Pressure Pulse in Aortic Valve Disease and in Hypertrophic Subaortic Stenosis. (1964) (0)
and Failure : Its Role In The Depletion Of Cardiac Norepinephrine Stores Reduction of Cardiac Tyrosine Hydroxylase Activity in Experimental Congestive Heart (2005) (0)
Underestimation of the effect of bleeding in clinical trials – Authors' reply (2009) (0)
Current Status of Interventions Designed to Limit Infarct Size (1985) (0)
Comparing pumps. (2010) (0)
Randomized Trial Heart Failure, Saxagliptin and Diabetes Mellitus: Observations from the SAVOR - TIMI 53 (2014) (0)
Trial Economic Impact of Angina After an Acute Coronary Syndrome : Insights (2009) (0)
A symposium : new insights into the pathogenesis and management of coronary artery disease (1998) (0)
THE ROLE OF VORAPAXAR IN PATIENTS WITH CORONARY ARTERY BYPASS GRAFTING: FINDINGS FROM THE TRA 2P-TIMI 50 TRIAL (2015) (0)
Optimal strategies in preventing the next event: The role of statins in cardiovascular protection - Foreword (2003) (0)
Development and evaluation of a novel device to standardise intravitreal injections in rabbits (2019) (0)
Abstract 9147: Undiagnosed Diabetes Mellitus, Pre-Diabetes, and Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes (2011) (0)
Margaret Kirby: A Cardiologist Against the Odds (2012) (0)
Dendritic cells: Division of DC labour in the gut (2009) (0)
Margaret Buckingham: Studying the Choreography of Cardiogenesis (2012) (0)
An Interview with Robert Califf. (2017) (0)
The Ambiguity of Hunting (1994) (0)
In this Issue (1999) (0)
Don't overreact (2006) (0)
Sequential hemodynamic and pressure volume changes in myo cardial infarction in rats (1980) (0)
Human Evolution: The View From Saturn (1985) (0)
The Origins of Life: From the Birth of Life to the Origin of Language (review) (2001) (0)
Helen Blau She Thinks Like a Cell (2012) (0)
A Conversation with Dennis Hochstrasser (2010) (0)
Review: The Origins of Life: From the Birth of Life to the Origin of Language (2001) (0)
Circulation Research "In This Issue" Anthology. (2012) (0)
An Interview with Hugo Katus. (2020) (0)
GALECTIN-3 AND THE DEVELOPMENT OF HEART FAILURE AFTER ACUTE CORONARY SYNDROME: A PILOT EXPERIENCE FROM PROVE IT-TIMI 22 (2011) (0)
BLEEDING IN STABLE PATIENTS WITH ATHEROSCLEROTIC DISEASE: INSIGHTS FROM TRA2°P- TIMI 50 TRIAL (2016) (0)
HAEMODYNAMICALTERATIONSINDUCED BY ISOPRENALINE INPATIENTSWITH OBSTRUCTIONTO RIGHT VENTRICULAR OUTFLOW (1965) (0)
Catharine Sturgeon. (2016) (0)
Ian Young. (2017) (0)
Abstract 3299: Efficacy and Safety of Enoxaparin vs. UFH in Patients with ST-Elevation Myocardial Infarction Also Treated Or Not Treated with Clopidogrel: Analysis from ExTRACT-TIMI 25 (2006) (0)
Abstract 11302: Improved Risk Stratification in Patients with ST-Elevation Myocardial Infarction Treated with Fibrinolysis by Combining New Q-Waves on the Initial Electrocardiogram with ST-Segment Resolution -- Observations from the CLARITY-TIMI 28 Trial (2011) (0)
Inspiring minds. Marilyn Huestis. (2011) (0)
Greg Miller. (2016) (0)
Book Review:Space, Time, and Man: A Prehistorian's View Grahame Clark (1994) (0)
An Interview with Nancy Andrews (2014) (0)
An Interview with Walter Willett. (2018) (0)
Graham Beastall. (2010) (0)
Gerald Cooper. (2008) (0)
Matthew McQueen. (2018) (0)
Steven Soldin. (2014) (0)
Complexity: Life at the Edge of Chaos. Roger Lewin (1995) (0)
Carl Wittwer. (2009) (0)
Transseptal left heart catheterization: birth, death, and resurrection. (2021) (0)
A Conversation with Elizabeth Blackburn (2009) (0)
EXTRACARDIAC ACTIONS OF DIGITALIS. (1964) (0)
John Savory. (2011) (0)
David Sacks. (2019) (0)
Symposium “Limiting of Infarct Size” (1982) (0)
The Taming of Evolution: The Persistence of Nonevolutlonary Views in the Study of Humans. DAVYDD GREENWOOD (1986) (0)
Børge Nordestgaard. (2020) (0)
David Bruns. (2015) (0)
Allan Jaffe. (2018) (0)
Fred Apple. (2014) (0)
Minimizing infarct size. Annual scientific report, 1 Jul 1975--15 Apr 1976 (1976) (0)
PULMONARY, HEPATIC, RENAL, MYOCARDIAL AND BONE DISEASE: A NEW PATHOLOGIC ENTITY? (1963) (0)
The role of physiology in medical education. (1967) (0)
VI. A clinician's view of physiological training for the future physician. (1968) (0)
Book Reviews (1985) (0)
Report of student committee on the medical students' point of view. (1953) (0)
[The surgical treatment of acquired aortic stenosis with calcifications. A study of the clinical aspects and hemodynamic changes after surgery on the open heart in general hypothermia]. (1960) (0)
Prevention of "future shock". (1972) (0)
Short change in glycolytic currency? (1968) (0)
460Edoxaban versus warfarin in atrial fibrillation patients with low, mid and high body weight: analysis of outcomes in the engage AF TIMI 48 trial (2019) (0)
A Symposium - Amrinone - Discussion (1985) (0)
Vorhofflimmern: Vergleich neuer oraler Antikoagulanzien mit Warfarin (2014) (0)
Meeting of The American Pediatric Society: Atlantic City, New Jersey, April 30, 1969 (1969) (0)
Preinfarction angina. (1996) (0)
Edmund H. Sonnenblick (2008) (0)
EINFLUSS VON CAPTOPRIL AUF DIE PROGRESSION DER VENTRIKELDILATATION NACH VORDERWANDINFARKT (1988) (0)
Abstract 15103: Inefficient Ventilation is an Easily Derived Marker of Cardiovascular Reserve Capacity in Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study (2013) (0)
Eugene Braunwald: escaping death and prolonging lives [part 1] Interview by Ruth Williams. (2010) (0)
Abstract 4762: Cessation of Rivaroxaban in Post-ACS Patients is Not Associated With Clinical Evidence of Rebound Hypercoagulability: An ATLAS ACS-TIMI 46 Substudy (2009) (0)
METABOLIC SYNDROME AND THE RISK OF ADVERSE CARDIOVASCULAR EVENTS AFTER AN ACUTE CORONARY SYNDROME: INSIGHTS FROM SOLID-TIMI 52 TRIAL (2016) (0)
TOTAL ANOMALOUS PULMONARY VENOUS CONNECTION ASSOCIATED WITH INCOMPLETE PERSISTENT A-V CANAL OR COMMON ATRIUM (CLINICAL, HEMODYNAMIC, AND OPERATIVE FINDINGS). (1963) (0)
EResearch Advances Series Ventricular Remodeling After Myocardial Infarction Experimental Observations and Clinical Implications (2005) (0)
Contractile failure during ischemia and congestive heart failure : role of defective excitation-contraction coupling (0)
PROCEDURAL BLEEDING WITH VORAPAXAR VERSUS PLACEBO IN THE TRA 2°P-TIMI 50 TRIAL (2013) (0)
HEMODYNAMIC ALTERATIONS IN PERICARDIAL DISEASES. (1964) (0)
Use of an angiotensin (AT1) to reduce morbidity and post-myocardial infarction mortality. (1993) (0)
Abstract 4610: Stent Thrombosis Exhibits a Diurnal Variation With a Higher Incidence of Morning Events (2009) (0)
Abstract 3487: Enoxaparin Reduces Recurrent MI and Death in Patients with STEMI Undergoing Fibrinolysis who Achieve Early ST Resolution: The ExTRACT-TIMI 25 ECG Study (2006) (0)
C-TERMINAL PROVASOPRESSIN (COPEPTIN), MID-REGION PRO-ADRENOMEDULLIN (MR-PROADM) AND MID-REGION PRO-ATRIAL NATRIURETIC PEPTIDE (MR-PROANP) AS NOVEL PROGNOSTIC BIOMARKERS AFTER NON-ST ELEVATION ACUTE CORONARY SYNDROME: ANALYSIS FROM MERLIN TIMI-36 (2011) (0)
CLINICAL PROBLEMS IN CARDIOPULMONARY DISEASE IdiopathiC HypertrophiC Subaortic Stenosis (2006) (0)
Introduction (1980) (0)
What is in this issue (2008) (0)
Deepak Srivastava: follows his heart to study the heart. (2014) (0)
1098-78 Low hemoglobin predicts worse clinical outcomes in acute coronary syndromes (2004) (0)
Summary of Issues Emanating from the Workshop on Congestive Heart Failure (2008) (0)
High-density lipoprotein metabolism as a therapeutic target for atherosclerosis (2003) (0)
The localization of circulatory shunts with a simplified indicator dilution technique. (1960) (0)
- Type Natriuretic Peptide at resentation and Prognosis in Patients ith ST-Segment Elevation Myocardial Infarction n ENTIRE – TIMI-23 Substudy essica (2016) (0)
Analysis of the Geometry of Myocardial Infarct Size Reduction with Hyaluronidase 1 (1980) (0)
Point of View Research on Unstable Coronary Syndromes Unstable Angina A Classification (2005) (0)
THER Eugene Braunwald The Next Step − − Clinical Efforts to Reduce Myocardial Infarct Size (2011) (0)
Abstract 11434: Low Level Elevation of Highly-Sensitive Cardiac Troponin I after Non-ST Elevation Acute Coronary Syndrome and Early Risk of Cardiac Ischemia and Ventricular Tachycardia: Analysis from MERLIN-TIMI 36 (2012) (0)
Atlas of cardiac imaging (1998) (0)
CYSTATIN C IS ASSOCIATED WITH THE RISK OF ADVERSE OUTCOMES INDEPENDENT OF ESTABLISHED AND NOVEL CARDIORENAL MARKERS: AN ANALYSIS FROM THE SOLID-TIMI 52 TRIAL (2017) (0)
PATIENTS WITH MITRAL STENOSIS AND ATRIAL FIBRILLATION ON THE RELATIONSHIPS BETWEENLEFT VENTRICULAR END-DIASTOLIC SEGMENT LENGTH , FILLING PRESSURE , AND THE CHARACTERISTICS OF VENTRICULAR CONTRACTION (2013) (0)
Texas heart institute medal and the Ray C. Fish award for scientific achievement in cardiovascular diseases. (2015) (0)
Percutaneous transluminal coronary angioplasty for acute myocardial ischemia The TIMI-3 experience (1994) (0)
Effects of anesthesia and the open chest on myocardial responses to sympathomimetic amines (1974) (0)
Is there a role for half-dose anticoagulation in atrial fibrillation? Randomized comparison of 2 doses of edoxaban in 14,014 patients in ENGAGE AF-TIMI 48 (2020) (0)
Hemodynamic characterization of nitroprusside in conscious dogs (1976) (0)
Editorial board (1993) (0)
Thrombolysis: Basic Contributions and Clinical Progress (1991) (0)
Editorial Board (2010) (0)
Abstract 16587: Edoxaban Associated With Fewer Serious Adverse Events and Lower Mortality Than Warfarin, Regardless of Burden of Comorbidities: Insights From the ENGAGE AF-TIMI 48 Trial (2016) (0)
Abstract 4588: Regional Safety and Efficacy of Prasugrel Compared to Clopidogrel: A TRITON - TIMI 38 Analysis (2008) (0)
Preparing for Responsible Sharing of Clinical Trial Data (2014) (0)
Aortic Stenosis: Physiological, Pathological, and Clinical Concepts (2020) (0)
Thrombolysis in Myocardial − Outcomes by Optimizing Platelet Inhibition With Prasugrel Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Print (2008) (0)
Osteochondroma of basi (2007) (0)
ATHEROTHROMBOTIC RISK STRATIFICATION AND EZETIMIBE USE IN IMPROVE-IT (2016) (0)
Depression on left ventricular contractility by anesthesia and the protective effects of digitalis. (1972) (0)
The Effects of Nitroglycerin and Amyl Nitrite (2005) (0)
Abstract 12644: Growth Differentiation Factor-15 (GDF-15) for Risk Stratification in Patients After an Acute Coronary Syndrome: Insights From the SOLID-TIMI 52 trial (2015) (0)
[TIMI group study of thrombolysis in myocardial infarction]. (2009) (0)
EVALUATION OF THE DIAGNOSTIC PERFORMANCE OF AN INVESTIGATIONAL ULTRA-SENSITIVE ASSAY FOR CARDIAC TROPONIN I (2011) (0)
Abstract 1132: Levels of Serum Soluble Lectin-like Oxidized LDL Receptor (sLOX-1) Predict Adverse Cardiovascular Outcomes in Patients With Stable Coronary Artery Disease (2009) (0)
Uptake of Iodine and Radionuclides by the Infarcted Cardiac Muscle (2005) (0)
The era of devices? Biventricular pacing and implantable cardioverter-defibrillators (2003) (0)
Circ Heart Fail July 2014 Age , Sex , Body Size , Hemoglobin , and Chronotropic Reserve as Predictors of Peak VO (0)
The Haemodynamic Effects of Circulatory Drugs in Patients with Idiopathic Hypertrophic Subaortic Stenosis (2008) (0)
Abstract 19109: Adverse Limb Events in Patients With Peripheral Artery Disease Presenting With Acute Coronary Syndrome: Observations From SOLID-TIMI 52 (2016) (0)
PATTERNS OF ASPIRIN UTILIZATION AND OUTCOMES AMONG PATIENTS WITH DIABETES MELLITUS: A PROPENSITY SCORE MATCHED ANALYSIS FROM THE SAVOR-TIMI 53 TRIAL (2016) (0)
Electrical stimulation of the carotid sinus nerves: A new approach to the treatment of incapacitating angina pectoris☆ (1968) (0)
Protective effect of perfluorocarbons (PFC) and supplemental O2 in acute myocardial ischemia as assessed by intramyocardial mass spectrome try (IMMS) (1981) (0)
Editorial Board (2009) (0)
The Effect of Beta Adrenergic Blockade on Patterns of Urinary Sodium Excretion (2020) (0)
Tricuspid regurgitation, a newly recognized cause of protein-losing gastroenteropathy, lymphocytopenia and an immunologic deficiency state (1967) (0)
Randomized Clinical Trials in HFpEF (2012) (0)
The year in non-ST-segment elevation acute coronary syndrome. (2008) (0)
Concise review: the polypill in cardiovascular disease prevention (2007) (0)
[SURGICAL TREATMENT OF AORTIC STENOSIS WITH VALVULAR CALCIFICATION]. (1964) (0)
Abstract 6091: A Simple TIMI Discharge Risk Score Post ACS Predicts CV Mortality at 2 Years (2008) (0)
Abstract 12577: The Efficacy and Safety of Third Generation P2Y12 Inhibitors in Women versus Men: A Sex-Specific Meta-Analysis (2015) (0)
Raffaella Lombardi: Steadfast and Committed. (2017) (0)
Abstract 13545: ST2 in Heart Failure With Preserved Ejection Fraction (2015) (0)
UNIVERSAL CLASSIFICATION SYSTEM TYPE OF INCIDENT MYOCARDIAL INFARCTION IN PATIENTS WITH STABLE ATHEROSCLEROSIS: OBSERVATIONS FROM TRA 2°P-TIMI 50 (2014) (0)
Fraud and other matters? (1987) (0)
1142-177 Antecedent hypertension and the risk of subsequent left ventricular remodelling after acute myocardial infarction: Insights from the survival and ventricular enlargement trial (2004) (0)
P3605The usefulness of the TIMI-AF score in the prediction of ischemic stroke and bleeding for Asian patients with atrial fibrillation (2017) (0)
Panel discussion on cardiac surgery. (1961) (0)
Dynamic DCs of the gut (2006) (0)
Making light of an interstitial process. (2012) (0)
Iconographies supplémentaires de l'article : Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes (2011) (0)
Funda.mental Mechanisms in Congestive Heart Failure (1968) (0)
A tribute to Donald W. Seldin. (2018) (0)
Congenital Aortopulmonary Septal Defect (2005) (0)
Baseline Characteristics of the Patients in the Two Treatment Groups * Placebo (2005) (0)
Withdrawn as Duplicate: Adolfo J de Bold PhD OC FRSC. (2015) (0)
Clinical Application of an Improved, Rapidly Responding Intravascular Fiber-Optic Catheter. (1965) (0)
In this issue (2010) (0)
In This Issue (2002) (0)
Treatment of AMI in the Post-Herrick Era (2012) (0)
2014 Association of American Physicians George M. Kober Medal. Introduction of Elizabeth G. Nabel. (2014) (0)
Dietary Treatment to prevent cardiovascular disease PART II : Effects on hyperlipidemia (0)
P cute Changes in Circulating Natriuretic eptide Levels in Relation to Myocardial Ischemia arc (2016) (0)
Abstract 1676: Evaluation of Continuous Holter Monitoring Following Percutaneous Coronary Intervention (PCI) as a Surrogate for Post-PCI Myonecrosis: An Analysis from The PROTECT-TIMI 30 Trial (2007) (0)
Use of the angiotensin antagonist (AT1) for the reduction of post-myocardial infarktmorbiditet and mortality (1993) (0)
BLOOD PRESSURE, SUBCLINICAL MYOCARDIAL INJURY AND CARDIOVASCULAR OUTCOMES AMONG PATIENTS WITH DIABETES AND HIGH CARDIOVASCULAR RISK: OBSERVATIONS FROM THE SAVOR-TIMI 53 TRIAL (2017) (0)
Abstract 20496: Time Dependence of Association of Bleeding Events With Mortality in Patients Treated With Prasugrel or Clopidogrel: Insights From the TRITON-TIMI 38 Trial (2010) (0)
Clinical Recognition of Acute Coronary Syndromes (2011) (0)
In this issue (2009) (0)
Invited Commentary (1994) (0)
References 1. Kanis JA. Disorders of calcium metabolism. In (1995) (0)
COMBINED MITRAL AND AORTIC STENOSIS 607 APEX (0)
P4606Comparing biomarker profiles in patients with stable atherosclerosis treated with anacetrapib versus placebo: a nested proteomic study from HPS3/TIMI 55-REVEAL (2019) (0)
Symposium on Heart Failure (1970) (0)
The dangers of categorizing BMI: reply (2006) (0)
1.P.149 Pravastatin prevents stroke in older patients (1997) (0)
Understanding the jargon: A glossary of terms used (and misused) in the study of ischaemia and reperfusion: Comments (1993) (0)
Abstract 12923: Development of a Novel Biomarker-based Risk Score for Heart Failure in Patients With Diabetes (2020) (0)
Paediatric Neurology 2nd edn Oxford Specialist Handbooks in Paediatrics Edited by RobForsyth and RichardNewton Oxford: Oxford University Press, 2012.£39.99 (Paperback), pp 672. ISBN: 978-0-19-960363-3 Pediatric Neurology A Color Handbook Edited by James F (2013) (0)
Abstract 20145: ST2 and the Risk of CV Death or Heart Failure in Patients with Non-ST elevation Acute Coronary Syndromes (NSTE-ACS): Observations from MERLIN-TIMI 36 (2010) (0)
Nonwhite race is associated with a higher rate of death and ischemic complications in patients with acute coronary syndromes despite modern early invasive treatment (2002) (0)
In This Issue. (2018) (0)
COMPLICATIONS AFTER CARDIAC SURGERY Table 1 Incidence of Major " Medical " Complications (2005) (0)
1.P.146 Cholesterol reduction with pravastatin in CARE patients is beneficial irrespective of fasting glucose levels (1997) (0)
Personal reflections on fibrinolytic therapy of acute myocardial infarction (2006) (0)
PROGNOSTIC VALUE OF SERIAL C-REACTIVE PROTEIN LEVELS AFTER AN ACUTE CORONARY SYNDROME: AN ANALYSIS FROM PROVE-IT TIMI 22 (2012) (0)
Pseudohyponatremia in Multiple Myeloma (2010) (0)
In Memoriam: Burton E. Sobel A Tribute from Family, Friends and Colleagues October 21, 1937 – May 3, 2013 (2013) (0)
Tion and Infection Therapy-thrombolysis in Myo- Cardial Infarction 22 Investigators: Intensive versus Moderate Lipid Lowering with Statins after Acute Jas Guideline and Statin Treatment (0)
Chapter 21: Summary (1968) (0)
Chapter 1: Introduction (1968) (0)
Randomized Controlled Trial Thrombolysis in Myocardial − ST-Elevation Acute Coronary Syndrome − Ischemia in Non Coronary Syndrome : Results From the Metabolic Efficiency (2007) (0)
P285Comparison of analysis methodologies for net outcome with edoxaban vs warfarin in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial (2018) (0)
LONG-TERM THIENOPYRIDINE THERAPY AND OUTCOMES IN PATIENTS WITH ACS TREATED WITH CORONARY STENTING: THE PRIMARY RESULTS OF THE TIMI-38 CORONARY STENT REGISTRY (2011) (0)
Cardiac Xenotransplantation (2022) (0)
Direct and Reflex Effects of Hypoxia on the Systemic Venous and Arterial Beds and Myocardial Contractile Force. (1962) (0)
Stimulated by Reperfusion of Ischemic Myocardium in Acute Myocardial Infarction (2005) (0)
WITHDRAWN: The Ten Advances that Have Defined Modern Cardiology (2014) (0)
myocardial infarction with subsequent mortality Association of creatinine and creatinine clearance on presentation in acute (2011) (0)
Abstract 10481: Predictors of Bleeding Events in Patients Treated With Prasugrel or Clopidogrel: Insights From the TRITON-TIMI 38 Trial (2010) (0)
TRS2P PREDICTS MORTALITY AFTER MI IN YOUNG ADULTS: FROM THE PARTNERS YOUNG-MI REGISTRY (2019) (0)
A new initiative of the European Heart Journal: the Desmond Julian Award. (2021) (0)
Acute Myocardial Infarction : A Century of Progress (2013) (0)
Future shock and medical research*. (1976) (0)
Abstract 2256: Increased Monocyte Activation Detected By Serum Neopterin and Long-Term Risk in Patients with Acute Coronary Syndromes: Analysis From PROVE IT-TIMI 22 (2006) (0)
Fibrinolysis with Adjunctive Enoxaparin with or without Abciximab-Results of the ENTIRE-TIMI 23 Trial (2001) (0)
1097-97 Safety of stress testing following an acute coronary syndrome (2004) (0)
Abstract 11035: Worsening Renal Function in Hospitalized Heart Failure Patients with Preserved vs. Reduced Ejection Fraction (2010) (0)
Unstable Coronary Syndromes (2005) (0)
Arnold M. Katz, MD (2016) (0)
In This Issue. (2020) (0)
P Acute Myocardial Infarction he Role of Clopidogrel in Early nd Sustained Arterial Patency After Fibrinolysis or ST-Segment Elevation Myocardial Infarction he ECG CLARITY – TIMI 28 Study (2006) (0)
STARLING'S LAW (1960) (0)
Task force VIII: Training in cardiovascular research (1986) (0)
SPECIAL ARTICLE (1956) (0)
Myocardial Scanning in Man Using Macroaggregates (1971) (0)
Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators. (1990) (0)
GROWTH DIFFERENTIATION FACTOR-15 (GDF-15) AND THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE (2014) (0)
Abstract 16393: Causes and Timing of Death in Patients With NSTE ACS: An Analysis of the TIMI Trials (2011) (0)
REPORTS ON THERAPY Role of Reflex Sympathetic Withdrawal in the Hemodynamic Response to an Increased Inotropic State in Patients With Severe Heart Failure (2010) (0)
RESTING VENTRICULAR-VASCULAR FUNCTION AND EXERCISE CAPACITY IN DIASTOLIC HEART FAILURE (DHF): A RELAX TRIAL ANCILLARY STUDY (2013) (0)
Some FactorsAffecting Determinationof Carotenoidsin Serum (1984) (0)
Aortic Stenosis (1968) (0)
Treatment of Acute Myocardial Infarction: The Potential of Anticoagulant Treatment in Acute Myocardial Infarction (1969) (0)
Current Status of Measurements and Efforts to Reduce Myocardial Infarct Size in Man (1982) (0)
Elevated white blood cell count is associated with higher mortality in patients with acute coronary syndromes independent of other cardiac markers: a TACTICS - TIMI 18 Substudy (2002) (0)
Harrison Manual de Medicina Interna 18ed (2013) (0)
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT. (2022) (0)
Elfects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure (2005) (0)
Air pollution: challenges and opportunities for cardiology. (2023) (0)
PROGNOSTIC IMPLICATIONS OF LOW-LEVEL CARDIAC TROPONIN ELEVATION USING THE HIGH-SENSITIVITY ASSAY FOR CARDIAC TROPONIN T: RESULTS FROM EARLY ACS & SEPIA-TIMI 42 (2013) (0)
Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial. (2022) (0)
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial. (2023) (0)
Is gender an independent predictor of angiographic & adverse outcomes following thrombolysis? (1996) (0)
Control of residual dyslipidaemic risk. (2022) (0)
Obstruction to Left Ventricular Outflow (2020) (0)
Abstract 16014: Evaluation of Cardiac Events in ATLAS ACS 2-TIMI 51 (2012) (0)
Abstract 10291: Fibroblast Growth Factor (FGF)-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Patients With Stable Coronary Artery Disease (2013) (0)
Defective fat storage (2006) (0)
APPLICATION OF THE TIMI RISK SCORE, A SIMPLE BEDSIDE TOOL, FOR TIMING OF DISCHARGE AFTER FIBRINOLYSIS OR PRIMARY ANGIOPLASTY FOR ST-ELEVATION MI IN THE EXTRACT-TIMI 25 AND TRITON-TIMI 38 TRIALS (2010) (0)
Reading: Keeping Current (2004) (0)
Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin The Cholesterol and Recurrent Events (CARE) Study Clinical Investigation and Reports (1998) (0)
In Memoriam: Arnold M. Katz, MD: 1932-2016. (2016) (0)
Abstract 16378: Growth Differentiation Factor-15 Independently Predicts 2 Year Mortality in Patients With Acute Coronary Syndrome: Observations From the A to Z Trial (2014) (0)
Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Reply. (2022) (0)
Geographic Differences in Patients With Acute Myocardial Infarction in The PARADISE-MI Trial. (2023) (0)
Screening byPolymerase ChainReaction ofBacillus thunrngiensis Serotypes forthePresence ofcryV-Like Insecticidal Protein GenesandCharacterization ofa cryV GeneCloned fromB.thuningiensis subsp. kurstaki (1993) (0)
PROGNOSTIC ROLE OF LEFT ATRIAL DYSFUNCTION AND ESTIMATION OF LEFT VENTRICULAR FILLING PRESSURE ON HEART FAILURE AND CARDIOVASCULAR DEATH IN NON VALVULAR ATRIAL FIBRILLATION: THE ENGAGE-AF TIMI ECHOCARDIOGRAPHIC SUB-STUDY (2019) (0)
A simple electrocardiographic method to predict patency of the infarct-related artery after fibrinolytic therapy (2003) (0)
549 Pulse pressure and the risk of heart failure hospitalization after acute myocardial infarction: insights from the SAVE trial (2008) (0)
Abstract 3995: Comparison of the Effects of Prasugrel and High Dose Clopidogrel on In Vivo and In Vitro Platelet Activation: Results from PRINCIPLE-TIMI 44 (2008) (0)
Burton E. Sobel: 1937–2013 (2013) (0)
Serial assessment of biomarkers and heart failure outcomes in patients with atrial fibrillation. (2023) (0)
PERFORMANCE OF A NOVEL GENETIC RISK SCORE TO IDENTIFY RISK OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CARDIOMETABOLIC DISEASE (2020) (0)
LEFT VENTRICULAR FUNCTION AND ANGIOTENSIN Table 2 Effects of Angiotensin Infusion on Patients in Group 2 Infusion Art (2005) (0)
Reply: Analyzing IMPROVE-IT Beyond LDL Cholesterol. (2022) (0)
Ruth Williams Developments of 2009 That Are Providing Hope in the Field of Heart Failure The Year ' s Successes in Failure : Circulation Research Takes a Look at the Key Research (2010) (0)
ASSESSMENT OF OPERATIVE RESULTS 265 Table 1 Correlation between the Results of Intraoperative Indicator-Dilution Curves and the Late Postoperative Evaluation in 260 Patients with Intracardiac Shunts (0)
Interstitial Lung Disease Aggressive Clinical Management Versus Diagnostic and Therapeutic Nihilism (2005) (0)
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/valsartan versus Valsartan in HFmrEF and HFpEF with a Worsening Heart Failure Event. (2023) (0)
Long-Term Prognostic Value of Neopterin A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome Coronary Heart Disease (2007) (0)
Lipoprotein-Associated Phospholipase A 2 and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction) Trial Coronary Heart Disease (2006) (0)
Alejandra San Martin: Academic Romantic. (2016) (0)
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial (2022) (0)
Abstract 906: KIF6 Genetic Variant Predicts Effect of Intensive Statin Therapy on Death and Cardiovascular Events in the PROVE IT-TIMI 22 Trial (2007) (0)
Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive Protein Clinical Investigation and Reports (1999) (0)
In This Issue. (2018) (0)
Abstract 207: Vorapaxar in Patients with Prior Ischemic Stroke: Primary Results from the Stroke Cohort of the Multinational TRA 2°P-TIMI 50 Trial (2013) (0)
The war on heart failure (2014) (0)
Abstract 13838: Efficacy and Safety of Sacubitril/Valsartan in Acute Decompensated Heart Failure in High-Risk Patients in the PIONEER-HF Trial (2019) (0)
Leaders in cardiovascular research: Eugene Braunwald. (2022) (0)
Comparison of Effectiveness of Implantable Cardioverter Defibrillator in Patients With Idiopathic Dilated Cardiomyopathy Versus Those With Proved Coronary Heart Disease (2003) (0)
Neutrophil-Lymphocyte Ratio and Clinical Outcomes in 19,697 Patients with Atrial Fibrillation: Analyses from ENGAGE AF-TIMI 48 Trial (2023) (0)
Could Neprilysin Be Already Inhibited by BNP in the LIFE Trial?-Reply. (2022) (0)
Hamm and Braunwald Classification of Unstable Angina (2000) (0)
Early intervention and abciximab — preserving myocardium : proceedings of an international symposium held in Paris, France, 23-26 May 2000 (2001) (0)
An unusual case of pleural nodularity (2018) (0)
Evolution of academic divisions of cardiology. (1997) (0)
Heart failure: a 70 year Odyssey†. (2022) (0)
Prehospital thrombolytic therapy for ST-elevation myocardial infarction: Reply (2003) (0)
Correction (1997) (0)
Abstract 16185: Biomarker-based Heart Failure Risk Stratification in Patients With Atherosclerotic Cardiovascular Disease: Observations From HPS-3/TIMI-55-REVEAL (2020) (0)
Mitochondrial cardiomyopathy: a fertile field for research. (2023) (0)
Early Dynamic Risk Stratification with Baseline Troponin Levels and 90-minute ST Segment Resolution to Predict 30 Day Cardiovascular Mortality in STEMI: Analysis from CLARITY TIMI-28 (2010) (0)
Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y 12 Antagonist, With Clopidogrel in Percutaneous Coronary Intervention Results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)–TIMI 26 Trial Coronary Heart Disease (2005) (0)
The Sympathetic Nervous System in Heart Failure (1970) (0)
Gut reaction: the case against IL-23 (2006) (0)
Bound for the brain (2006) (0)
Robert P. Grant, M.D., 1915-1966. (1966) (0)
WIRKUNG VON CAPTOPRIL AUF MORTALITAT UND MORBIDITAT BEI PATIENTEN MIT LINKSVENTRIKULARER DYSFUNKTION NACH MYOKARDINFARKT. ERGEBNISSE DER 'SURVIVAL-AND-VENTRICULAR-ENLARGEMENT'-STUDIE (1992) (0)
P h a rmacokinetics of a Slower Clearing Tissue Plasminogen Activator Variant , TNK-tPA , in Patients with Acute Myocard i a l (2018) (0)
High-dose statins in acute coronary syndromes. Authors' replies (2005) (0)
P4808Edoxaban and implantable cardiac device interventions - Insights from the ENGAGE AF-TIMI 48 trial (2018) (0)
Quantitative histopathologic comparisons of patients with and without thrombolytic therapy for first acute myocardial infarction (1990) (0)
NEUTROPHIL-LYMPHOCYTE RATIO AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION: ANALYSES FROM ENGAGE AF-TIMI 48 TRIAL (2022) (0)
Short interfering RNA: a rapidly developing drug class. (2022) (0)
Meeting Report ESC Forum on Drug Eluting Stents European Heart House, Nice, 27 – 28 2007 (2009) (0)
Heart Failure and Other Outcomes in Patients with Atrial Fibrillation by Heart Failure Phenotype (2022) (0)
INFLAMMATORY AND CARDIAC BIOMARKERS ARE ASSOCIATED WITH RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: INSIGHTS FROM SAVOR-TIMI 53 (2018) (0)
ASSESSMENT OF ATHEROTHROMBOTIC RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (2022) (0)
EDOXABAN 30 MG VS WARFARIN IN 2,406 PATIENTS AGE ≥80 YEARS: A RANDOMIZED ANALYSIS FROM ENGAGE AF-TIMI 48 (2023) (0)
Gross Left Atrial Enlargement without Pressure Elevation in Severe Mitral Regurgitation. (1962) (0)
Electrocardiographic left ventricular hypertrophy is associated with mortality and left ventricular rupture in patients with acute myocardial infarction (2002) (0)
Comprar Atlas of Cardiovascular Magnetic Resonance Imaging | Braunwald, Eugene | 9781573402996 | Springer (2008) (0)
Ventricular Arrhythmias in€Patients With a Continuous-Flow Left Ventricular Assist Device (0)
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in heart failure and high risk myocardial infarction (2003) (0)
Reply (2022) (0)
The simultaneous recording of blood pressures in the left heart and aorta before and after mitral surgery. (1955) (0)
1021-101 Association of glomerular filtration rate on presentation with subsequent mortality in non-ST elevation acute coronary syndromes (2004) (0)
Structure and function of the normal myocardiumt (0)
Intracoronary Thallium-20l Scintigraphy After Thrombolytic Therapy for Acute Myocardial Infarction Compared With lO and lOO Day Intravenous Thallium-20l Scintigraphy (2010) (0)
Eleventh Annual Becton, Dickinson and Company Oscar Schwidetzky Memorial Lecture. (1971) (0)
Detection of pulmonic and tricuspid valvular regurgitation with an indicator-dilution technic☆ (1959) (0)
Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes Clinical Investigation and Reports (2003) (0)
Acute Myocardial Infarction in a Pregnant Woman at Term (2016) (0)
Heparin and Aspirin for Acute Myocardial Infarction (2016) (0)
Abstract 19878: Metalloproteinase PAPP-A and Outcomes in Patients with ACS: Observations from the MERLIN-TIMI 36 Trial (2010) (0)
SERIAL ASSESSMENT OF BIOMARKERS AND THE RISK OF HEART FAILURE IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ENGAGE AF-TIMI 48 TRIAL (2022) (0)
Abstract 18549: High-sensitivity Troponin I in Stable Patients With Atherosclerotic Disease in the TRA2°P- TIMI 50 Trial (2015) (0)
17th Bethesda conference: Adult cardiology training. Task Force VIII: Training in cardiovascular research. (1986) (0)
Short interfering RNA: a rapidly developing drug class. (2022) (0)
In This Issue. (2017) (0)
Francis Collins: manning the helm with optimism. (2010) (0)
Profiles in Cardiovascular Science Margaret Buckingham: Studying the Choreography of Cardiogenesis (2012) (0)
In Focus (2020) (0)
François Abboud: Relishing the Academic Environment (2013) (0)
Restenosis : Is the cure finally here ? (0)
CONGESTIVE HEART FAILLURE Elfects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure (0)
In this issue (1999) (0)
In This Issue (2011) (0)
Circulation Research "In This Issue" Anthology. (2016) (0)
Abstract 12777: More Bleeding but No Additional Efficacy with Increasing Age in High-risk ACS Patients Treated with Early vs. Delayed, Provisional Eptifibatide (2010) (0)
Raising more than just hope for cancer treatment (2006) (0)
iPS genomes investigated. (2011) (0)
Activating autoimmunity (2007) (0)
In This Issue. (2018) (0)
Beating Leishmania's iron armor (2006) (0)
Heart attack or cancer? (2006) (0)
In This Issue. (2017) (0)
The secret autoreactivity of B cells (2007) (0)
IRF3 balances killing and cleaning (2006) (0)
Pravastatin reduces mortality: The Prospective Pravastatin Pooling Project (2000) (0)
Myocardial-Infarction in the Elderly (1986) (0)
Ali J. Marian: life and science are one. (2014) (0)
In this issue (2012) (0)
Me, myself, and eye (2006) (0)
Hunting for histamine's source (2006) (0)
Jeffrey Robbins: does not do discouragement. (2010) (0)
The significance of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis (1966) (0)
Induced pluripotent stem cells and the promise of proliferation. (2009) (0)
Thomas W. Smith, MD (1997) (0)
ES cells mend broken hearts (2006) (0)
Cell replacement therapy—are MAPCs the answer? (2007) (0)
In This Issue. (2017) (0)
In This Issue. (2018) (0)
Reducing cell–cell stickiness with JAM-C (2006) (0)
Michael Potente: No Time to Waste. (2017) (0)
POLYVASCULAR DISEASE, DIABETES MELLITUS AND LONG-TERM VASCULAR RISK: INSIGHTS FROM THE IMPROVE-IT TIMI 40 TRIAL (2016) (0)
Management of cardiac arrhythmias (2001) (0)
Curtailing infection (2006) (0)
Investigating the role of SLC24A5 in Xenopus laevis pigmentation development (2011) (0)
Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control (2022) (0)
Abstract 18205: Rivaroxaban and Improved Modified Rankin Scale Score Among Patients With Acute Coronary Syndrome who Experience Stroke - Insights From the ATLAS ACS-2-TIMI-51 Clinical Trial (2016) (0)
In This Issue. (2016) (0)
Is war necessary (for transplant success)? (2006) (0)
Circulation Research "In This Issue" Anthology. (2019) (0)
Why lymph nodes grow (2006) (0)
Clinical Tria Randomized Trial to Evaluate the elative Protection Against Post-Percutaneous oronary Intervention Microvascular ysfunction , Ischemia , and Inflammation mong Antiplatelet and Antithrombotic Agents he PROTECT – TIMI-30 Trial (2006) (0)
FSAP reduces risk of repair (2006) (0)
In This Issue. (2017) (0)
Development and Ex-vivo Evaluation of a Novel Device to Facilitate and Standardize Intravitreal Injections in Rabbits (2018) (0)
The Effects of Catecholamines on the Mechanics and Energetics of the Heart (1967) (0)
Doris Taylor: All Heart. (2018) (0)
In This Issue. (2018) (0)
Comprar Harrison's Cardiovascular Medicine | Eugene Braunwald | 9780071702911 | Mcgraw-Hill Education (2010) (0)
In This Issue. (2020) (0)
PROGNOSTIC VALUE OF BIOMARKER OF COLLAGEN TURNOVER (C-TERMINAL TELOPEPTIDE) IN PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROMES: INSIGHTS FROM MERLIN-TIMI 36 (2018) (0)
Secretomotor substances in the rat lacrimal gland : immunocytochemical functional and ligand binding studies. (1994) (0)
Marit Westerterp: Communication Is Key. (2017) (0)
Rajat Gupta: A Scientist in Doctor's Clothing. (2018) (0)
In this issue (2010) (0)
Percutaneous coronary intervention during the index hospitalization is associated with reduced recurrent myocardial infarction and improved survival following thrombolytic administration (2003) (0)
In this issue (2018) (0)
José Jalife: Perseverance Pays Off. (2018) (0)
In this issue (2020) (0)
Scot Matkovich: Keep on Keeping on. (2018) (0)
Circulation Research "In This Issue" Anthology. (2020) (0)
Stay Away From Self: 5th International Congress on Autoimmunity, Sorrento, Italy, November 29–December 3, 2006 (2007) (0)
Escape from fatal fusion (2006) (0)
THE EFFECTS OF AUTONOMIC NERVOUS SYSTEMINHIBITION ON THE CIRCULATORYRESPONSETO MUSCULAR EXERCISE * By (0)
Age and Routine Invasive Management of Acute Coronary Syndromes (2004) (0)
SEX AND PERMANENT DRUG DISCONTINUATION IN CLINICAL TRIALS: INSIGHTS FROM THE TIMI TRIALS (2020) (0)
Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48 (2020) (0)
Abstract 3480: Neopterin Levels Improve Risk Prediction for Heart Failure Hospitalization Over and Above C-reactive Protein and B-type Natriuretic Peptide in the PROVE IT-TIMI 22 Study (2009) (0)
In This Issue. (2017) (0)
High-dose statins in acute coronary syndromes [1] (multiple letters) (2005) (0)
The diagnosis of congenital cardiac defects using a fiberoptic catheter-pressure-cinefilm system☆ (1968) (0)
Reduced Arterial Dilator Capacity : A Characteristic Abnormality of the Peripheral Vascular Bed in Human Congestive Heart Failure. (1967) (0)
New Drugs and Technologies Prasugrel (2010) (0)
884-4 Higher levels of thrombus precursor protein are associated with increased death and ischemic complications in patients with acute coronary syndromes (2004) (0)
Response by Bohula et al to Letters Regarding Article, "Prevention of Stroke With the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)". (2018) (0)
Abstract 3295: Enoxaparin is Superior to Unfractionated Heparin in Patients with STEMI Undergoing Fibrinolysis Regardless of the Choice of Lytic-type: ExTRACT-TIMI 25 Analysis (2006) (0)
Reversal of aminophylline's coronary vasoconstrictor action in conscious dogs with acute myocardial ischemia (1978) (0)
Comprar Biomarkers in Heart Failure, An Issue of Heart Failure Clinics | Eugene Braunwald | 9781437714463 | Saunders (2009) (0)
CHOLESTEROL LOWERING IN OLDER PATIENTS. AUTHORS' REPLY (1999) (0)
Issues of protocol modification after initiation of a large multi-center trial (1998) (0)
Profiles in Cardiovascular Science (2010) (0)
EDOXABAN VERSUS WARFARIN IN ATRIAL FIBRILLATION ABLATION: FIRST EXPERIENCE FROM THE ENGAGE AF TIMI 48 TRIAL (2017) (0)
Abstract 2874: Sudden Cardiac Death in Patients with Stable Coronary Disease and Preserved Left Ventricular Systolic Function (2007) (0)
A Noninvasive Method for the Detection of Dual Atrioventricular Node Physiology in Chronic Atrial Fibrillation (1999) (0)
In this issue (2017) (0)
An analysis of the determinants of ventricular dimensions and force-velocity relations in man. (1970) (0)
Acute Cardiac Unloading and Recovery Proceedings of the first annual Acute Cardiac Unloading and REcovery ( A-CURE ) (2017) (0)
Abstract 14419: Natural History of Atherothrombotic Events According to the Primary Diseased Vascular Bed - Insights from the TRA2P-TIMI 50 Trial (2012) (0)
In This Issue. (2018) (0)
Microcirculatory changes during acute myocardial ischemic injury (1977) (0)
Use of angiotensin antagonists (AT1) for the reduction of morbidity and death risk after myocardial infarction (1993) (0)
Harrison's Cardiovascular Medicine (2010) (0)
Higher Weight Adjusted Doses of TNK are Associated with Improved Non-Culprit, Global and Post PTCA Flow in Addition to Improved Culprit Flow (1998) (0)
Response to Letter Regarding Article, "Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel: Thrombolysis in Myocardial Infarc (2009) (0)
1060-83 Calcification of the culprit lesion is associated with adverse clinical outcomes in ST elevation myocardial infarction patients treated with fibrinolytic therapy (2004) (0)
The effects of a selective β1 adrenoreceptor agonist on left ventricular dynamics in the conscious dog (1980) (0)
Abstract 3298: Effect of Enoxaparin vs Unfractionated Heparin in Diabetic Patients with ST-Elevation MI in the ExTRACT-TIMI 25 Trial (2006) (0)
Prognosis of patients without myocardial necrosis after thrombolytic therapy: A TIMI II data bank study (1991) (0)
Pharmacology (Heart and Vascular System) (1965) (0)
Symposium on experimental and clinical aspects of coronary vasoconstriction, Miami FL, November 10, 1984 (1985) (0)
Acute coronary syndromes: BNP measurement predicts AMI risk in the elderly (2009) (0)
Circulation Research. (2016) (0)
Title Page / Contents / Preface (1982) (0)
Abstract 16993: Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation Without Heart Failure in the ENGAGE AF-TIMI 48 Trial (2016) (0)
Comprar Harrison’s Neurology in Clinical Medicine | Eugene Braunwald | 9780071741033 | Mcgraw-Hill Education (2010) (0)
Characterization of Contraction and Perfusion in the Lateral Border Zone Between Normal and Ischemic Myocardium Following Coronary Occlusion by Myocardial Contrast Echocardiography (2001) (0)
From Heart Failure to Cardiomyopathy (2017) (0)
Robert P. Grant, M.D. 1915-1966. (1966) (0)
DECONGESTION STRATEGIES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM ACTIVATION IN ACUTE HEART FAILURE (2014) (0)
Acute Myocardial Infarction ssociation of a Pulsatile Blood Flow Pattern n Coronary Arteriography and Short-Term linical Outcomes in Acute Myocardial Infarction (2016) (0)
The Incidence and Management of " Medical " Complications Foilowing Cardiac Operations (2005) (0)
enoxaparin in unstable angina: a TIMI-11B substudy Cardiac troponin I for stratification of early outcomes and the efficacy of (2009) (0)
Get Syk and get cycling (2006) (0)
4331Safety and efficacy of sacubitril/valsartan by dose level in patients hospitalized with acute heart failure: Observations from PIONEER-HF (2019) (0)
myocardial infarction Right ventricular dysfunction and risk of heart failure and mortality after (2011) (0)
Harrison's Principles of Internal Medicine: Pretest Self-Assessment and Review (1998) (0)
1060-101 Angiographically apparent thrombus after fibrinolytic administration is associated with impaired epicardial flow and myocardial perfusion in ST elevation myocardial infarction patients with open arteries (2004) (0)
P Acute Myocardial Infarction rognostic Implications of Elevated Troponin n Patients With Suspected Acute Coronary yndrome But No Critical Epicardial Coronary Disease TACTICS-TIMI-18 Substudy (2016) (0)
HEMODYNAMICS OF NITROPRUSSIDE / Pagani , Vatner , Braunwald implanted around the left circumflex coronary artery . A miniature pressure transducer * was implanted through a stab wound in the LV (0)
Discussion-session I (1981) (0)
SUDDEN CARDIAC DEATH IN 21,105 PATIENTS WITH ATRIAL FIBRILLATION: INSIGHTS FROM THE ENGAGE AF- TIMI 48 TRIAL (2016) (0)
Abstract 15737: The Association Between Congestion and Outcomes for Patients Treated With Sacubitril-Valsartan Compared to Enalapril in the PIONEER-HF Trial (2019) (0)
CLASSIC PAPERS REVISITED (2007) (0)

This paper list is powered by the following services:

Other Resources About Eugene Braunwald